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ABSTRACT 
The Role of Acyl-CoA Oxidase in Peroxisome Division and Longevity in Yeast 
Christopher Gregg, Ph.D. 
Concordia University 2009 
Acyl-CoA oxidase (Aox) is an enzyme that carries out the first step of P-
oxidation of free fatty acids in peroxisomes. Here I describe a novel role for Aox in 
peroxisome biogenesis. I found that the peroxisome becomes competent for division only 
after it acquires the complete set of matrix proteins involved in lipid metabolism. 
Overloading the peroxisome with matrix proteins promotes the relocation of Aox from 
the matrix to the membrane. The binding of Aox to Pexl6p, a membrane-associated 
peroxin required for peroxisome biogenesis, initiates the biosynthesis of phosphatidic 
acid and diacylglycerol (DAG) in the membrane. The formation of these two lipids and 
the subsequent transbilayer movement of DAG initiate the assembly of a complex 
between the peroxins PexlOp and Pexl9p, the dynamin-like GTPase Vpslp, and several 
actin cytoskeletal proteins on the peroxisomal surface. This protein team promotes 
membrane fission, thereby executing the terminal step of peroxisome division. 
One of my objectives was to understand what role (if any) Aox and other 
peroxisomal enzymes of fatty acid oxidation may play in regulating yeast longevity. I 
found that Aox is an essential component of the protein network controlling the 
chronological lifespan of yeast placed on a low-calorie diet called calorie restriction 
(CR). My findings lead to the conlusion that fatty acid oxidation in peroxisomes controls 
iii 
longevity by modulating the rate of ATP synthesis in mitochondria, but not by generating 
the ROS hydrogen peroxide. 
Recent studies in Dr. Titorenko's laboratory identified novel small molecules that 
greatly increase the chronological lifespan of yeast. My experiments with one of these 
novel anti-aging drugs, a commercially available compound further referred to as "LA", 
revealed that it extends yeast longevity under CR conditions. My studies aimed at 
elucidating the molecular mechanisms by which LA increases yeast lifespan revealed that 
lack of Aox or any other enzyme of peroxisomal fatty acid oxidation does not impair the 
anti-aging effect of LA. My findings demonstrated that LA extends yeast longevity by: 
(1) reducing the damaging effect of ROS on cellular macromolecules; and (2) amplifying 
the so-called "hormetic" effect of ROS through the activation of stress-protecting and 
other anti-aging proteins. 
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1.1 Peroxisome function and pathology 
Most eukaryotic cells possess organelles called peroxisomes [1-3]. Delimited by a 
single lipid bilayer, peroxisomes contain a fine granular matrix and occasionally a 
paracrystalline core [3]. These organelles contain at least one hydrogen peroxide-
producing oxidase and a catalase that decomposes the hydrogen peroxide produced 
during oxidation of fatty acids, purines and amino acids [1]. Peroxisomes do not have 
their own DNA and lack independent transcription and protein synthesis machineries [1-
3]. Therefore all peroxisomal proteins are encoded by nuclear genes [1-3]. The majority 
of these proteins are synthesized on free polysomes in the cytosol [1-3], though two 
peroxisomal membrane proteins (PMPs) are produced on ribosomes found on the rough 
endoplasmic reticulum (ER) [4, 5]. 
Peroxisomes are typically responsible for the degradation and biosynthesis of 
lipids [6-8]. The degradation of prostaglandin and polyamines can also occur within the 
peroxisomes, while purines and amino acids are often catabolized by a- and P-oxidation 
[9, 10]. Biosynthetic metabolic pathways that result in the formation of ether 
phospholipids (plasmalogens), cholesterol, bile acids and polyunsaturated fatty acids are 
also housed in the peroxisome [10, 11]. 
The so-called peroxisomal disorders are often lethal, as they result in global 
developmental delay and cause progressive neurological deficits [12-21]. The failure of 
peroxisomes to assemble into functionally intact organelles results in peroxisome 
biogenesis disorders that affect many peroxisomal metabolic pathways [12-16]. The 
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failure of peroxisomes to assemble correctly is caused by autosomal recessive mutations 
in any of twelve PEX genes encoding proteins called peroxins [17, 18]. Interest in 
peroxisome biogenesis disorders greatly stimulated studies aimed at understanding of the 
molecular mechanisms that govern peroxisome assembly, maintenance and inheritance 
[6,7,15,23]. 
Peroxisomes also serve as an intracellular signaling compartment and organizing 
platform that orchestrate developmental decisions from inside of the cell [23-38]. A 
greater understanding of how peroxisomes fit into the process of development, 
differentiation and morphogenesis has been gained in recent years [38]. Such research 
provides insight into the mechanisms underlying the severe neurological dysfunction and 
developmental delay characteristic of peroxisome biogenesis disorders [30, 38]. 
1.2 A revision of the peroxisome biogenesis paradigm: The peroxisomal 
endomembrane system 
Because peroxisomes function outside of the secretory and endocytic pathways of 
dynamic vesicular flow [39] it was believed that they were autonomous, static and 
homogenous organellar compartments [40]. This view on peroxisome biogenesis did not 
include intercompartmental vesicular trafficking or membrane fusion [41]. Until recently, 
the "growth and division" model for peroxisome biogenesis was a generally accepted 
paradigm of the assembly and maintenance of this organelle. In this model, all 
peroxisomes have the same function and structure and their progressive growth is due 
solely to the posttranslational import of peroxisomal membrane and matrix proteins 
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(Figure 1.1). The "growth and division" model for peroxisome biogenesis envisioned that 
new peroxisomes are formed only due to division of the pre-existing peroxisomes and 
that the endoplasmic reticulum (ER) serves only as a source of lipids for the growing 
peroxisomes. 
I Membrane proteins 
Matrix proteins I 
• 0 Lipids 
Figure 1.1. The "growth and division" model for peroxisome biogenesis postulated that all peroxisomal 
matrix and membrane proteins are posttranslationally imported into identical peroxisomes. According to 
this model, peroxisomes then undergo division to form new ones. This model considered ER only as a 
source of lipids for the growing peroxisomes. 
In the current model for peroxisome biogenesis, the ER is used as an 
endomembrane template for the formation of vesicles that contain a distinct set of 
proteins. In the yeast Yarrowia lipolytica, the formation of peroxisomes begins with the 
movement of group I peroxisomal membrane proteins (PMPs) such as Pex2p and Pexl6p 
to the ER (Figure 1.2) [23,42,43]. This process is followed by the TV-linked 
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glycosylation of the PMPs and their subsequent movement to a distinct subdomain of the 
ER, which becomes the pre-peroxisomal template (PPT) [7, 30]. The PPT then buds from 
the ER to form two different kinds of vesicles, PPV1 and PPV2, each containing Pex2p 
and Pexl6p (Figure 1.2) [7, 30, 43]. These vesicles are distinct from secretory vesicles 
(SV) derived from other specialized domains of the ER. These SV bud from the ER to 
initiate the export of their cargo proteins via the Golgi apparatus to the external medium 
of a cell, to the cell's plasma membrane and to the cell wall [23, 43, 44]. 
PPV1 and PPV2 undergo post-translation sorting of two partially overlapping sets 
of group II PMPs. This process results in the formation of peroxisomal precursors called 
PI and P2, the most immature peroxisomal vesicles (Figure 1.2) [7, 30, 45]. These 
vesicles contain a limited amount of matrix proteins but almost a complete set of PMPs 
[7, 30, 45]. They undergo fusion to form P3 which has a greater density than its 
precursors [7, 30, 45, 46]. The maturation of P3 is a stepwise process, involving the 
selective import of lipids and matrix proteins. This leads to the formation of P4, P5 and 
finally the mature P6 peroxisome, the largest and most dense peroxisomal subform, 
which contains a complete set of matrix and membrane proteins (Figure 1.2) [7, 30, 45, 
46]. 
Selective import of matrix proteins is dependent on how intermediates in the 
peroxisomal assembly pathway differ in their competency to import specific matrix 
proteins. Only PI and P2 are competent for the import of matrix enzyme malate synthase 
(MLS), but they lose this competency as they mature such that P3 to P6 cannot import the 
enzyme. P3 peroxisomes are the only subform able to import a 62-kD protein reactive 
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to the type 1 peroxisomal targeting signal (62-kD SKL). P4 peroxisomes selectively 
import isocitrate lyase (ICL), another matrix protein. This could imply that peroxisomal 
import machinery is assembled in a temporally ordered manner in distinct intermediates 





Figure 1.2. A model for the multistep peroxisome assembly pathway acting in the yeast Y. lipolytica. 
In Y. lipolytica, peroxisomes do not grow and divide at the same time [45, 51]. 
The maturation process - which involves the import of matrix proteins and lipids - leads 
to the maturation of peroxisomes, and only fully mature peroxisomes, P6, are able to 
divide (Figure 1.3). In immature peroxisomes membrane scission is inhibited by Pexl6p, 
a membrane associated peroxin. The negative action of this protein is abolished in 
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Figure 1.3. Pex 16p/Aox-dependent mechanism of peroxisome division. 
the import of matrix proteins leads to an increase in the density of proteins inside of the 
peroxisome. In P6 peroxisomes the matrix protein Aox is no longer only located in the 
matrix of the peroxisomes but is evenly distributed between the matrix and the membrane 
(Figure 1.3) [45, 51]. The membrane-bound Aox interacts with Pex 16, thereby 
terminating its negative effect on membrane scission and allowing the division of the 
mature peroxisome (Figure 1.3) [45, 51]. The temporal and spatial regulation of Aox and 
Pexl6p interaction separates the processes of peroxisome maturation and division, 
ensuring that only mature, metabolically active peroxisomes undergo division. The 
multistep pathway of peroxisome assembly described in Y. lipolytica has also been 
observed in human fibroblasts and the yeast Pichiapastoris [15, 120, 124]. 
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1.3 Coordination of compartment assembly and division in the peroxisomal 
endomembrane system 
Division and assembly of the peroxisomal endomembrane system are governed by 
a distinct set of proteins. Two proteins, ADP-ribosylation factor 1 (ARF1) and the coat 
protein complex type I (COPI), both known for their role in the peroxisome-to-ER 
retrograde protein transport in virus-infected cells, have also been shown to induce the 
proliferation of the peroxisomal endomembrane system [52-56]. These proteins have 
been demonstrated to promote the membrane scission event required for peroxisome 
division in evolutionarily diverse organisms. Yeast and mammalian cells deficient in 
ARF1 and COPI accumulate elongated tubular peroxisomes, suggesting that both 
proteins drive peroxisome division [52, 53]. Furthermore, the incubation of highly 
purified rat liver peroxisomes with cytosol resulted in the recruitment of ARF1 and COPI 
to the peroxisomal membrane [57]. This observation supports the notion that ARF1 and 
COPI must bind to peroxisomes for the proliferation of the peroxisomal endomembrane 
system to be initiated. Moreover, the type 3 of yeast ARF1 has been found to negatively 
control peroxisome division in vivo [53]. Taken together, these findings imply that the 
peroxisomal endomembrane system uses the same set of core proteins as the classical 
secretory system of vesicular flow in order to communicate with the ER for purposes of 
proliferation. Some peroxisome-specific proteins are also implicated in this process, 
including a distinct set of PMPs as well as dynamin-related protein DLP1/DRP3A/Vpslp, 
which is recruited from the cytosol to the peroxisome surface using the Fisl preceptor 
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[58, 59]. How these proteins interact under different metabolic conditions in a given cell 
or tissue type has yet to be established. 
Two pathways seemed to be involved in the assembly and division of 
peroxisomes in the peroxisomal endomembrane system. One pathway involves the ER-
dependent formation of individual compartments within the peroxisomal endomembrane 
system and is coordinated with the second pathway, which controls the division of 
peroxisomal compartments [45, 51]. One strategy for the coordination of compartment 
assembly and division is that a few peroxisomal vesicles derived from the ER undergo 
stepwise maturation and then divide [45, 51]. A second strategy involves the rapid 
formation of many vesicles from the ER or the proliferation of a few pre-existing ER-
derived carriers [45, 51] followed by their maturation into folly functional peroxisomes 
by the import of membrane and matrix proteins. 
Regardless of the strategy(s) that evolutionarily distant organisms employ for 
coordinating the assembly and division of individual compartments of the peroxisomal 
endomembrane system, the tubulation, constriction and scission of these compartments is 
regulated, depending on cellular and/or environmental conditions of a particular cell type, 
either by signals emanating from within these compartments [45] or by extraperoxisomal 
signals that are generated inside the cell in response to certain extracellular stimuli [59]. 
A distinct group of transcriptional factors induce the transcription of genes encoding 
proteins of the Pexllp family [58]. Pexllp-type proteins play a role in peroxisome 
division either directly, by activating peroxisome division, or indirectly, by recruiting 
dynamin-related proteins from the cytosol [59]. Before peroxisome division occurs, it is 
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necessary for each peroxisome's membrane to undergo expansion of their membranes by 
acquiring lipids. The most likely source of these lipids is the ER, which is a principle site 
for the biosynthesis of phospholipids [61]. It has been suggested that oil bodies are a 
source of lipids for the peroxisomes in oilseeds [62] and in Y. lipolytica [63]. The transfer 
of phospholipids in Y. lipolytica has been observed to take place between a 
subcompartment of the ER and acceptor membranes of the P3 and P4 peroxisomal 
intermediates [64]. Although several working models have been proposed for ER-
associated lipid-transfer proteins [65], the mechanism underlying the transfer of lipids 
from the ER to the peroxisomal membrane is yet to be established. 
1.4 Yeast as a valuable model system for unveiling the molecular and cellular 
mechanisms of aging 
Biological aging can be defined as the progressive decline in the ability of an 
organism to resist stress, damage and disease [66]. It is characterized by the appearance 
of degenerative and neoplastic disorders [67-69]. At the demographic level, aging 
manifests itself as an exponential increase in the mortality rate with the age of the cohort 
[66]. 
The yeast Saccharomyces cerevisiae has proven to be a valuable model in aging 
research [70] and the mechanics of aging seem to be conserved from yeast to humans 
[71]. In the lab one can monitor the chronological aging of yeast cells or the replicative 
aging of yeast cells. Replicative aging is defined as the number of times a mother cell is 
able to bud (Figure 1.4) [71]. Replicative aging has proven to be a good model for 
studying how "mitotic" cells in higher eukaryotes age and divide [72]. 
9 
Figure 1.4. The replicative lifespan of yeast is defined as the maximum number of buds (i.e., daughter 
cells) that a mother cell can produce before senescence. It mimics aging of dividing or "mitotic" human 
cells. 
Chronological aging is the amount of time a population of yeast cells remain viable in a 
non-dividing state (Figure 1.5) [71, 72]. A simple assay can be done to measure the 
amount of viable cells versus the amount of total cells in a yeast culture in stationary 
phase for a range of time-points. The curves obtained from such an analysis represent the 
chorological lifespan of a yeast cells and is a good model for the majority of cells in 
higher eukaryotes {i.e., "post-mitotic" cells which are no longer dividing) [71, 72]. 
1.5 Effect of genetic manipulations and dietary regimens on lifespan 
The lifespan of yeast can be extended by certain genetic manipulations. Sir2p, an 
NAD+ histone deacetylase, was the first protein extensively studied in the regulation of 
replicative aging of S. cerevisiae [71, 73, 74]. Mutations in the gene encoding Sir2p result 
in the silencing of extrachromosomal rDNA circles, which shortens the replicative 
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lifespan of yeast cells. Conversely, overproduction of Sir2p protein leads to an extension 
of lifespan that is dependant on stress response transcription factors and effectors such as 
Msn2p/Msn4p and superoxide dismutase [71 - 73]. Sirtl is the mammalian homologue of 
Sir2p and has been shown to extend lifespan in mice by the deacetylation and regulation 
of various proteins such as the tumor suppressor p53 [75 - 77]. Various components of 
Chronological life span •»*K 
Measure the total number of 
cells per ml of the culture 
Calculate % of alive cells 
Plate aliquots of appropriate 
dilutions of the culture 
After 2 days, count the number of 
alive cells per ml of the culture 
Figure 1.5. The chorological lifespan is defined as the length of time a yeast cell remains viable in a 
nondividing state. It mimics aging of nondividing or "post-mitotic" human cells. 
the insulin/IGF-1 glucose signalling pathway have also been implicated in the 
regulation of both replicative and chronological aging in S. cerevisiae [71, 73, 74]. 
Mutations in the genes RAS2, CYR1, PKA1 and SCH9 lengthen both types of lifespan 
while mutations in the genes encoding either Msn2p or Msn4p stress-resistance 
transcriptional factors nullify this lifespan extension (Figure 1.6) [75, 77, 78]. Similar 
phenotypes have been found in three other model organisms (i.e. mice, the nematode 
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Figure 1.6. Longevity pathways are conserved across phyla and governed by an evolutionarily conserved 
nutrient-sensing signal transduction network. 
the insulin/IGF-1 pathway enhances lifespan of these higher eukaryotic organisms in a 
stress response-dependent fashion [75, 77, 78]. Taken together, these findings strongly 
suggest that longevity pathways are conserved across phyla and governed by an 
evolutionarily conserved nutrient-sensing signal transduction network (Figure 1.6) [75, 
77, 78]. 
Many mutations that extend lifespan have major side effects, including 
irreversible developmental or reproductive defects [79, 80]. One intervention that extends 
lifespan without such costs is the imposition of a calorie restriction (CR) diet. CR diet is 
defined as a dietary regimen that is low in calories but does not undernourish the 
organism [79,80]. CR has been shown to extend lifespan in a wide range of 
12 
evolutionarily distant organisms including yeast, rotifers, spiders, worms, fish, mice, rats 
and nonhuman primates [79 - 82]. Lifespan extension is observed when animals are fed 
25%-60% of the carbohydrates, fats or proteins that are given to control animals fed ad 
libitum [79, 80]. CR has also been found to delay the onset of age related diseases such as 
cancer, atherosclerosis, type II diabetes and neurodegeneration [83]. In fact, CR reduces 
age-associated neuronal loss in most mouse models of neurodegenerative disorders such 
as Parkinson's disease [64] or Alzheimer's disease [85]. The CR dietary regimen also 
prevents age-associated declines in psychomotor and spatial memory tasks [86], loss of 
dendritic spines necessary for learning [87] and improves the brain's plasticity and ability 
for self-repair [88]. 
In yeast, CR is imposed by reducing the glucose concentration in the complete 
YEPD medium from 2% to 0.5% [89] or to 0.2% (this study). This rich medium allows 
cells to continue to feed on yeast extract and peptone which provide an abundance of 
amino acids, nucleotides and vitamins, even as glucose levels are rapidly depleted. This 
reduction in the level of glucose from 2% to 0.5% or to 0.2% could impose a state of 
partial energy (ATP) limitation. Other dietary restriction protocols, which limit amino 
acids and other nutrients [90, 91], drastically slow the growth rate and make it more 
difficult to impose energy limitation. 
1.6 Reactive oxygen species (ROS) and aging 
It has been known for many years that CR extends lifespan but only recently have 
the mechanisms governing its anti-aging effect emerged. The answer to how CR extends 
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lifespan has proven to be quite complex as there are many observed consequences to such 
a diet, including specific changes in metabolism, neuroendocrine signaling and apoptotic 
cell death machinery. These effects often have striking differences depending on the 
tissue type that they are observed in [73, 77]. The "free radical theory" of aging, a 
generally accepted theory of aging, is that cumulative oxidative damage of various 
cellular constituents inflicted by the progressive generation of reactive oxygen species 
(ROS) causes organisms to function less effectively over time and results in age-
associated degenerative disorders [92]. The age-related irreversible oxidative damage can 
be observed in DNA, RNA, protein and lipids. Importantly, the extent of such oxidative 
damage correlates with the age of an organism [93 - 96]. Thus, it seems very likely that 
oxidative damage does limit lifespan. In fact, the enzyme superoxide dismutase (SOD), 
which is responsible for reducing ROS in cells, has been found to extend lifespan when 
over-expressed in Drosophila [97] and in stationary phase yeast cells [98]. 
Though ROS are generated in multiple compartments in the cell and by multiple 
enzymes within the cell, most ROS produced in a cell (up to 90%) are made in the 
mitochondrion (Figure 1.7) [99 - 102]. ROS are also generated by a family of NADP/H 
oxidases and by so-called phagocytic oxidases in the plasma membrane [99 - 102], in 
reactions catalyzed by cytosolic amino acid oxidases, cyclooxygenases, lipid oxigenases 
and xanthine oxidase [99 - 102], and during lipid metabolism in peroxisomes [7, 30]. The 
steady-state level of ROS within a cell is the result of a balance between the rate of its 
formation and decomposition due to anti-oxidant scavenger reactions that take place in 
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Figure 1.7. ROS are generated by numerous enzymes in multiple compartments within the cell, mostly (~ 
90%) within mitochondria. 
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Figure 1.8. Detoxification of ROS occurs in antioxidant scavenger reactions. 
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CuZnSOD (SOD1) subform of superoxide dismutase in the cytosol and the MnSOD 
(SOD2) subform of the same enzyme found in mitochondria (Figure 1.8). Both these 
enzymes are responsible for converting superoxide radicals to a less toxic and more 
stable ROS, hydrogen peroxide [99 - 102]. Hydrogen peroxide is then further detoxified 
by: 1) glutathione peroxidases in the cytosol, mitochondria and peroxisomes; 2) catalases 
in the cytosol, mitochondria and peroxisomes; and 3) peroxiredoxins in the cytosol, 
mitochondria and peroxisomes (Figure 1.8) [99 - 102]. 
Most of the known targets for the oxidative damage caused by ROS are 
mitochondrial proteins, DNA and lipids, including: 1) aconitase, a [4Fe-4S] cluster 
enzyme of the TCA cycle; 2) Lys4p, a [4Fe-4S] cluster enzyme of lysine biosynthesis 
that takes place in the mitochondrion; 3) succinate dehydrogenase (SDH), a [3Fe-3S] 
cluster- and heme-containing enzyme of the TCA that also functions as complex II of the 
electron transfer chain (ETC) in the mitochondrial membrane; 4) cytochrome c, a heme-
containing mobile component of the mitochondrial ETC; 5) cytochrome c oxidase, a 
Mitochondrial targets for ROS: 
• Aconitase (a [4Fe-4S] cluster enzyme) 
• Lys4p (a [4Fe-4S] cluster enzyme) 
• SDH (a [3Fe-3S] cluster- & heme-
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• Cytochrome c (a heme-containing mobile 
component of the ETC) 
• Cytochrome c oxidase (heme-containing 
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• mtDNA (is not protected by histones) 
• Saturated fatty acids of membrane lipids 
Intracellular targets: Proteins, Lipids, Nuclear DNA 
Figure 1.9. Major targets of oxidative damage by ROS in mitochondria. 
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heme-containing complex IV of the mitochondrial ETC; 6) the mitochondrial DNA 
(mtDNA) nucleoid that, in contrast to chromatin in the nucleus, lacks histones; and 7) 
saturated fatty acids of membrane lipids (Figure 1.9) [99 - 102]. 
Although high intracellular and intraorganellar levels of ROS can cause oxidative 
damage to various cellular constituents, low concentrations of intracellular ROS can 
activate cellular processes that protect cellular macromolecules from oxidative damage 
(Figure 1.10) [99 - 102]. Furthermore, such low concentrations of ROS activate a protein 
team that protects the cell from apoptosis [99 - 102], one of the forms of programmed cell 
death [39]. Extension of lifespan by the induction of a mild-stress response is called 
hormesis. These protective functions of the cell are initiated by ROS sensors present in 
the mitochondrion (i.e., protein kinases PKD1, PKC8, Src, Abl, PI3 kinase and Akt), 
plasma membrane {i.e., the Ras protein), and cytosol (i.e., the PNC1 protein) (Figure 
1.10) [99 - 102]. Some of these sensors interact with cytosol-to-nucleus and 
mitochondria-to-nucleus shuttling proteins (i.e., p32 and Hsp27p, respectively), thereby 
promoting their relocation to the nucleus. In the nucleus, these two shuttling proteins 
activate a distinct group of transcriptional factors and cofactors (i.e., SIRT1, FOX03, 
p53, NF-KB, DET1 and COP1), all of which function as global transcriptional activators 
of genes encoding oxidative stress-response and anti-apoptotic proteins [99 - 102]. 
Moreover, some of the ROS sensors in the cytosol and mitochondrion phosphorylate and 
inactivate the pro-apoptotic factors Bad and JNK, thereby delaying the intrinsic, 
mitochondria-dependent apoptotic pathway of programmed cell death (Figure 1.10) [99 -
102]. The intrinsic pathway of apoptosis also depends on the delicate balance between 
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Figure 1.10. Low concentrations of intracellular ROS activate cellular processes that protect cellular 
macromolecules from oxidative damage. 
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Figure 1.11. A delicate balance between mitochondrial fission and fusion controls the intrinsic pathway of 
apoptosis and, perhaps, aging. 
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mitochondrial fission and fusion [101, 104 - 106]. Mitochondrial fusion maintains a 
tubular mitochondrial network, thereby: 1) facilitating transfer of the mitochondrial 
membrane potential (i.e., energy) from CVrich to C>2-poor cellular regions; 2) 
complementing mtDNA mutations that accumulate with aging; and 3) hampering the 
intrinsic pathway of apoptosis (Figure 1.11) [101, 104 - 106]. On the other hand, 
mitochondrial fission breaks down the mitochondrial network, thereby: 1) ensuring 
inheritance of mitochondria by newly formed daughter cells; 2) causing respiratory 
defects; 3) leading to loss or mutation of mtDNA that remains uncomplemented; and 4) 
promoting the intrinsic pathway of apoptosis (Figure 1.11) [101, 104 - 106]. 
Apoptosis is known to be an essential part of human development and physiology 
[39]. Recent evidence suggests that mitochondria-dependent apoptosis, a pathway of 
programmed cell death, may play a role in the aging of evolutionarily distant organisms 
including many unicellular organisms [107]. Characteristic markers of apoptosis such as 
DNA cleavage, chromatin condensation, externalization of phosphatidylserine to the 
outer leaflet of the plasma membrane, and cytochrome c release from the mitochondria 
has recently been observed in yeast (Figure 1.12; data from Dr. Titorenko's laboratory) 
[108]. The apoptotic phenotype was observed in yeast cells with a mutation in the 
CDC48 gene [109]. ROS have been implicated as central regulators of yeast apoptosis, 
which leads to even more similarity towards apoptosis in metazoan organisms [110]. The 
identification of several yeast orthologues of mammalian apoptotic regulators has 
provided the final proof that yeast and metazoan apoptosis are two versions of the same 
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Figure 1.12. Hallmark events of apoptotic cell death in yeast. Data from Dr. Titorenko's laboratory. 
metacaspase Ycalp [109]; 2) an HtrA2/Omi-like protein, the yeast apoptotic serine 
protease Nmal 1 lp [111]; 3) the yeast apoptosis inducing factor Aiflp [112]; 4) the yeast 
histone chaperone Asflp [113]; and 5) the yeast mitochondrial fission protein Drplp 
[114] (Figure 1.13). The hallmark events of apoptosis have been observed in aging yeast 
cells [115], suggesting that apoptosis plays a role in regulating yeast longevity. Recent 
unpublished findings from Dr. Titorenko's laboratory provided evidence that the 
oxidation of free fatty acids in peroxisomes initiates a cascade of events that leads to an 
intrinsic, mitochondria-dependent apoptotic pathway of age-related programmed cell 
death. 
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Figure 1.13. The basic machinery of yeast apoptosis. 
In this thesis I will also look at the role of a novel anti-aging small molecule that 
was identified in Dr. Titorenko's laboratory. This molecule is called LA. I found that LA 
greatly increases the lifespan of yeast grown under CR conditions. My findings provide 
evidence that LA extends longevity in part by modulating ROS production in 
mitochondria. It seems that such LA-dependent specific modulation of ROS increases 
yeast lifespan not only by reducing the damaging effect of ROS on cellular 
macromolecules but also by amplifying the "hormetic" effect of ROS through the 
activation of stress-protecting and other anti-aging proteins. 
1.7 Thesis outline and contributions of colleagues 
Chapter 2 describes findings providing evidence for a novel role for Aox in 
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peroxisome biogenesis. I found that the peroxisome becomes competent for division only 
after it acquires the complete set of matrix proteins involved in lipid metabolism. 
Overloading the peroxisome with matrix proteins promotes the relocation of Aox from 
the matrix to the membrane. The binding of Aox to Pexl6p, a membrane-associated 
peroxin required for peroxisome biogenesis, initiates the biosynthesis of phosphatidic 
acid and diacylglycerol (DAG) in the membrane. The formation of these two lipids and 
the subsequent transbilayer movement of DAG initiate the assembly of a complex 
between the peroxins PexlOp and Pexl9p, the dynamin-like GTPase Vpslp, and several 
actin cytoskeletal proteins on the peroxisomal surface. This protein team promotes 
membrane fission, thereby executing the terminal step of peroxisome division. Chapter 3 
outlines evidence that Aox is an essential component of the protein network controlling 
the chronological lifespan of yeast placed on a CR diet. My analysis of the mechanism by 
which Aox and other peroxisomal enzymes of fatty acid oxidation regulate yeast 
longevity led to the conclusion that fatty acid oxidation in peroxisomes controls longevity 
by modulating the rate of ATP synthesis in mitochondria, but not by generating the ROS 
hydrogen peroxide. In particular, my findings provide evidence that the efficiency of 
acetyl-CoA formation via peroxisomal fatty acid oxidation modulates the efficiency of 
electron flow through the mitochondrial electron transport chain, activities of several 
well-known target enzymes for the oxidative damage by ROS, the mitochondrial 
membrane potential, and the maintenance of a mitochondrial tubular network. The 
mechanism by which a novel anti-aging small molecule called LA greatly extends yeast 
longevity under CR conditions is described in Chapter 4. My findings demonstrate that, 
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although fatty acid oxidation in peroxisomes is essential for delaying aging, it is not 
required for the ability of LA to extend yeast longevity. This chapter also describes a 
body of evidence that LA extends yeast longevity not only by reducing the damaging 
effect of ROS on cellular macromolecules but also by amplifying the so-called 
"hormetic" effect of ROS through the activation of stress-protecting and other anti-aging 
proteins. 
The findings presented in Chapter 2 have been published in The Journal of Cell 
Biology [Guo, T., Gregg, C , Boukh-Viner, T., Kyryakov, P., Goldberg, A., Bourque, S., 
Banu, F., Haile, S., Milijevic, S., Hung Yeung San, K., Solomon, J., Wong, V. and 
Titorenko, V.I. A signal from inside the peroxisome initiates its division by promoting 
the remodeling of the peroxisomal membrane. J. Cell Biol. (2007) 177:289-303]. This 
article was an Editors' Choice article in Science (2007) 316:801. I carried out and 
supervised more than 40% of all of the work described in this publication and prepared 
the first draft of sections relevant to my work. I am an equally contributed (together with 
Dr. Guo Tong) co-author on this publication. Dr. V. Titorenko provided intellectual 
leadership of this project and edited the manuscript. 
The data described in Chapter 3 are presented in the manuscript of a paper that is 
currently in preparation for submission to Cell Metabolism. I carried out and supervised 
more than 40% of all of the work described in this manuscript and prepared the first draft 
of sections relevant to my work. Dr. V. Titorenko provided intellectual leadership of this 
project and is editing the manuscript. 
The data described in Chapter 4 are presented in the manuscript of a paper that is 
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currently in preparation for submission to Nature Chemical Biology. I carried out and 
supervised more than 30% of all of the work described in this manuscript and prepared 
the first draft of sections relevant to my work. Dr. V. Titorenko provided intellectual 
leadership of this project and is editing the manuscript. 
All abbreviations, citations, and the numbering of figures and tables that have 
been used in the published paper and in the manuscripts in preparation have been 
changed to the format of this thesis. 
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2 Acyl-CoA oxidase functions as a molecular switch that controls peroxisome 
division 
2.1 Abstract 
In the yeast Y. lipolytica, peroxisomes begin as two vesicles called PI and P2 that 
gradually mature into metabolically active peroxisomes, P6. Only P6 peroxisomes are 
able to divide. The step-wise maturation of peroxisomes involves the import of matrix 
proteins and membrane lipids over time. The division of the mature peroxisome P6 
requires a change in the composition of its membrane lipids, which is preceded by the 
relocation of a protein called Aox from the matrix to the membrane of P6. My findings 
show that the movement of Aox from the matrix to the membrane of peroxisomes does 
not require interaction of Aox with a specific protein but rather occurs whenever the 
protein concentration within the peroxisomal matrix reaches a critical mass. The 
interaction of Aox with Pexl6p initiates a cascade of events that ultimately alters the lipid 
composition in the membrane to assume a shape that is more energetically favourable for 
peroxisome division. Such re-shaping of the membrane of mature peroxisomes P6 
promotes the recruitment to the peroxisomal surface of a protein machinery that drives 
peroxisome division by promoting the fission of the peroxisomal membrane. 
2.2 Introduction 
In the "growth and division" model of peroxisome biogenesis, peroxisomal 
membrane and matrix proteins are synthesized on cytosolic polyribosomes and then 
specifically targeted to the peroxisome. Daughter peroxisomes are formed by the division 
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of these peroxisomes [116]. Daughter peroxisomes then undergo the same process of 
growth and division [61]. Though some findings support this model, certain details of this 
process had not been elucidated including the means by which the growth and division of 
peroxisomes is coordinated. It was possible that only peroxisomes that had undergone 
growth and maturation were competent for division. It was also possible that immature 
peroxisomal vesicles first proliferated by dividing and only then grew and matured by 
importing matrix and membrane proteins. This latter pattern, whereby it is the immature 
peroxisomes that divide, was observed in the yeast Candida boidinii [60]. Finally, there 
was a possibility that both mature and immature peroxisomes divided in a process that 
was independent to that of their growth and maturation. 
Data on purification, protein profiling and electron microscopic analysis of 
mammalian and yeast peroxisomes have provided important information regarding the 
process of peroxisomal development. It was established that the population of 
peroxisomes in a cell consists of several peroxisomal subforms that differ in their size, 
morphology, buoyant density and protein composition [64, 117 - 120]. By monitoring of 
the in vivo dynamics of peroxisomal protein localization, it was demonstrated that there 
are several peroxisomal subforms, each differing in their competency to import various 
proteins [64, 117 - 120]. In yeast [120] and in mammals [121], most peroxisomal proteins 
are imported into small peroxisomal vesicles of intermediate buoyant density. By 
acquiring various proteins, these peroxisomal vesicles gradually mature to peroxisomes 
of high buoyant density. Recent findings in human and yeast cells have suggested that 
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several peroxisomal subforms are organized into a multistep peroxisome assembly 
pathway [15, 45, 50, 122 - 124]. The pathway operates by the conversion of subforms in 
a temporally ordered manner, involves the stepwise import of distinct subsets of matrix 
and membrane proteins into different intermediates along the pathway, and leads to the 
assembly of mature peroxisomes (Figure 1.2) [7, 15, 30, 123, 125]. 
It has been demonstrated that the mass of immature peroxisomal vesicles PI to P5 
is not more than 1-2% of that of mature peroxisomes [42, 45]. The peroxin Pexl6p, 
which is attached to the matrix surface of the membrane [126], negatively regulates the 
division of immature peroxisomal vesicles, preventing their excessive proliferation [45, 
50, 127]. The negative control of membrane scission by Pexl6p is necessary for the 
growth of yeast grown on medium containing oleic acid. Indeed, the lack of Pexl6p 
resulted in the excessive proliferation of immature peroxisomal precursors [45, 126] and 
impaired the utilization of oleic acid as a carbon source [126]. 
As peroxisomes mature from PI to P5 subforms, the import of distinct subsets of 
matrix proteins results in increasing fractions of matrix proteins that are present in mature 
peroxisomes [45, 125]. When the increase of the total mass of matrix proteins reaches a 
critical level, the redistribution of the heteropentameric Aox complex from the matrix of 
the peroxisome to its membrane is observed. Aox is present in the early P2 intermediate 
[45] of the peroxisome assembly pathway and its relocation to the peroxisomal 
membrane occurs only in the mature peroxisome P6, in which the mass of matrix proteins 
is greatest [45]. Overloading peroxisomes with any matrix proteins other than Aox was 
suggested be a major factor in the relocation of Aox complex to the membrane of 
27 
peroxisomes [45]. 
Inside mature peroxisomes, the membrane-bound pool of Aox complex interacts 
with Pexl6p. The interaction between Pexl6p and Aox requires that the Aox 
heteropentamer has its Aox4p and Aox5p subunits [45]. The formation of the 
Pexl6p/Aox supramolecular complex, which contains 2 molecules of Aox and two 
molecules of Pexl6p [45], terminates the negative action of Pexl6p on scission of the 
peroxisomal membrane. Thus, mature peroxisomes become division-competent. It is this 
interaction between Aox and Pexl6p that regulates the temporal and spatial separation of 
the processes of peroxisome assembly and division in Y. lipolytica. Such separation may 
provide an important advantage for the efficient, stepwise assembly of mature, 
metabolically active peroxisomes. 
In the above described model for peroxisome growth and division in Y. lipolytica 
(Figure 1.3), the interaction between Aox and Pexl6p terminates the negative action of 
Pexl6p on scission of the peroxisomal membrane, thereby allowing mature peroxisomes 
to divide [45]. Membrane scission involves strong membrane bending and a transient 
reorganization of the equilibrium bilayer configuration of the membrane into highly 
curved non-bilayer intermediates (Figure 2.1) [128 - 135]. These energetically 
unfavourable processes require a specialized team of proteins [136 - 155] and a distinct 
set of membrane lipids, including phosphoinositides [134, 140, 146, 156 - 160], 
phosphatidic acid (PA) [134-136, 139, 142, 157-160] and diacylglycerol (DAG) [134, 
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Figure 2.1. Membrane scission involves strong membrane bending and a transient reorganization of the 
equilibrium bilayer configuration of the membrane into highly curved non-bilayer intermediates. The 
molecular shape of lipids influences membrane curving. 
Cone-shaped PA induces negative monolayer curvature in the outer (cytosolic) leaflet of 
a membrane bilayer in the constricted neck (Figure 2.2) [134, 135, 157 - 160] DAG, 
which has even more conical shape [133, 157 - 161] and is capable of very rapid 
transbilayer movement and lateral partitioning [135, 161 - 163], is a particularly potent 
inducer of negative monolayer curvature and membrane bending (Figure 2.2) (Figure 2.2) 
[133-135,157-163]. 
The key challenge for me was to determine whether or not the interaction between 
Pexl6p and Aox promotes specific changes in the lipid composition of the peroxisomal 
membrane that could trigger membrane destabilization, bending, scission and fission 
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Figure 2.2. By influencing membrane curvature, the molecular shape of lipids could regulate the rate and 
efficiency of the membrane destabilization, bending, scission and fission events required for the division of 
mature peroxisomes. 
events required for the division of mature peroxisomes. It should be stressed that 
aforementioned model for the Pex 16p/Aox-dependent mechanism of peroxisome division 
(Figure 1.3) does not specify what it is that causes Aox to be relocated from the matrix to 
the membrane in mature peroxisomes P6. Using an in vitro assay to reconstruct the 
processes that occur within the peroxisome, I tested three possible molecular mechanisms 
underlying such relocation of Aox within P6. First, it is plausible that the relocation of 
Aox is due only to an increase in the total mass of matrix proteins above a critical level. 
In this mechanism, this movement of Aox is not caused by its interaction with any 
specific protein in the matrix (Figure 2.3). Second, it is possible that: 1) a specific matrix 
protein rather than protein mass in the peroxisomal matrix initiates the relocation of Aox 
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Figure 2.3. First possible molecular mechanism underlying the relocation of Aox from the matrix to the 
membrane within mature peroxisomes P6. The relocation of Aox is due only to an increase in the total mass 
of matrix proteins above a critical level. In this mechanism, this movement of Aox is not caused by its 
interaction with any specific protein in the matrix. 
from the matrix to the membrane; and 2) this specific matrix protein is present already in 
the early peroxisomal precursors P1 and P2 and is activated only when the total mass of 
matrix proteins exceeds a critical level (Figure 2.4). Third, it is conceivable that: l ) a 
Figure 2.4. Second possible molecular mechanism underlying the relocation of Aox from the matrix to the 
membrane within mature peroxisomes P6. A specific matrix protein rather than protein mass in the 
peroxisomal matrix initiates the relocation of Aox from the matrix to the membrane. This specific matrix 
protein is present already in the early peroxisomal precursors P1 and P2 and is activated only when the total 
mass of matrix proteins exceeds a critical level. 
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Figure 2.5. Third possible molecular mechanism underlying the relocation of Aox from the matrix to the 
membrane within mature peroxisomes P6. A specific matrix protein rather than protein mass in the 
peroxisomal matrix initiates the relocation of Aox from the matrix to the membrane. This specific matrix 
protein is imported to the peroxisome only during the last step of peroxisome maturation, during the 
conversion of P5 to P6. 
specific matrix protein rather than protein mass in the peroxisomal matrix initiates the 
relocation of Aox; and 2) this specific matrix protein is imported to the peroxisome only 
during the last step of peroxisome maturation, during the conversion of P5 to P6 (Figure 
2.5). The data presented in this chapter provide comprehensive evidence that the 
relocation of Aox from the matrix to the membrane of P6 is due to an increase in the total 
mass of matrix proteins above a critical level and that it is not promoted by the interaction 
of Aox with any specific matrix protein. Moreover, the findings that I describe in this 
chapter clearly demonstrate that the interaction between Pexl6p and Aox results in an 
intraperoxisomal signalling cascade that activates the biosynthesis and transbilayer 
movement of a distinct set of membrane lipids. The change in the lipid content of the 
peroxisomal membrane is followed by the assembly of a multicomponent protein 
complex on the surface of the mature peroxisome, P6. The protein complex that forms 
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carries out membrane fission and completes the process of peroxisome division. 
2.3 Materials and Methods 
Strains, media and reagents 
The Y. lipolytica wild-type strain POld [164], the mutant strains pexlA [64], pexl9A 
[\65],pexl6A and PEX16-TH [126], the single AOX gene knock-out strains [164], and 
the media, growth conditions and genetic techniques for Y. lipolytica [48] have been 
previously described. Targeted integrative disruption of the ABP J, DPP I, PEX10, SLA1, 
SLC1 and VPS1 genes was performed with the URA3 gene of Y. lipolytica, using a 
previously described modification of the sticky-end polymerase chain reaction procedure 
[164]. Antibodies to Pex2p [64], Pexl6p [48], Pexl9p [165] and thiolase [50] have been 
previously described. Monospecific antibodies to Dpplp, PexlOp, Slclp and Vpslp were 
raised in rabbit against their peptides GAPRPDMLARCRPMSWMRP, 
CRQGVREQNLLPIR, GRIFPQYCSVTAKKALKWYP and 
MDKELISTVNKLQDALA, respectively. Purification of the DAG-binding Clb domain 
of protein kinase C [166] and its labeling with the fluorophore Alexa Fluor 488 [167] 
were performed as described previously. SDS-PAGE and immunoblotting [48] were 
performed as described. Cholic acid (sodium salt), ergosterol, hydroxylapatite, n-octyl-B-
D-glucopyranoside, palmitoyl-CoA agarose, and Triton X-100 were purchased from 
Sigma-Aldrich Canada Ltd. PIP-Strips were from Echelon Biosciences. Alexa Fluor 488 
signal-amplification kit for fluorescein-conjugated probes was purchased from Molecular 
Probes. Monoclonal anti-phosphatidylserine antibody was purchased from Upstate USA. 
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Fluorescein-conjugated goat anti-rabbit IgG antibodies and fluorescein-conjugated goat 
anti-mouse IgM antibodies were from Jackson ImmunoResearch Laboratories. N-
palmitoyl-D-eryf/zro-sphingosine (ceramide), 1,2-dioleoyl-sH-glycerol (diacylglycerol), 
l,2-dioleoyl-5«-glycero-3-phosphate (phosphatidic acid), l,2-dioleoyl-s?j-glycero-3-
phosphocholine (phosphatidylcholine), 1 -oleoyl-2-hydroxy-5«-glycero-3-phosphate 
(lysophosphosphatidic acid), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(phosphatidylethanolamine), L-ct-phosphatidylinositol (phosphatidylinositol), and 1,2-
dioleoyl-5«-glycero-3-[phospho-L-serine] (phosphatidylserine) were from Avanti Polar 
Lipids. [Cl4]-labeled lipids, HiTrap Blue HP, Resource Q, Resource S, and Superose 12 
were from GE Healthcare. 
Subcellular fractionation and isolation of organelles 
The initial step in the subcellular fractionation of oleic acid-grown cells included the 
differential centrifugation of lysed and homogenized spheroplasts at 1,000 x g for 10 min 
at 4°C in a JS 13.1 rotor (Beckman) to yield a postnuclear supernatant (PNS) fraction. The 
PNS fraction was further subjected to differential centrifugation at 20,000 x g for 30 min 
at 4°C in a JS 13.1 rotor (Beckman) to yield pellet (20KgP) and supernatant (20KgS) 
fractions. The 20KgS fraction was further subfractionated by differential centrifugation at 
200,000 x
 g for 1 h at 4°C in a TLA110 rotor (Beckman) to yield pellet (200KgP) and 
supernatant (200KgS) fractions. To purify immature peroxisomal vesicles PI to P5, the 
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200KgP subcellular fraction was subjected to centrifugation on a discontinuous sucrose 
(18, 25, 30, 35, 40, and 53%, wt/wt) gradient at 120,000 x g for 18 h at 4°C in a SW28 
rotor (Beckman). 36 fractions of 1 ml each were collected. Different subforms of 
immature peroxisomal vesicles peaked at densities of 1.18 g/cm3 (fraction 5, P5), 1.14 
g/cm3 (fraction 15, P3 + P4), 1.11 g/cm3 (fraction 23, PI), and 1.09 g/cm3 (fraction 30, 
P2) were recovered [46]. The peak fractions containing immature peroxisomal vesicles 
PI, P2, P3 + P4 and P5 were recovered, and 4 vol of 0.5 M sucrose in buffer H (5 mM 
MES, pH 5.5, 1 mM KC1, 0.5 mM EDTA, 0.1% ethanol, 1 x protease inhibitor cocktail 
[PIC] [46] were added to each of them. Peroxisomes were pelleted onto a 150-ul cushion 
of 2 M sucrose in buffer H by centrifugation at 200,000 x g for 20 min at 4°C in a 
TLA110 rotor (Beckman). Individual pellets of different subforms of immature 
peroxisomal vesicles were resuspended in 3 ml of 50% (wt/wt) sucrose in buffer H. 
For purification of immature peroxisomal vesicles PI and P2, pellets of PI andP2 
resuspended in 50% (wt/wt) sucrose in buffer H were overlaid with 30, 28, 26, 24, 22, 
and 10% sucrose (all wt/wt in buffer H). After centrifugation at 120,000 x g for 18 h at 
4°C in a SW28 rotor (Beckman), 18 fractions of 2 ml each were collected. PI and P2 
were pelleted, resuspended and subjected to a second flotation on the same multistep 
sucrose gradient. Gradients were fractionated into 2-ml fractions as above, and PI and P2 
were recovered [46] and used for biochemical analyses. 
For purification of immature peroxisomal vesicles P3 and P4, pellets of P3 and P4 
resuspended in 50% (wt/wt) sucrose in buffer H were overlaid with 38%, 35%, 33% and 
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20% sucrose (all wt/wt in buffer H). After centrifugation at 120,000 * g for 18 h at 4°C in 
a SW28 rotor (Beckman), 18 fractions of 2 ml each were collected. P3 and P4 were 
pelleted, resuspended in 3 ml of 50% (wt/wt) sucrose in buffer HE (20 mM MES, pH 5.5, 
20 mM EDTA, 0.1% ethanol), overlaid with 39, 37, 35, 33, and 20% sucrose (all wt/wt in 
buffer HE), and subjected to centrifugation as above. Gradients were fractionated into 2-
ml fractions, and P3 and P4 were recovered and pelleted. After resuspension in 3 ml of 
50% (wt/wt) sucrose in buffer H, P3 and P4 were again subjected to flotation on the 
second multistep sucrose gradient described above. Gradients were fractionated into 2-ml 
fractions, and P3 and P4 were recovered [46] and used for biochemical analyses. 
Highly purified mature peroxisomes P6 were isolated from the 20 KgP subcellular 
fraction by isopycnic centrifugation on a discontinuous sucrose gradient as described 
previously [64]. 4 vol of 0.5 M sucrose in buffer H were added to the peak peroxisomal 
fraction 4 recovered after isopycnic centrifugation on a discontinuous sucrose gradient. 
Peroxisomes were sedimented through a 150-ul cushion of 2 M sucrose in buffer H by 
centrifugation at 200,000 * g for 20min at 4°C in a TLA110 rotor (Beckman). The 
resultant pellet of mature peroxisomes P6 was resuspended in buffer H containing 1 M 
sorbitol and was subjected to further centrifugation on a linear 20-60% (wt/wt) sucrose 
gradient (in buffer H) at 197,000 x g for 18 h at 4°C in a SW41Ti rotor (Beckman). Peak 
peroxisomal fraction 5 equilibrating at a density of 1.21 g/cm3 was recovered, and 
peroxisomes were sedimented through a 150-ul cushion of 2 M sucrose in buffer H by 
centrifugation at 200,000 x g for 20 min at 4°C in a TLA110 rotor (Beckman). Pellet of 
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mature peroxisomes P6 was resuspended in 55% (wt/wt) sucrose in buffer H, overlaid 
with 50, 45, 40, 30, and 20% sucrose (all wt/wt in buffer H), and subjected to 
centrifugation at 120,000 x g for 18 h at 4°C in a SW28 rotor (Beckman). 18 gradient 
fractions of 2 ml each were collected. Peak peroxisomal fraction 11 equilibrating at a 
density of 1.21 g/cm3 was recovered [64] and used for biochemical analyses. 
The free form of the ER [64] and the P3- and P4-associated subcompartment of 
the ER [46] were purified from Y. lipolytica cells as described previously. Subcellular 
fractionation of S. cerevisiae cells grown in glucose-containing YEPD medium and 
isolation of functional ER membranes were performed according to established 
procedures [168]. 
Peroxisome subfractionation and extraction 
Highly purified peroxisomes were lysed by addition of 10 vol of ice-cold LB buffer (20 
mM HEPES-KOH, pH 8.0, 50 mM NaCl, and 1 x protease inhibitor cocktail [PIC] [48], 
followed by incubation on ice for 30 min with occasional agitation. The suspension was 
centrifuged at 200,000 x g for 20 min at 4°C in a TLA110 rotor (Beckman). The pellet 
of membranes recovered after centrifugation of osmotically lysed peroxisomes was 
resuspended in ice-cold EB buffer (10 mM HEPES-KOH, pH 8.0, 5 mM EDTA, and 1 x 
protease inhibitor cocktail [PIC] [48] to a final concentration of 1.0 mg/ml. Equal 
aliquots of the suspension of membranes were then exposed to 1 M NaCl, 0.1 M Na2C03, 
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pH 11.0, or 0.5% (vol/vol) Triton X-100 [48]. After incubation on ice for 30 min with 
occasional agitation, the samples were subjected to centrifugation at 100,000 x g for 30 
min at 4°C in a TLA110 rotor (Beckman). Equal portions of the pellet and supernatant 
fractions were analyzed by SDS-PAGE, followed by immunoblotting. 
Protease protection analysis 
The pellet of highly purified mature peroxisomes was gently resuspended in ice-cold PPB 
buffer (5 mM MES, pH 5.5, 1 M sorbitol, 1 mM KC1, and 0.5 mM EDTA). Equal 
aliquots (10 or 20 ug of total protein) of these peroxisomes were incubated with 0, 5, 10 
or 50 ug of trypsin for 30 min on ice, either in the presence or absence of Triton X-100 at 
0.5% (vol/vol) final concentration. The reaction was terminated by addition of 
trichloroacetic acid to 10% final concentration. The protein precipitates were washed 
with ice-cold 80% (vol/vol) acetone, and equivalent fractions of each reaction were 
subjected to SDS-PAGE and immunoblotting. 
Lipid analyses 
Highly purified peroxisomes were lysed by addition of 10 vol of ice-cold LB buffer (20 
mM HEPES-KOH, pH 8.0, 50 mM NaCl, and 1 * protease inhibitor cocktail [PIC] 
[48], followed by incubation on ice for 30 min with occasional agitation. The suspension 
was centrifuged at 200,000 x g for 20 min at 4°C in a TLA110 rotor (Beckman). For 
extraction of membrane lipids, the pellet of membranes recovered after centrifugation of 
osmotically lysed peroxisomes and contained 1 mg of membrane protein was 
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resuspended in 1.0 ml of chloroform/methanol (1:1, v/v). After incubation on ice for 15 
min with occasional agitation, samples were subjected to centrifugation at 20,000 x g for 
15 min at 4°C. The chloroform phase was separated and dried under nitrogen. The lipid 
film was dissolved in 100 ul of chloroform (for the analysis of diacylglycerol, ergosterol 
and ceramide) or 100 ul of chloroform/methanol (1:1, v/v) (for the analysis of 
phosphatidylethanolamine, phosphatidic acid, phosphatidylcholine, phosphatidylinositol, 
phosphatidylserine, and lysophosphosphatidic acid). 25 ul of each sample were spotted 
on 60A silica gel plates for thin-layer chromatography (TLC) (Whatman). The lipids 
were developed in the following solvent systems: chloroform/acetone (4.6:0.4, v/v) (for 
the analysis of diacylglycerol, ergosterol and ceramide) and chloroform/methanol/water 
(65:25:4, v/v) (for the analysis of phosphatidylethanolamine, phosphatidic acid, 
phosphatidylcholine, phosphatidylinositol, phosphatidylserine, and lysophosphatidic 
acid). All lipids were detected using 5% phosphomolybdic acid in ethanol and visualized 
by heating for 30 min at 110°C. Lipids were quantitated by densitometric analysis of TLC 
plates as described previously [169], using lipid standards in the 0.1-0.5 ug range for 
calibration. 
For monitoring enzymatic activities of LPAAT and PAP, highly purified 
peroxisomes were lysed by addition of 10 vol of ice-cold LB buffer (20 mM HEPES-
KOH, pH 8.0, 50 mM NaCl, and 1 x protease inhibitor cocktail [PIC] [48], followed by 
incubation on ice for 30 min with occasional agitation. The suspension was centrifuged at 
200,000 x g for 20 min at 4°C in a TLA110 rotor (Beckman). The pellet of membranes 
recovered after centrifugation of osmotically lysed peroxisomes was resuspended in ice-
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cold buffer R (20 mM MES-KOH, pH 6.0, 150 mM NaCl, 5 raM DTT, 10% glycerol) 
containing 1% (w/v) n-octyl-P-D-glucopyranoside (OG). After incubation on ice for 20 
min with occasional agitation, the sample of detergent-solubilized peroxisomal 
membrane proteins (PMPs) was subjected to centrifugation at 100,000 * g for 20 min at 
4°C in a TLA110 rotor. The resulting supernatant of solubilized PMPs was depleted of 
Pexl6p by immunoaffinity chromatography under native conditions using anti-Pexl6p 
antibodies covalently linked to protein A-Sepharose [170]. For the reconstitution of 
peroxisomal liposomes carrying Pexl6p, detergent-solubilized PMPs immunodepleted of 
Pexl6p were supplemented with Pexl6p, which was purified from membranes of 
osmotically lysed immature peroxisomal vesicles PI by immunoaffinity chromatography 
under native conditions using anti-Pexl6p antibodies covalently linked to protein A-
Sepharose [170]. After elution with buffer E (20 mM HEPES-KOH, pH 7.5, 250 mM 
MgCb, 5 mM DTT, 10% glycerol) containing 1% (w/v) OG, purified Pexl6p was 
dialyzed against buffer R supplemented with 1% (w/v) OG. For the reconstitution of 
peroxisomal liposomes lacking Pexl6p, detergent-solubilized PMPs immunodepleted of 
Pexl6p were supplemented only with buffer R containing 1% (w/v) OG. Detergent-
solubilized PMPs immunodepleted of Pexl6p and either supplemented or not 
supplemented with purified Pexl6p in buffer R containing 1% (w/v) OG were then 
added to the films of unlabeled lipids, which were initially extracted from the membranes 
of highly purified peroxisomes using chloroform/methanol (1:1, v/v) and then dried down 
by a gentle stream of nitrogen. The lipid films were dissolved by gentle agitation for 20 
min at room temperature. For monitoring LPAAT activity, the unlabeled lipids, which 
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were extracted from the membranes of highly purified peroxisomes using 
chloroform/methanol (1:1, v/v), were supplemented with [ C]-labeled lysophosphatidic 
acid and unlabeled oleoyl-CoA (a co-substrate of LPAAT) dissolved in 
chloroform/methanol (1:1, v/v). The mix of unlabeled membrane lipids and [ C]-labeled 
lysophosphatidic acid was then dried down by a gentle stream of nitrogen. For 
monitoring PAP activity, the unlabeled lipids, which were extracted from the membranes 
of highly purified peroxisomes using chloroform/methanol (1:1, v/v), were supplemented 
with [ C]-labeled phosphatidic acid dissolved in chloroform/methanol (1:1, v/v). The 
mix of unlabeled membrane lipids and [ C]-labeled phosphatidic acid was then dried 
down by a gentle stream of nitrogen. For evaluating the positive effect of 
phosphatidylcholine on LPAAT and PAP, equal aliquots of unlabeled lipids extracted 
from the membranes of highly purified peroxisomes using chloroform/methanol (1:1, 
v/v) were first mixed with an appropriate [ C]-labeled lipid substrate of LPAAT or PAP 
in chloroform/methanol (1:1, v/v) and were then supplemented with various quantities of 
phosphatidylcholine dissolved in chloroform/methanol (1:1, v/v). The mix of unlabeled 
14 
membrane lipids, a [ C]-labeled lipid substrate, and unlabeled phosphatidylcholine was 
then dried down by a gentle stream of nitrogen. The lipid films were finally dissolved by 
gentle agitation for 20 min at room temperature in buffer R containing detergent-
solubilized PMPs, immunodepleted or not immunodepleted of Pexl6p, in 1% (w/v) OG. 
To dilute the detergent OG below its critical micellar concentration, thereby promoting 
the formation of peroxisomal liposomes, 3 volumes of buffer D (20 mM MES-KOH, pH 
6.0, 150 mM NaCl) were added to the mixture of detergent-solubilized PMPs and 
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membrane lipids dissolved in buffer R containing 1% (w/v) OG. To remove the 
detergent, the samples were dialyzed in a Tube-O-Dialyzer (7.5-kD cutoff) (Chemicon) 
against buffer D containing 0.1% Biobeads SM2 (Bio-Rad). After overnight dialysis at 
4°C, samples were transferred to the bottom of ultraclear centrifuge tubes (Beckman) and 
supplemented with 4 volumes of 65% (w/w) sucrose in buffer D in order to adjust the 
sucrose concentration of the samples to 52% (w/w). Samples were overlaid with 40% and 
then with 20% sucrose (both w/w in buffer D) and lastly with buffer D alone. After 
centrifugation at 200,000 * g for 18 h at 4°C in a SW50.1 rotor (Beckman), 18 fractions 
of 275 ul each were collected. Peroxisomal liposomes were recovered at the 40%/20% 
sucrose interface. The recovered peroxisomal liposomes were transferred from ice to 
26°C. Samples were taken at the indicated times after the transfer. Lipids were extracted 
from the membrane and analyzed by TLC. To calculate the initial rates of the LPAAT 
and PAP reactions, the [ C]-labeled lysophosphatidic acid, phosphatidic acid and 
diacylglycerol were separated by TLC and quantified by autoradiography. 
To evaluate the transbilayer distribution of DAG and PS in the membrane bilayers 
of different peroxisomal subforms, the suspension of highly purified peroxisomes in ice-
cold H250S buffer (5 mM MES-KOH, pH 5.5, 250 mM sorbitol, 1 mM KC1, 0.5 raM 
EDTA, 1 x protease inhibitor cocktail [PIC] [48] at 1 mg protein/ml was divided into 
two equal aliquots. One aliquot remained untreated, whereas peroxisomal vesicles in the 
other aliquot were lysed by addition of 10 vol of ice-cold LB buffer (20 mM HEPES-
KOH, pH 8.0, 50 mM NaCl, and 1 x protease inhibitor cocktail [PIC] [48], followed by 
incubation on ice for 30 min with occasional agitation. The suspension of lysed 
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peroxisomes was divided into two equal aliquots. One aliquot was dialyzed in a Tube-O-
Dialyzer (7.5-kD cutoff) (Chemicon) against buffer MR (10 mM MES/KOH, pH 5.5, 1 
mM KC1, and 0.5 mM EDTA) containing 250 mM sorbitol. The suspension of lysed 
peroxisomes in the other aliquot was dialyzed in a Tube-O-Dialyzer (7.5-kD cutoff) 
(Chemicon) against buffer HR (10 mM HEPES/KOH, pH 7.5, 1 mM KC1, and 0.5 mM 
EDTA) containing 250 mM sorbitol. After overnight dialysis at 4°C, resealed 
peroxisomes RPA that were formed in the aliquot dialyzed against buffer MR containing 
250 mM sorbitol and resealed peroxisomes RPB that were formed in the aliquot dialyzed 
against buffer HR containing 250 mM sorbitol were pelleted onto a 150-ul cushion of 2 
M sucrose in buffer MR or HR, respectively, by centrifugation at 100,000 x g for 20 min 
at 4°C in a TLA110 rotor (Beckman). Individual pellets of RPA and RPB were 
resuspended in 500 ul of 50% (wt/wt) sucrose in buffer MR or HR, respectively. The 
sample containing RPA was overlaid with 1.5 ml of 45% sucrose, 1 ml of 40% sucrose, 1 
ml of 25% sucrose, and 1 ml of 10% sucrose (all wt/wt in buffer MR). The sample 
containing RPB was overlaid with 1.5 ml of 45% sucrose, 1 ml of 40% sucrose, 1 ml of 
25% sucrose, and 1 ml of 10% sucrose (all wt/wt in buffer HR). Both samples were 
subjected to centrifugation at 200,000 x g for 18 h at 4°C in a SW50.1 rotor (Beckman). 9 
fractions of 555 ul each were collected. Resealed peroxisomes RPA and RPB floated to 
low density during centrifugation in the sucrose density gradient. Proteins from equal 
volumes of gradient fractions were analyzed by immunoblotting with antibodies to 
Pexl6p and Pexl9p. Equal volumes of gradient fractions were also subjected to lipid 
extraction, which was followed by TLC and visualization of lipids. 
43 
Resealed peroxisomes RPA and RPB, which were recovered in the peak fractions 
of the flotation gradients, and a highly purified subform of the intact peroxisomes from 
which these two types of resealed peroxisomes were formed, were used to evaluate the 
orientation in which the membranes delimiting RPA and RPB were resealed. RPA and 
RPB were pelleted onto a 150-ul cushion of 2 M sucrose in buffer MR or HR, 
respectively, by centrifugation at 100,000 x g for 20 min at 4°C in a TLA110 rotor 
(Beckman). Intact peroxisomes were pelleted onto a 150-ul cushion of 2 M sucrose in 
buffer H (5 mM MES, pH 5.5, 1 mM KC1, 0.5 mM EDTA, 0.1% ethanol, 1 x protease 
inhibitor cocktail [PIC] [48] by centrifugation at 100,000 x g for 20 min at 4°C in a 
TLA110 rotor (Beckman). Individual pellets of RPA, RPB and intact peroxisomes were 
resuspended in ice-cold buffer H at 1 mg protein/ml. Serial dilutions of RPA, RPB and 
intact peroxisomes in the range of 10-50 ug protein/ml were made in ice-cold buffer H. 
Anti-Pexl6p rabbit IgG or anti-Pexl9p rabbit IgG were added to concentrations 4 and 5 
ug/ml, respectively. After incubation for 30 min on ice, samples were subjected to 
centrifugation at 100,000 x g for 10 min at 4°C in a TLA110 rotor (Beckman). The 
pellets were resuspended in 200 ul of ice-cold buffer H and supplemented with 
fluorescein-conjugated goat anti-rabbit IgG. After incubation for 30 min on ice, samples 
were subjected to centrifugation at 100,000 x g for 10 min at4°C in aTLAHO rotor 
(Beckman). The pellets were resuspended in 200 ul of ice-cold buffer H and 
supplemented with Alexa Fluor 488 goat anti-fluorescein/Oregon Green IgG at 15 ug/ml. 
Following incubation for 30 min on ice, samples were subjected to centrifugation at 
100,000 x
 g for 10 min at 4°C in a TLA110 rotor (Beckman). The pellets were 
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resuspended in 200 (J.1 of ice-cold buffer H and supplemented with Alexa Fluor 488 
chicken anti-goat IgG at 20 ug/ml. After incubation for 30 min on ice, samples were 
subjected to centrifugation at 100,000 * g for 10 min at 4°C in a TLA110 rotor 
(Beckman). The pellets were resuspended in 200 ul of ice-cold buffer H and placed into 
the wells of a 96-well microplate. The fluorescence of samples was measured using the 
Wallac Victor 2 Multi-label microplate fluorescence reader with filters set at 485 (+/- 7.5) 
nm (excitation) and 510 (+/- 5) nm (emission). Controls were made for each dilution of 
RPA, RPB and intact peroxisomes. The controls included normal rabbit IgG at 4 or 5 
Hg/ml added instead of anti-Pexl6p rabbit IgG or anti-Pexl9p rabbit IgG, respectively. 
Background fluorescence, which was due to the nonspecific binding of rabbit IgG and/or 
fluorescein- or Alexa Fluor 488-labeled antibodies to the peroxisomal membrane, was 
subtracted. 
In intact peroxisomes, Pexl9p is a peripheral membrane protein that resides on 
the outer (cytosolic) face of the peroxisome [51]. Because this protein is attached to the 
surface of intact peroxisomes, it is accessible to anti-Pexl9p IgG exogenously added to 
these peroxisomes [51]. Importantly, the membranes of intact peroxisomes RPA and RPB 
are not permeable to the exogenously added IgG molecules. In fact, none of Pexl6p, a 
peripheral membrane protein residing on the inner (lumenal) face of the peroxisome, in 
intact peroxisomes and only a minor portion of this protein in RPA was accessible to 
anti-Pexl6p IgG [51]. The observed accessibility of the RPB-associated form of Pexl6p 
to anti-Pexl6p IgG was due to the inside-out orientation of the membrane delimiting 
most of the RPB species formed during peroxisome resealing. In addition, although the 
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levels of Pexl9p, a peripheral membrane protein residing on the peroxisomal surface, in 
intact peroxisomes, RPA and RPB were very similar to each other [51], only a minor 
portion of Pexl9p in the mostly inside out-oriented RPB species was accessible to anti-
Pexl9p IgG [51]. Altogether, these findings imply that, if the ratio "fluorescence for RPA 
(FRPA)/fluorescence for intact peroxisomes (FIP)" or "fluorescence for RPB 
(FRPB)/fluorescence for intact peroxisomes (FiP)" is calculated for Pexl9p, it is equal to 
the fraction of the total pool of Pexl9p that resides on the outer (cytosolic) face of those 
RPA or RPB species whose delimiting membranes acquired the outside-out orientation 
during their resealing. At the same time, the ratio "(FiP - FRPA)/F]P" or "(FiP - FRPB)/FIP", if 
calculated for Pexl9p, equals the fraction of Pexl9p that resides on the inner (lumenal) 
face of those RPA or RPB species whose delimiting membranes acquired the inside-out 
orientation during their resealing. Hence, the ratio "FRPA/FIP" or "FRPB/FIP" for Pexl9p is 
equal to the fraction of those RPA or RPB species that are present in the outside-out 
orientation (n00pj>A and n00RpB, respectively). Moreover, the ratio "(FiP - FRPA)/FIP" or "(FiP 
- FRPB)/FIP" for Pexl9p equals the fraction of those RPA or RPB species that were 
resealed in the inside-out orientation (nIORpA and n10RpB, respectively). 
Resealed peroxisomes RPA and RPB, which were recovered in the peak fractions 
of the flotation gradients, and a highly purified subform of the intact peroxisomes from 
which these two types of resealed peroxisomes were formed, were used to calculate the 
percentage of DAG and PS residing in the cytosolic and lumenal leaflets of the 
membrane bilayers in different peroxisomal subforms. RPA and RPB were pelleted onto 
a 150-jxl cushion of 2 M sucrose in buffer MR or HR, respectively, by centrifugation at 
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100,000 x g for 20 min at 4°C in a TLA110 rotor (Beckman). Intact peroxisomes were 
pelleted onto a 150-ul cushion of 2 M sucrose in buffer H (5 mM MES, pH 5.5, 1 mM 
KC1, 0.5 mM EDTA, 0.1% ethanol, 1 x protease inhibitor cocktail [PIC] [48] by 
centrifugation at 100,000 x g for 20 min at 4°C in a TLA110 rotor (Beckman). Individual 
pellets of RPA, RPB and intact peroxisomes were resuspended in ice-cold buffer H at 1 
mg protein/ml. Serial dilutions of RPA, RPB and intact peroxisomes in the range of 10-
50 ug protein/ml were made in ice-cold buffer H. The DAG-binding Clb domain of 
protein kinase C labeled with the fluorophore Alexa Fluor 488 or anti-PS mouse IgM 
were added to concentrations 5 and 1 ug/ml, respectively. After incubation for 30 min on 
ice, samples were subjected to centrifugation at 100,000 x g for 10 min at 4°C in a 
TLA110 rotor (Beckman). For samples that were exposed to Alexa Fluor 488-tagged Clb 
domain, the pellets were resuspended in 200 ul of ice-cold buffer H and placed into the 
wells of a 96-well microplate. The fluorescence of these samples was measured using the 
Wallac Victor 2 Multi-label microplate fluorescence reader with filters set at 485 (+/- 7.5) 
nm (excitation) and 510 (+/- 5) nm (emission). Controls for monitoring DAG were made 
for each dilution of intact peroxisomes P5 and P6 and of the P5- and P6-based RPA and 
RPB, all of which contained DAG [51]. The controls included the corresponding 
dilutions of intact peroxisomes P4 and of the P4-based RPA and RPB, all of which did 
not contain DAG [51]. Background fluorescence, which was due to the nonspecific 
binding of Alexa Fluor 488-tagged Clb domain to the peroxisomal membrane, was 
subtracted. For samples that were exposed to anti-PS mouse IgM, the pellets were 
resuspended in 200 ul of ice-cold buffer H and supplemented with fluorescein-conjugated 
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goat anti-mouse IgM antibodies at 5 ug/ml. After incubation for 30 min on ice, samples 
were subjected to centrifugation at 100,000 x g for 10 min at 4°C in a TLA110 rotor 
(Beckman). The pellets were resuspended in 200 ul of ice-cold buffer H and 
supplemented with Alexa Fluor 488 rabbit anti-fluorescein/Oregon Green IgG at 15 
fig/ml. Following incubation for 30 min on ice, samples were subjected to centrifugation 
at 100,000 x
 g for 10 min at 4°C in a TLA110 rotor (Beckman). The pellets were 
resuspended in 200 ul of ice-cold buffer H and supplemented with Alexa Fluor 488 goat 
anti-rabbit IgG at 20 ug/ml. After incubation for 30 min on ice, samples were subjected to 
centrifugation at 100,000 x g for 10 min at 4°C in a TLA110 rotor (Beckman). The 
pellets were resuspended in 200 ul of ice-cold buffer H and placed into the wells of a 96-
well microplate. The fluorescence of samples was measured using the Wallac Victor 2 
Multi-label microplate fluorescence reader with filters set at 485 (+/- 7.5) nm (excitation) 
and 510 (+/- 5) nm (emission). Controls were made for each dilution of RPA, RPB and 
intact peroxisomes. The controls included normal mouse IgM at 1 ug/ml added instead of 
anti-PS mouse IgM. Background fluorescence, which was due to the non-specific 
binding of mouse IgM and/or fluorescein- or Alexa Fluor 488-labeled antibodies to 
the peroxisomal membrane, was subtracted. 
The fraction of a monitored lipid, either DAG or PS, residing in the cytosolic 
leaflet of the membrane bilayer of the intact peroxisome can be calculated as: 
F,P/(FIP + FIL),(1) 
where F]P is the fluorescence of a lipid-specific fluorescent probe specifically bound to 
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intact peroxisomes or to the species of RPA and RPB that are present in the outside-out 
orientation. In equation 1, FIP equals the fluorescence of this probe specifically bound to 
the outer (cytosolic) leaflet of the peroxisomal membrane bilayer delimiting intact 
peroxisomes or those species of RPA and RPB that were resealed in the outside-out 
orientation. Furthermore, FJL in equation 1 is the fluorescence of a lipid-specific 
fluorescent reporter molecule that would, if it could, bind specifically to the inner 
(lumenal) leaflet of the peroxisomal membrane bilayer delimiting intact peroxisomes. FIL 
can be monitored by measuring the fluorescence of this reporter molecule bound to the 
surface of those species of RPA and RPB that were resealed in the inside-out orientation. 
The value of FRPA, the fluorescence of a lipid-specific fluorescent reporter 
molecule specifically bound to the surface of RPA, can be calculated as: 
FRPA = (n00RPA * F IP) + (ni0RPA * F I L), (2) 
where n00RpA is the fraction of the RPA species that are present in the outside-out 
orientation. The value of n00RpA for each of the outside out-oriented species of RPA 
formed during resealing of osmotically lysed peroxisomal subforms PI to P6 was 
calculated for a Pexl9p-specific fluorescent reporter molecule as described above. In 
equation 2, the value of n10RPA for each of the inside out-oriented species of RPA formed 
during resealing of osmotically lysed peroxisomal subforms PI to P6 was calculated for a 
Pexl9p-specific fluorescent reporter molecule as described above. Based on equation 2, 
FIL can be calculated as: 
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FRPA - (n RPA x FIP) 
F,L = (3) 
n RPA 
The value of FRPB, the fluorescence of a lipid-specific fluorescent reporter molecule 
specifically bound to the surface of RPB, can be calculated as: 
FRPB = (n00RPB x F1P) + (ni0RPB x FIL), (4) 
where n00RPB is the fraction of the RPB species that are present in the outside-out 
orientation. The value of n00RpB for each of the outside out-oriented species of RPB 
formed during resealing of osmotically lysed peroxisomal subforms PI to P6 was 
calculated for a Pexl9p-specific fluorescent reporter molecule as described above. In 
equation 4, the value of n10RpB for each of the inside out-oriented species of RPB formed 
during resealing of osmotically lysed peroxisomal subforms PI to P6 was calculated for a 
Pexl9p-specific fluorescent reporter molecule as described above. Based on equation 4, 
FIL can be calculated as: 
FRPB - (n RPB X FIP) 
F,L = (5) 
n RPB 
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Based on equation 3, equation 1 for calculating the fraction of a monitored lipid, either 
DAG or PS, residing in the cytosolic leaflet of the membrane bilayer of the intact 
peroxisome can be rewritten as: 
Fjp 
(6). 
FRPA - (n RPA x F]p) 
F,P + 
n RPA 
Furthermore, based on equation 5, equation 1 for calculating the fraction of a monitored 
lipid, either DAG or PS, residing in the cytosolic leaflet of the membrane bilayer of the 
intact peroxisome can be also rewritten as: 
Fip 
(7). 
FRPB— (n RPB x FIP) 
F,P + 
n RPB 
For each of the intact peroxisomal subforms PI to P6, equations 6 and 7 were used for 
calculating the fraction of a monitored lipid, either DAG or PS, residing in the cytosolic 
leaflet of the membrane bilayer. 
51 
Protein-lipid overlay assay 
To evaluate the lipid-binding specificity of Pexl6p, the pellet of membranes recovered 
after centrifugation of osmotically lysed peroxisomes was resuspended in buffer TBSO 
(10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% n-OG) and incubated for 30 min on ice. 
Samples were subjected to centrifugation at 100,000 x g for 30 min at 4°C in TLA110 
rotor (Beckman). Under these conditions, n-OG completely solubilized the vast majority 
of all membrane proteins [171]. The supernatants of n-OG-solubilized proteins were then 
incubated at 5 ug/ml with the PIP-Strips (Echelon Biosciences) at 4°C overnight. After 
washing the PIP-Strip five times for 5 min each with TBSO, Pexl6p was detected by 
immunoblotting with anti-Pexl6p antibodies. 
Chemical cross-linking and immunoprecipitation under denaturing 
conditions 
Highly purified mature peroxisomes of wild-type and mutant strains were osmotically 
lysed by addition of 10 vol of ice-cold LCC buffer (20 mM sodium phosphate buffer, pH 
7.5, and 150mM NaCl), followed by incubation on ice for 30 min with occasional 
agitation. The suspension was centrifuged at 200,000 x g for 20 min at 4°C in a TLA110 
rotor (Beckman). The pellet of membranes recovered after centrifugation of osmotically 
lysed peroxisomes was resuspended in ice-cold LCC buffer to a final concentration of 0.5 
mg/ml. Cross-linking with the thiol-cleavable cross-linker dithiobis 
(succinimidylpropionate) (DSP) (Pierce Chemical Co.) was initiated by the addition of 
cross-linker (50 mM stock in DMSO) and continued for 1 h at 4°C. Cross-linking was 
quenched by addition of 0.1 vol of 1 M Tris-HCl, pH 7.5, and incubation for 30 min at 
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4°C. SDS was added to 1.25%, and samples were warmed at 65°C for 20 min and then 
cooled to room temperature. 4 vol of 60 mM Tris-HCl, pH 7.4, 1.25% (vol/vol) Triton X-
100, 190 mMNaCl, and 6 mM EDTA were added to the cooled samples, which were then 
cleared of any nonspecifically binding proteins by incubation for 20 min at 4°C with 
protein A-Sepharose washed five times with 10 mM Tris-HCl, pH 7.5. The cleared 
samples were then subjected to immunoprecipitation with anti-Vpslp, anti-PexlOp or 
anti-Pexl9p antibodies under denaturing, nonreducing conditions. These antibodies were 
covalently linked to protein A-Sepharose as described previously [172]. Bound proteins 
were washed five times with 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% (v/v) Triton 
X-100, and eluted with 2% SDS at 95°C for 5 min. Eluted proteins were analyzed by 
SDS-PAGE under reducing conditions, i.e., withDTT in the sample buffer, followed by 
silver staining. 
For identifying proteins that interact with Vpslp or Pexl9p in the cytosol, wild-
type and mutant cells were subjected to subcellular fractionation (see above) to yield the 
200S (cytosolic) fraction in buffer H (5 mM MES, pH 5.5, 1 mM KC1, 0.5 mM EDTA, 
0.1% ethanol, 1 x protease inhibitor cocktail [PIC] [48] containing 1 M sorbitol. 9 vol of 
ice-cold LCC buffer (20 mM sodium phosphate buffer, pH 7.5, and 150 mM NaCl) were 
added to the recovered cytosolic fraction. Cross-linking with DSP was initiated by the 
addition of cross-linker (50 mM stock in DMSO) and continued for 1 h at 4°C. Cross-
linking was quenched by addition of 0.1 vol of 1 M Tris-HCl, pH 7.5, and incubation for 
30 min at 4°C. SDS was added to 1.25%, and samples were warmed at 65°C for 20 min 
and then cooled to room temperature. 4 vol of 60 mM Tris-HCl, pH 7.4, 1.25% (vol/vol) 
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Triton X-100, 190 mMNaCl, and 6 mM EDTA were added to the cooled samples, which 
were then cleared of any nonspecifically binding proteins by incubation for 20 min at 4°C 
with protein A-Sepharose washed five times with 10 mM Tris-HCl, pH 7.5. The cleared 
samples were then subjected to immunoprecipitation with anti-Vpslp or anti-Pexl9p 
antibodies under denaturing, nonreducing conditions. These antibodies were covalently 
linked to protein A-Sepharose as described previously [172]. Bound proteins were 
washed five times with 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% (v/v) Triton X-100, 
and eluted with 2% SDS at 95°C for 5 min. Eluted proteins were analyzed by SDS-PAGE 
under reducing conditions, i.e., with DTT in the sample buffer, followed by silver 
staining. 
Electron microscopy and morphometric analysis 
Whole cells were fixed in 1.5% KMn04 for 20 min at room temperature, dehydrated by 
successive incubations in increasing concentrations of ethanol, and embedded in 
Poly/Bed 812 epoxy resin (Polysciences). Ultrathin sections were cut using an Ultra-Cut 
E Microtome (Reichert-Jung). Silver/gold thin sections from the embedded blocks were 
examined in a JEOL JEM-2000FX transmission electron microscope. For morphometric 
analysis of random electron microscopic sections of cells, 12 x 14-cm prints and 8 x 10-
cm negatives of 35-40 cell sections of each strain at 24,000-29,000 magnification were 
scanned and converted to digitized images with an HP ScanJet 4400c (Hewlett-Packard 
Co.) and Adobe Photoshop 6.0 software (Adobe Systems Inc.). Quantitation of digitized 
images was performed using the Discovery Series Quantity One 1-D Analysis Software 
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(Bio-Rad Laboratories). Relative area of peroxisome section (%) was calculated as "area 
of peroxisome section/area of cell section x 100". Peroxisomes were counted in electron 
micrographs, and data are expressed as the number of peroxisomes per um3 of cell section 
volume. 
Resealed peroxisomes RPA and RPB floated to low density during centrifugation 
in a multistep sucrose density gradient. A 200-ul aliquot of the peak fraction of purified 
RPA in MR buffer (10 mM MES/KOH, pH 5.5, 1 mM KC1, and 0.5 mM EDTA) or a 
200-ul aliquot of the peak fraction of purified RPB in HR buffer (10 mM HEPES/KOH, 
pH 7.5, 1 mM KC1, and 0.5 mM EDTA) was mixed with 400 ul of ice-cold 150 mM 
sodium cacodylate buffer, pH 7.2, containing 3% glutaraldehyde. Immediately after 
mixing the sample and glutaraldehyde solution, 600 ul of 2% OSO4 in ice-cold CD buffer 
(100 mM sodium cacodylate, pH 7.2) was added. After a 2-h incubation on ice, the 
resealed peroxisomes RPA and RPB were sedimented at 100,000 x g for 20 min at 4°C in 
a Beckman TLS55 rotor (Beckman) onto a bed (25-50 ul) of hardened, low-melting 2.5% 
NuSieve GTG agarose (FMC). The pellet was postfixed in a solution of 1% Os04 plus 
2.5% K^C^Oy in ice-cold CD buffer for 2 h on ice. The pellet was then rinsed twice with 
ice-cold CD buffer and exposed to 0.05% tannic acid in the same buffer. After a 30-min 
incubation on ice, the pellet was washed once with ice-cold CD buffer and three times 
with water. The pellet was incubated overnight with 2% uranyl acetate in water at 4°C 
and then washed three times with water. After dehydration in a graded ethanol series, the 
fixed and stained sample was embedded in Poly/Bed 812 epoxy resin (Polysciences). 
Silver/gold thin sections from the embedded blocks were examined in a JEOL JEM-
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2000FX transmission electron microscope. 
Immunoaffinity chromatography under native conditions 
Covalent coupling of affinity-purified antibodies to protein A-Sepharose for 
immunoaffinity chromatography was performed as described previously [47]. For 
immunoaffinity chromatography under native conditions, peroxisomal matrix proteins 
recovered in the supernatant fraction after centrifugation of osmotically lysed 
peroxisomes and peroxisomal liposomes were diluted with an equal volume of 50 mM 
Tris-HCl, pH 7.5, buffer containing 300 mM NaCl, 1% (v/v) Triton X-100 and protease 
inhibitor cocktail. The pellets of PMPs recovered after centrifugation of osmotically 
lysed peroxisomes and peroxisomal liposomes were resuspended in 25 mM Tris-HCl, pH 
7.5, buffer containing 150 mM NaCl, 0.5% (v/v) Triton X-100 and protease inhibitor 
cocktail. Samples were cleared of any non-specifically binding proteins by incubation for 
20 min at 4°C with protein A-Sepharose washed five times with 10 mM Tris-HCl, pH 
7.5. The cleared samples were then subjected to immunoaffinity chromatography. Bound 
proteins were washed five times with 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% 
(v/v) Triton X-100, and eluted with 100 mM glycine, pH 2.8. Proteins were precipitated 
by addition of trichloroacetic acid to 10%, washed in ice-cold 80% (v/v) acetone, and 
then subjected to SDS-PAGE followed by immunoblotting. 
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Reconstructing in vitro the relocation of Aox from the matrix to the membrane and 
its interaction with membrane-bound Pexl6p using peroxisomal and non-
peroxisomal proteins 
For preparing peroxisomal liposomes, the immature peroxisomal vesicles PI to P5 and 
mature peroxisomes P6 were purified as described above. Peroxisomes were osmotically 
lysed by incubation on ice for 20 min in 20 mM HEPES-KOH buffer, pH 8.0, containing 
50 mM NaCl and protease inhibitor cocktail. The lysate was subjected to centrifugation at 
100,000 x
 g for 20 min at 4°C in a TLA110 rotor (Beckman) to yield a supernatant 
containing peroxisomal matrix proteins (including Aox) and a pellet of peroxisomal 
membrane proteins (PMPs). Matrix proteins were dialyzed against buffer R (20 mM 
MES-KOH, pH 6.0, 150 mM NaCl, 5 mM DTT, 10% glycerol) containing 1% (w/v) n-
octyl-6-D-glucopyranoside (OG). Immunoaffinity chromatography under native 
conditions (see the protocol described above) using anti-Aoxlp antibodies covalently 
linked to protein A-Sepharose was used to deplete these peroxisomal matrix proteins of 
Aox. Aox complex for the reconstitution of peroxisomal liposomes was purified from the 
matrix of peroxisomes by immunoaffinity chromatography using anti-Aox3p antibodies 
covalently linked to protein A-Sepharose, as described above. After elution with buffer E 
(20 mM HEPES-KOH, pH 7.5, 250 mM MgCl2, 5 mM DTT, 10% glycerol), purified 
Aox complex was dialyzed against buffer R containing 1% (w/v) OG. The pellet of PMPs 
recovered after centrifugation of osmotically lysed peroxisomes was resuspended in ice-
cold buffer R containing 1% (w/v) OG. After incubation on ice for 20 min with 
occasional agitation, the sample of detergent-solubilized PMPs was subjected to 
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centrifugation at 100,000 x
 g for 20 min at 4°C in a TLA110 rotor. The resulting 
supernatant of solubilized PMPs was depleted of the Aox-Pexl6p complex by 
immunoaffinity chromatography under native conditions (see the protocol described 
above) using anti-Aoxlp antibodies covalently linked to protein A-Sepharose. Pexl6p for 
the reconstitution of peroxisomal liposomes was purified, by immunoaffinity 
chromatography using anti-Pexl6p antibodies covalently linked to protein A-Sepharose 
(as described above), from the pellet of PMPs recovered after centrifugation of 
osmotically lysed peroxisomes resuspended in ice-cold buffer R containing 1% (w/v) 
OG. After elution with buffer ER (20 mM HEPES-KOH, pH 7.5, 250 mM MgCl2, 5 mM 
DTT, 10% glycerol, 1% (w/v) OG), purified Aox complex was dialyzed against buffer R 
containing 1% (w/v) OG. 
Detergent-solubilized PMPs immunodepleted of the Aox-Pexl6p complex and 
either supplemented or not supplemented with purified Pexl6p were mixed with either 
dialyzed matrix proteins immunodepleted of Aox or dialyzed soluble non-peroxisomal 
proteins, as well as and with purified Aox complex. After incubation on ice for 20 min 
with occasional agitation, the mixture of peroxisomal matrix proteins (or of soluble non-
peroxisomal proteins) and PMPs (all in buffer R containing 1 % (w/v) OG) was added to 
the lipids extracted from the membrane of the corresponding peroxisomal subform and 
dried down by a gentle stream of nitrogen. The lipid film was dissolved by gentle 
agitation for 20 min at room temperature. To dilute the detergent OG below its critical 
micellar concentration, thereby promoting the formation of peroxisomal liposomes, 3 
volumes of buffer D (20 mM MES-KOH, pH 6.0, 150 mM NaCl) were added to the 
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mixture of peroxisomal matrix proteins (or soluble non-peroxisomal proteins), detergent-
solubilized PMPs and membrane lipids dissolved in buffer R containing 1% (w/v) OG. 
To remove the detergent, the samples were dialyzed in a Tube-O-Dialyzer (7.5-kD 
cutoff) (Chemicon) against buffer D containing 0.1% Biobeads SM2 (Bio-Rad). After 
overnight dialysis at 4°C, samples were transferred to the bottom of ultraclear centrifuge 
tubes (Beckman) and supplemented with 4 volumes of 65% (w/w) sucrose in buffer D in 
order to adjust the sucrose concentration of the samples to 52% (w/w). Samples were 
then overlaid with 40% and then with 20% sucrose (both w/w in buffer D) and lastly with 
buffer D alone. After centrifugation at 200,000 *g for 18 h at 4°C in a SW50.1 rotor 
(Beckman), 18 fractions of 275 ul each were collected. Peroxisomal liposomes were 
recovered at the 52%/40% sucrose interface. 
Mass spectrometry 
Proteins were resolved by SDS-PAGE and visualized by silver staining (Shevchenko et 
al., 1996). Protein bands were excised from the gel, reduced, alkylated and in-gel-
digested with trypsin (Shevchenko et al., 1996). The proteins were identified by matrix-
assisted laser desorption/ionization mass spectrometric peptide mapping (Jimenez et al., 
1998), using a Micromass M@LDI time-of-flight mass spectrometer (Waters). Database 
searching using peptide masses was performed with the Mascot web-based search engine. 
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2.4 Results 
2.4.1 Lipid composition of the peroxisomal membrane is changed during the last 
step of the assembly of the division-competent mature peroxisome 
Thin layer chromatography revealed that, in wild-type cells, the levels of phosphatidic 
acid (PA) and diacylglycerol (DAG) increased in peroxisomal vesicles that were being 
converted from P5 to P6 (Figure 2.6). PA and DAG are cone-shaped lipids that can 
induce membrane fission during organelle division (Figure 2.1). As the levels of PA and 
DAG increased, the levels of lysophosphatidic acid (LPA) decreased during the 
conversion of P5 to P6 (Figure 2.6). LPA is an inverted cone-shaped molecule and its 
presence makes membrane fission energetically unfavourable (Figure 2.1). In pexl6A 
mutant cells, which lack Pexl6p, PA and DAG accumulated and LPA disappeared even 
• Diacylglycerol (DAG) 
• Ergo sterol (Erg) 
• Ceramide (Cer) 
• Phosphatidylethanolamine (PE) 
• Phosphatidic acid (PA) 
• Phosphatidylcholine (PC) 
• Phosphatidylinositol (PI) 
• Phosphatidylserine (PS) 
• Lysophosphatidic acid (LPA) 
Figure 2.6. As peroxisomes mature to become division-competent, LPA is converted into PA and DAG. A) 
In wild-type cells, P6 contains negligible amounts of LPA and increased amounts of PA and DAG as 
compared to immature peroxisomal sub forms. B) In cells lacking Pexl6p, the conversion of LPA to PA and 
DAG occurs even in immature peroxisomes P3. These mutant cells cannot assemble P4, P5 or P6 
peroxisomes. C) In cells that overproduce Pexl6p, peroxisomes can mature but LPA is not converted to PA 
or DAG and therefore never becomes division-competent. 
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in the membrane of immature peroxisomal vesicles P3 (Figure 2.6). This pattern 
coincided with the excessive proliferation of immature peroxisomal vesicles P3 and their 
inability to be converted to P4 inpexl6A mutant cells [126]. Conversely, PEX-TH mutant 
cells, which overproduce Pexl6p [1261], did not accumulate PA or DAG and maintained 
high levels of LP A even in the membrane of P6 (Figure 2.6). Importantly, I found that in 
peroxisomal liposomes reconstituted from PI liposomes and radiolabeled [l4C]LPA, the 
amount of [14C]PA increased as the amount of [14C]LPA decreased provided the 
liposomes were depleted of Pexl6p (Figure 2.7). Over time, these PI liposomes would 
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Figure 2.7. Dynamics of radiolabeled lipids in PI liposomes that contain Pexl6p (+ Pexl6p) or lack it (-
Pexl6p). In the absence of Pexl6p, LPA acid is converted into PA and then DAG in about 1 hour. By 
contrast, LPA is not metabolized in the presence of Pexl6p. Conversely, the conversion of PA to DAG is 
independent of the presence of Pexl6p. 
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contain decreasing amounts of [14C]PA and increasing amounts of [14C]DAG (Figure 
2.7). However, if PI liposomes were reconstituted with [,4C]PA instead of [14C]LPA, I 
found that [14C]DAG accumulated in the presence or absence of Pexl6p (Figure 2.7). 
Taken together, my aforementioned findings provide evidence that: 1) the 
conversion of P5 to P6 is marked by the biosynthesis of PA and DAG in the peroxisomal 
membrane; 2) PA and DAG are formed in a two-step biosynthetic pathway, which 
includes two consecutive enzymatic reactions catalyzed by an LPA acyltransferase 
(LPAAT) and a PA phosphatase (PAP); and 3) Pexl6p, a negative regulator of the 
division of immature peroxisomal vesicles, inhibits LPAAT (Figure 2.8). 
® ® 
T LPAAT (Acyltransferase) T PAP (Phosphatase) 
0 7 === >0 >-0H 
' FA-OH CoA 
Pex16p 
LPA PA DAG 
Figure 2.8. Pexl6p inhibits LPAAT, the first enzyme in a two-step biosynthetic pathway leading to the 
formation of DAG in the peroxisomal membrane during conversion of P5 to P6. 
2.4.2 The conversion of LPA to PA and then to DAG is a two-step biosynthetic 
pathway carried out by Skip (an LPAAT) and Dpplp (a PAP) 
Dr. Guo provided evidence that the LPAAT and PAP reactions are the only reactions 
leading to the formation of PA and DAG, respectively, in the peroxisomal membrane. 
She found that this membrane lacked the activities of all other enzymes that can promote 
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the biosynthesis of PA or DAG [141, 175, 176], including phospholipase D, inositol 
phosphosphingolipid phospholipase C (PLC), phosphoinositide-specific PLC, DAG 
kinase, inositol phosphorylceramide synthase, and inositolphosphotransferase 1). 
Furthermore, Dr. Guo purified LPAAT and PAP from the membrane of P6. Using mass 
spectrometry, Dr. Guo identified purified LPAAT and PAP as Slclp, an acylglycerol-3-
phosphate acyltransferase [177], and Dpplp, a diacylglycerol pyrophosphate phosphatase 
[178], respectively. Using highly purified peroxisomes of wild-type cells, she found that 
all six peroxisomal subforms have similar amounts of both Slclp (LPAAT) and Dpplp 
(PAP). Dr. Guo also demonstrated that, akin to the peroxisomal integral membrane 
protein Pex2p [126] and in contrast to the peroxisomal peripheral membrane protein 
Pexl6p [126], neither Slclp (LPAAT) nor Dpplp (PAP) was solubilized by either 1 M 
NaCl or 0.1 M Na2C03 (pH 11.0) [51]. She therefore concluded that both Slclp 
(LPAAT) and Dpplp (PAP) are integral membrane proteins. Furthermore, Dr. Guo found 
that, like Pexl6p attached to the lumenal face [126] and unlike the peripheral membrane 
protein Pexl9p on the cytosolic face of peroxisomes [126], both Slclp (LPAAT) and 
Dpplp (PAP) were resistant to digestion by external protease added to intact peroxisomes 
[51]. Altogether, these data of Dr. Guo imply that, in all six peroxisomal subforms, both 
Slclp (LPAAT) and Dpplp (PAP) are integral membrane proteins that do not face the 
cytosol, being integrated into the lumenal leaflet of the membrane. 
I therefore decided to investigate the effect of mutations eliminating Slclp or 
Dpplp on lipid composition of the peroxisomal membrane and on the ability of mature 
peroxisomes P6 to divide. I found that the lack of LPAAT in sic J A mutant cells: 1) 
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abolished the formation of PA and DAG and prevented the disappearance of LPA in the 
membrane of P6 (Figure 2.9); and 2) resulted in a reduced number of greatly enlarged 
mature peroxisomes (Figure 2.10). Moreover, I found that the lack of PAP in dpplA 
mutant cells: 1) did not impair the Slclp (LPAAT)-dependent biosynthesis of PA from 
LPA in the membrane of P6 (Figure 2.9); 2) prevented the conversion of PA to DAG in 
the membrane of P6 (Figure 2.9); and 3) resulted in fewer, but greatly enlarged, mature 
peroxisomes (Figure 2.10). 
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Figure 2.9. Slclp promotes the conversion of LPA to PA, whereas Dpplp catalyzes the subsequent 
biosynthesis of DAG from PA. A) In wild-type cells, mature peroxisomes P6 are able to convert LPA to 
PA and DAG. B) Mature P6 peroxisomes in cells lacking Slclp are unable to convert LPA to PA. C) 
Mature P6 peroxisomes in cells lacking Dpplp gene cannot convert PA to DAG. 
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wild type sldA dpplA 
Figure 2.10. Lack of Skip (LPAAT) or Dpplp (PAP) greatly increases the size of peroxisomes and 
dramatically reduces their number. Transmission electron micrographs of the wild-type, sic]A and dpplA 
strains grown for 9 h in oleic acid-containing medium. P, peroxisome. 
Altogether, my aforementioned findings provide evidence that: 1) both the Slclp 
(LPAAT)-dependent formation of PA from LP A and the subsequent Dpplp (PAP)-
dependent biosynthesis of DAG from PA, which occur in the lumenal leaflet of the 
peroxisomal membrane only during conversion of P5 to P6, are essential for the division 
of P6; and 2) although the biosynthesis of PA is necessary for the division of P6, the 
presence of PA alone is not sufficient for promoting this process, which also requires the 
biosynthesis of DAG. It remains to be established whether DAG alone stimulates 
peroxisome division or, alternatively, the simultaneous presence of PA and DAG in the 
membrane of P6 is mandatory for its fission. 
2.4.3 The binding of Pexl6p to LPA prevents the formation of PA and DAG in the 
membranes of immature peroxisomal vesicles 
Because Pexl6p inhibits LPAAT in the membranes of PI to P5, thereby preventing the 
formation of both PA and DAG, I sought to define the mechanism for the negative 
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regulation of LPAAT by Pexl6p in immature peroxisomal vesicles. I found that Pexl6p 
solubilized with the detergent n-octyl-J3-D-glucopyranoside (n-OG) from the membranes 
of PI to P5 purified from wild-type cells was able to bind only to LPA, a substrate of 
LPAAT, but not to any other lipid tested (Figure 2.11). In contrast, n-OG-soluble Pexl6p 
of mature peroxisomes P6 did not bind to LPA if these peroxisomes were recovered from 
B 
LPA J. 
Binding of Pexl6p to various lipids 
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Figure 2.11. Pexl6p binds to LPA only in the membranes of division-incompetent peroxisomal subforms. 
(A and B) Different peroxisomal subforms purified from wild-type cells (A) and highly purified mature 
peroxisomes P6 of wild-type and mutant strains (B) were osmotically lysed and subjected to centrifugation. 
The pellet of membranes after such centrifugation was solubilized with a detergent, n-OG. Equal quantities 
of detergent-soluble membrane proteins were analyzed by protein-lipid overlay assay using commercial 
PIP-Strips. Pexl6p was detected by immunoblotting with anti-Pexl6p antibodies. 
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wild-type or aoxlA, aox2A and aox3A mutant strains (Figure 2.11). I found that all these 
strains lack LPA and carry both PA and DAG in the membranes of their division-
competent mature peroxisomes (Figure 2.12). Of note, Pexl6p has been shown to be 
attached to the membranes of immature peroxisomal vesicles only in its free form, 
whereas all the Pexl6p on the inner face of mature peroxisomes of wild-type or aoxlA, 
aox2A and aoxSA mutant cells is titrated by its interaction with Aox [51]. Importantly, the 
interaction between Pexl6p and Aox is not affected by n-OG (Dr. Guo's data). 
Altogether, my aforementioned findings suggest that the binding of Aox to Pex 16p in 
mature peroxisomes of wild-type cells greatly decreases the affinity between Pex 16p 
and LPA, thereby allowing LPA to enter the two-step biosynthetic pathway leading to the 
formation of PA and DAG. My hypothesis is supported by the observation that n-OG-
soluble Pexl6p of mature peroxisomes was capable of binding to LPA if these mature 
peroxisomes were purified from aox4A, aox5A or PEX16-TH strains (Figure 2.11). All 
these mutant strains: 1) carry Pexl6p in a free form that is not titrated by its interaction 
with Aox; 2) are deficient in the division of mature peroxisomes; and 3) accumulate a 
reduced number of greatly enlarged mature peroxisomes [45] that contain LPA but lack 
both PA and DAG (Figure 2.12). 
2.4.4 The relocation of Aox from the matrix to the membrane of P6 peroxisomes is 
due only to an increase in the total mass of matrix proteins above a critical level 
I hypothesized that there might be three molecular mechanisms underlying the observed 
relocation of Aox from the matrix to the membrane within mature peroxisomes P6. First, 
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Figure 2.12. Mutations that abolish the binding of Aox to Pexl6p, thereby impairing peroxisome division, 
prevent the biosynthesis of PA and DAG in the peroxisomal membrane. Highly purified peroxisomal 
sub forms were osmotically lysed and subjected to centrifugation. Equal quantities of the pelleted membrane 
proteins recovered from different peroxisomal subforms were subjected to lipid extraction, which was 
followed by TLC and visualization of lipids. 
it is plausible that the relocation of Aox is due only to an increase in the total mass of 
matrix proteins above a critical level. In this mechanism, this movement of Aox is not 
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caused by its interaction with any specific protein in the matrix (Figure 2.3). Second, it is 
possible that: 1) a specific matrix protein rather than protein mass in the peroxisomal 
matrix initiates the relocation of Aox from the matrix to the membrane; and 2) this 
specific matrix protein is present already in the early peroxisomal precursors PI and P2 
and is activated only when the total mass of matrix proteins exceeds a critical level 
(Figure 2.4). Third, it is conceivable that: 1) a specific matrix protein rather than protein 
mass in the peroxisomal matrix initiates the relocation of Aox; and 2) this specific matrix 




Centrifuge @ 100,000 g Q £ ' \ Q I Osmotic lysis fffeN p i p g 
o'\. /d& \ o y 
Purify Aox by immunoaffinity chromatography 
Immunodeplete matrix proteins of Aox 
Add detergent; 
[detergent] > CMC 
Add detergent; 
[detergent] > CMC -
X 
Solubilize membrane Solubilize membrane 
proteins with a detergent; lipids with Chloroform: 
[detergent] > CMC MeOH 
• / 
Dry down solubilized 
membrane lipids 
Mix 
Dissolve lipid films 
- in a detergent; 
[detergent] > CMC 
Reconstitute peroxisomal liposomes by 
diluting the detergent below its CMC 
£8w • v F I P1- ... P6 - based liposomes 
Purify reconstituted peroxisomal liposomes by flotation on a sucrose density gradient 
Figure 2.13. Reconstructing in vitro (i.e., in peroxisomal liposomes) the relocation of Aox from the matrix 
to the membrane and its interaction with membrane-bound Pexl6p using peroxisomal matrix and 
membrane proteins recovered from each of the six peroxisomal subforms purified from wild-type strain of 
the yeast Y. lipolytica. See Materials and methods for details. 
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during the conversion of P5 to P6 (Figure 2.5). To test if the third of the aforementioned 
mechanisms is responsible for the relocation of Aox from the matrix to the membrane in 
mature peroxisomes P6, I reconstituted such relocation of Aox in vitro {i.e., in 
peroxisomal liposomes) using peroxisomal matrix and membrane proteins recovered 
from each of the six peroxisomal subforms purified from wild-type strain of the yeast Y. 
lipolytica (Figure 2.13). Importantly, I found that, regardless of which of the six 
peroxisomal subforms has been taken for the reconstruction of peroxisomal liposomes, 
Aox associated with their membranes if the concentration of matrix proteins used for the 
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Figure 2.14. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aoxlp subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of matrix proteins that have been taken for their 
reconstitution and recovered in their matrix. 
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membrane-bound Aoxlp and Aox5p subunits in these peroxisomal liposomes was 
proportional to the level of matrix proteins that have been taken for their reconstirution 
and recovered in their matrix (Figures 2.14 and 2.15). It should be stressed that the 
observed relocation from the matrix of peroxisomal liposomes to their membranes was 
observed only for Aox but not for malate synthase or thiolase, the two abundant proteins 
in the matrices of various peroxisomal subform (note that thiolase is not present in PI 
[45] (Figures 2.16 and 2.17). Altogether, my aforementioned findings invalidate the third 
possible molecular mechanism for the relocation of Aox from the matrix to the 
membrane of P6, in which a specific matrix protein imported to the peroxisome only 
during the last step of peroxisome maturation (i.e., during the conversion of P5 to P6) 
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Figure 2.15. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aox5p subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of matrix proteins that have been taken for their 
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Figure 2.16. In contrast to Aox, malate synthase (MLS) does not relocate from the matrix to the membrane 
of peroxisomal liposomes reconstituted from various amounts of matrix proteins that have been recovered 
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Figure 2.17. In contrast to Aox, thiolase (THI) does not relocate from the matrix to the membrane of 
peroxisomal liposomes reconstituted from various amounts of matrix proteins that have been recovered 
from the five different peroxisomal subforms. Note that thiolase is not imported into the immature 
peroxisomal vesicle PI [45]. 
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To test if the second of the aforementioned mechanisms is responsible for the 
relocation of Aox from the matrix to the membrane in mature peroxisomes P6, I 
reconstituted such relocation of Aox in vitro (i.e., in peroxisomal liposomes) using 
several non-peroxisomal proteins (Figure 2.18). Importantly, I found that, regardless of 
which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, Aox associated with their membranes if the concentration of the 
non-peroxisomal proteins cytochrome c, bovine serum albumin or apoferritin used for the 
reconstruction exceeded a certain level (Figures 2.19, 2.20, 2.21, 2.22, 2.23 and 2.24). In 
fact, the percentage of membrane-bound Aoxlp and Aox5p subunits in these peroxisomal 
liposomes was proportional to the level of the non-peroxisomal proteins cytochrome c, 
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Figure 2.18. Reconstructing in vitro (i.e., in peroxisomal liposomes) the relocation of Aox from the matrix 
to the membrane and its interaction with membrane-bound Pexl6p using non-peroxisomal. See Materials 
and methods for details. 
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Figure 2.19. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aoxlp subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of the non-peroxisomal protein cytochrome c that has 
been taken for their reconstitution and recovered in their matrix. 
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Figure 2.20. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aox5p subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of the non-peroxisomal protein cytochrome c that has 
been taken for their reconstitution and recovered in their matrix. 
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Figure 2.21. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aoxlp subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of the non-peroxisomal protein bovine serum albumin 
that has been taken for their reconstitution and recovered in their matrix. 
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Figure 2.22. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aox5p subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of the non-peroxisomal protein bovine serum albumin 
that has been taken for their reconstitution and recovered in their matrix. 
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Figure 2.23. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aoxlp subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of the non-peroxisomal protein apoferritin that has 
been taken for their reconstitution and recovered in their matrix. 
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Figure 2.24. Regardless of which of the six peroxisomal subforms has been taken for the reconstruction of 
peroxisomal liposomes, the percentage of membrane-bound Aox5p subunit of the Aox complex in these 
peroxisomal liposomes was proportional to the level of the non-peroxisomal protein apoferritin that has 
been taken for their reconstitution and recovered in their matrix. 
bovine serum albumin or apoferritin that have been taken for their reconstitution and 
recovered in their matrix (Figures 2.19, 2.20, 2.21, 2.22, 2.23 and 2.24). It should be 
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emphasized that my data strongly suggest that the observed ability of the non-
peroxisomal proteins, if present in a concentration exceeding a critical level, to cause the 
relocation of Aox from the matrix to the membrane of reconstituted peroxisomal 
liposomes is specific. Indeed, as I found, such relocation requires both the Aox4p subunit 
of the Aox complex (which is known to be required for the attachment of the entire 
complex to the peroxisomal membrane [51] and Pexl6p (Figures 2.25, 2.26, 2.27 and 
2.28). Taken together, my aforementioned findings invalidate the second possible 
molecular mechanism for the relocation of Aox from the matrix to the membrane of P6, 
in which a specific matrix protein present already in the earliest peroxisomal precursors 
PI and P2 promotes such relocation only when the total mass of other matrix proteins 
P1| — - - - | 
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Figure 2.25. The observed relocation of the Aox complex from the matrix to the membrane of peroxisomal 
liposomes "packed" with cytochrome c requires Aox4p, a subunit of this heteropentameric protein complex 
that is essential for the anchoring of the entire complex to the peroxisomal membrane. Peroxisomal 
liposomes were reconstituted using various amounts of cytochrome c, membrane proteins immunodepleted 
of Aox, and Aox complex purified from aox4A mutant cells. 
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Figure 2.26. The observed relocation of the Aox complex from the matrix to the membrane of peroxisomal 
liposomes "packed" with bovine serum albumin requires Aox4p, a subunit of this heteropentameric protein 
complex that is essential for the anchoring of the entire complex to the peroxisomal membrane. 
Peroxisomal liposomes were reconstituted using various amounts of bovine serum albumin, membrane 
proteins immunodepleted of Aox, and Aox complex purified from aox4A mutant cells. 
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Figure 2.27. The observed relocation of the Aox complex from the matrix to the membrane of peroxisomal 
liposomes "packed" with cytochrome c requires Pexl6p, a membrane-bound docking factor for the entire 
Aox complex. Peroxisomal liposomes were reconstituted using various amounts of cytochrome c, 
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Figure 2.28. The observed relocation of the Aox complex from the matrix to the membrane of peroxisomal 
liposomes "packed" with bovine serum albumin requires Pexl6p, a membrane-bound docking factor for the 
entire Aox complex. Peroxisomal liposomes were reconstituted using various amounts of bovine serum 
albumin, membrane proteins immunodepleted of Pexl6p and Aox, and Aox complex purified from wild-
type cells. 
exceeds a critical level (i.e., in mature peroxisomes P6). 
Thus, my data provide comprehensive evidence for the validity of the first 
proposed mechanism underlying the relocation of Aox from the matrix to the membrane 
of P6. That is, such relocation of Aox: 1) is due only to an increase in the total mass of 
matrix proteins other than Aox above a critical level; and 2) is not promoted by the 
interaction of Aox with any specific matrix protein. 
2.4.5 Dynamics of changes in the transbilayer distribution of DAG and 
phosphatidylserine (PS) in the peroxisomal membrane during peroxisome 
maturation 
My aforementioned data strongly suggest that LPA enters the two-step pathway for the 
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biosynthesis of PA and DAG only when the efficiency of its binding to Pexl6p declines. 
Pexl6p is a peripheral membrane protein that is attached only to the lumenal leaflet of 
the peroxisomal membrane [179]. Furthermore, it seems unlikely that LP A can 
translocate from the lumenal to the cytosolic leaflet of the peroxisomal membrane, as its 
spontaneous transbilayer movement is very slow [45]. Moreover, as Dr. Guo 
demonstrated, neither LPAAT nor PAP faces the cytosol, being integrated into the 
lumenal leaflet of the peroxisomal membrane [45]. Altogether, these findings imply that 
the biosynthesis of PA and DAG is spatially restricted to the lumenal leaflet of the 
peroxisomal membrane. 
To evaluate the arrangement of DAG between the two leaflets of the membrane 
bilayers in different peroxisomal subforms, I decided to reconstitute two types of resealed 
peroxisomes, termed RPA and RPB, from osmotically lysed intact peroxisomes. RPA 
were reconstituted in a MES-based buffer at pH 5.5, whereas RPB were made in a 
HEPES-based buffer at pH 7.5.1 found that, similar to intact peroxisomes [51], both RPA 
and RPB could float out of the most dense sucrose during centrifugation to equilibrium in 
sucrose density gradients (Figure 2.29 A) and were bound by a single membrane (Figure 
2.29 C). In intact peroxisomes, Pexl9p is a peripheral membrane protein that resides on 
the cytosolic face of the peroxisome, whereas the peripheral membrane protein Pexl6p is 
attached to its lumenal face (Figure 2.29, B and D). In RPA, most of Pexl9p, but only a 
minor portion of Pexl6p, was accessible to trypsin and to the corresponding antigen-
specific IgG molecules exogenously added to this type of resealed peroxisomes (Figure 
2.29, B and D). Therefore, I concluded that the membrane delimiting most of the RPA 
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species formed during peroxisome resealing was present in the outside-out orientation, 
whereas only a minor fraction of RPA species had their membrane resealed in the inside-
out orientation. In contrast, in RPB, only a minor portion of Pexl9p, but most of Pexl6p, 
was accessible to trypsin and to the corresponding antigen-specific IgG molecules 
exogenously added to this type of resealed peroxisomes (Figure 2.29, B and D). Hence, I 
concluded that only a minor fraction of RPB had their membrane resealed in the outside-
out orientation, while the membrane delimiting most of the RPB species formed during 
peroxisome resealing was present in the inside-out orientation. Using a Pexl9p-specific 
fluorescent probe, I then calculated the percentage of outside out- and inside out-oriented 
species of RPA and RPB that were formed by resealing of osmotically lysed peroxisomal 
subforms PI to P6 (Figure 2.29, E and F). 
The ability to calculate the percentage of outside out- and inside out-oriented 
species of RPA and RPB allowed me to calculate the percentage of DAG residing in the 
cytosolic and lumenal leaflets of the membrane bilayers in intact peroxisomes. The DAG-
binding Clb domain of protein kinase C [51] labeled with the fluorophore Alexa Fluor 
488 was used as a DAG-specific fluorescent probe. In intact P5, only 13 ± 4% of the total 
pool of DAG was detected in the cytosolic leaflet of the membrane bilayer (Figure 2.29 
H). Thus, DAG resides predominantly in the lumenal membrane leaflet of P5. In contrast, 
DAG is distributed symmetrically between the two leaflets of the membrane bilayer in 
mature peroxisomes P6. In fact, 57 ± 3% of this lipid resided in the cytosolic membrane 
leaflet of P6 (Figure 2.29 H). 
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F i g u r e 2 .29. A s peroxisomes mature , D A G and P S change their transbilayer distr ibution in the pe rox i somal 
m e m b r a n e . A) Resealed peroxisomes R P A and R P B w e r e created from osmot ica l ly lysed matu re 
peroxisomes P 6 as descr ibed in Mater ia ls and methods . R P A and R P B were subjected to flotation on a 
mul t is tep sucrose gradient. Resealed perox isomes floated to low density dur ing centrifiigation in the 
sucrose density gradient. Proteins from equal vo lumes o f gradient fractions were analyzed b y 
immunoblo t t ing with ant ibodies to the P M P s P e x l 6 p and P e x l 9 p . Equal volumes o f gradient fractions were 
82 
also subjected to lipid extraction, which was followed by TLC and visualization of lipids. Sucrose density 
(%, w/w) of fractions, as well as the percentage of PMPs and lipids recovered in fractions, are presented. 
(B) Resealed peroxisomes RPA and RPB, which were recovered in the peak fractions of the flotation 
gradients, and a highly purified subform of the intact peroxisomes P6 from which these two types of 
resealed peroxisomes were formed, were subjected to protease protection analysis. Equal aliquots (10 ug of 
total protein) of RPA, RPB and intact peroxisomes P6 were treated with the indicated amounts of trypsin in 
the absence (-) or presence (+) of 0.5% (vol/vol) Triton X-100 for 30 min on ice. Samples were subjected to 
SDS-PAGE and immunoblotting with antibodies to Pexl6 and Pexl9. (C) Electron micrographs of the PS-
based RPA and RPB recovered in the peak fraction 5 of the flotation sucrose density gradient presented in 
A. Bars, 500 nm. (D) Resealed peroxisomes RPA and RPB, which were recovered in the peak fractions of 
the flotation gradients, and a highly purified subform of the intact peroxisomes P6 from which these two 
types of resealed peroxisomes were formed, were exposed to the Pexl6p- and Pexl9p-specific fluorescent 
reporter molecules as described in Materials and methods. The Alexa Fluor 488 fluorescence at 510 nm 
was monitored in individual samples. (E) The percentage of the P6-based RPA and RPB present in the 
outside-out or inside-out orientation. The percentage of the RPA or RPB species that were resealed in the 
outside-out or inside-out orientation was calculated as described in Materials and methods. (F) The 
percentage of RPA and RPB resealed in the outside-out or inside-out orientation following osmotic lysis of 
different peroxisomal subforms. (G) Resealed peroxisomes RPA and RPB, which were recovered in the 
peak fractions of the flotation gradients, and a highly purified subform of the intact peroxisomes P6 from 
which these two types of resealed peroxisomes were formed, were exposed to the DAG- and PS-specific 
fluorescent reporter molecules as described in Materials and methods. The Alexa Fluor 488 fluorescence at 
510 nm was monitored in individual samples. (H) The percentage of a monitored lipid, either DAG or PS, 
residing in the cytosolic leaflet of the membrane bilayer was calculated for intact peroxisomes PI to P6 as 
described in Materials and methods. 
to monitor its transbilayer distribution in the membranes of different peroxisomal 
subforms. I found that PS in the membranes of immature peroxisomal vesicles PI to P3 
resides predominantly in their cytosolic leaflets (Figure 2.29 H). As peroxisomes mature, 
PS gradually moves from the cytosolic to the lumenal leaflets of their membranes. 
Indeed, only 15 ± 1% of this lipid resided in the cytosolic membrane leaflet of P6 (Figure 
2.29 H). In summary, the aforementioned findings led me to the conclusion that the 
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assembly of mature peroxisomes promotes the specific redistribution of DAG and PS 
between the two leaflets of the peroxisomal membrane. Specifically, I found that the 
movement of DAG from the lumenal to the cytosolic leaflet of the membrane bilayer 
coincides with the translocation of PS in the opposite direction. 
2.4.6 Endoplasmic reticulum-derived phosphatidylcholine in the peroxisomal 
membrane activates both LPAAT and PAP 
As I found, the levels of phosphatidylcholine (PC), a major glycerophospholipid of the 
peroxisomal membrane [179], in P4, P5 and P6 peroxisomes of wild-type cells were 
significantly higher than in PI, P2 and P3 peroxisomes (Figure 2.6 A). I concluded that 
the observed increase in the levels of PC was not due to its de novo synthesis. In fact, the 
membranes of P3 and P4 did not contain PA and DAG (Figure 2.6 A), two substrates for 
PC biosynthesis via the PE methylation and CDP-choline pathways, respectively [141]. 
Thus, I assumed that PC is transported to the membranes of P3 and P4 during their 
conversion to P4 and P5, respectively. Three established mechanisms of intracellular 
lipid transport to organellar membranes include: 1) transport catalyzed by cytosolic lipid 
transfer proteins [180, 181]; 2) vesicle-mediated transport [182, 183]; and 3) transport at 
regions of close apposition between specialized microdomains of the endoplasmic 
reticulum (ER) membrane and the membranes of the trans Golgi or mitochondria [181, 
184]. My data imply that: 1) PC is transferred from the donor membrane of a distinct 
subcompartment of the ER to the acceptor membranes of P3 and P4 associated with this 
subcompartment; and 2) this transfer of PC requires the peroxisome-associated peroxin 
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Pex2p, provides membranes of P3 and P4 with the bulk quantities of PC, and is essential 
for the conversion of P4 to P5. My hypothesis is based on the following findings. First, a 
distinct form of the ER co-purifies with P3 and P4 peroxisomes and can be separated 
from them by treatment with EDTA [50, 64]. Second, the P3- and P4-associated ER 
subcompartment can be distinguished from the free form of the ER by buoyant density 
and the total level of membrane glycerophospholipids [64], as well as by protein 
spectrum (Figure 2.30 B). Third, the pex2A mutation increases the levels of membrane 
glycerophospholipids in the P3- and P4-associated subcompartment of the ER [64], 
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Figure 2.30. The Pex2p-dependent transfer of PC from a P3- and P4-associated subcompartment of the ER 
provides the peroxisomal membrane with the bulk quantities of this lipid. (A) The spectra of lipids found in 
the membranes of different peroxisomal subforms that were purified from wild-type and pex2A mutant 
cells. (B) The spectra of proteins recovered in the free form of the ER and in the P3- and P4-associated 
subcompartment of the ER. Organelles were purified from wild-type and pex2A mutant cells as described in 
Materials and Methods. Arrowheads mark proteins found only in the ER subcompartment associated with 
P3 and P4 or significantly enriched in this subcompartment of the ER as compared with its free form. 
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substantially decreases the level of PC in P4 (Figure 2.30 A), and impairs its conversion 
to P5 (Guo et al., unpublished data). 
Moreover, some of my findings strongly suggest that PC in the peroxisomal 
membrane is a positive regulator of both LPAAT and PAP. In fact, the specific activities 
of these two membrane-bound enzymes in liposomes reconstituted from the Pex 16p-
immunodepleted PMPs and membrane lipids of PI, P2 and P3 were significantly lower 
than in liposomes reconstituted from membrane components of P4, P5 and P6 (Figure 
2.31, A and B). Importantly, I found that LPAAT and PAP activities detected in the 
membranes of these peroxisomal liposomes were proportional to the steady-state levels 
of PC recovered in these membranes (Figure 2.31, A and B). Moreover, I was able to 
reconstruct the positive effect of PC on both LPAAT and PAP in four different types of 
the Pexl6p-immunodepleted liposomes that were reconstituted from membrane 
components of PI, P2 or P3 and varied only in the quantities of PC present in their 
membranes (Figure 2.31, C, D, E, and F). Noteworthy, I found that, by rising the 
quantities of PC in the membranes of P1-, P2- and P3-based liposomes to the levels 
comparable to those present in the membranes of P4-, P5- and P6-based liposomes, both 
LPAAT and PAP could be significantly stimulated, matching their enzymatic activities in 
liposomes reconstituted from membrane components of P4, P5 and P6 (Figure 2.31, E 
and F). Considering that all six peroxisomal subforms have similar amounts of both 
LPAAT and PAP [51], my aforementioned findings support the notion that PC in the 
peroxisomal membrane activates these two enzymes. 
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Figure 2.31. PC in the peroxisomal membrane is a positive regulator of both LPAAT and PAP. (A and B) 
The initial rates of the LPAAT (A) and PAP (B) reactions and the levels of PC recovered in the membranes 
of liposomes reconstituted from the Pexl6p-immunodepleted PMPs and membrane lipids of different 
peroxisomal subforms. Peroxisomal liposomes that lack Pexl6p were reconstituted as described in 
14 
Materials and Methods. [ C]-labeled lipid substrates were incorporated into liposomes during their 
reconstitution. (C - F) The initial rates of the LPAAT (C and E) and PAP (D and F) reactions and the levels 
of PC recovered in the membranes of four different types of liposomes reconstituted from the Pexl6p-
immunodepleted PMPs and membrane lipids of PI (C, D, E and F), P2 (E and F) or P3 (E and F) 
peroxisomes. These four different types of P1-, P2- or P3-based liposomes varied only in the quantities of 
PC used for their reconstitution and recovered in their membranes after the reconstitution. For comparison, 
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the initial rates of the LPAAT (E) and PAP (F) reactions and the levels of PC recovered in the membranes 
of liposomes reconstituted from the Pexl6p-immunodepleted PMPs and membrane lipids of P4, P5 and P6 
14 
peroxisomes are shown. To calculate the initial rates of the LPAAT and PAP reactions, the [ C]-labeled 
LPA, PA and DAG were separated by TLC and quantified by autoradiography. To visualize non-
radiolabeled PC, lipids were separated by TLC and detected using phosphomolybdic acid. 
2.4.7 The biosynthesis of PA and DAG in the peroxisomal membrane promotes the 
recruitment of Vpslp from the cytosol to the surface of the mature peroxisome 
The S. cerevisiae protein Vpslp is essential for peroxisome division [185]. Vpslp is a 
member of the dynamin protein superfamily of large GTPases that carry out a broad 
range of functions including organelle division and fusion, budding of transport vesicles, 
and cytokinesis [187]. In an attempt to test an assumption that, akin to its S. cerevisiae 
counterpart, Y. lipolytica Vpslp is required for peroxisome division, I found that lack of 
this protein in Y. lipolytica resulted in a reduced number of greatly enlarged peroxisomes 
(Figure 2.32). Morphometric analysis of random electron sections further confirmed that 
lack of Vpslp impairs the ability of completely assembled peroxisomes to divide, 
resulting in fewer, but greatly enlarged, mature peroxisomes. Importantly, these 
morphological patterns of the vpslA mutant were very similar to those observed in the 
aox4A and PEXJ 6-TH mutant strains deficient in the division of mature peroxisomes P6 
(Figure 2.32). 
S. cerevisiae Vpslp is mainly a cytosolic protein [186]. It can also be found in a 
variety of cellular locations, including the Golgi, peroxisomes and vacuoles [185]. 
Likewise, as Dr. Guo found, most of 7. lipolytica Vpslp localized to the cytosol, whereas 
the minor portion of it was associated with both low-speed (20,000 x g) and high-speed 
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Figure 2.32. The dynamin-related large GTPase Vpslp is essential for the division of mature peroxisomes. 
Transmission electron micrographs of the wild-type, vpslA, aox4A and PEX16-TH strains grown for 9 h in 
oleic acid-containing medium. P, peroxisome. 
(200,000 x g) pelletable organelles [51]. Using highly purified peroxisomal subforms of 
wild-type cells, Dr. Guo revealed that Vpslp was only present in division-competent 
mature peroxisomes P6 but not in the division-incompetent immature peroxisomal 
vesicles PI to P5 [45]. Dr. Guo also provided evidence that Vpslp is a peripheral 
membrane protein associated with the outer (cytosolic) face of mature peroxisomes P6 
[45]. 
Taken together, my aforementioned findings and Dr. Guo's data suggested that 
the conversion of P5 to P6 in wild-type cells is marked by the recruitment of Vpslp from 
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the cytosol to the surface of mature peroxisomes P6, where Vpslp drives their division. 
But how does such recruitment relate to the Pexl6p/Aox intraperoxisomal signaling 
cascade that regulates the fission of the membrane delimiting mature peroxisomes P6? 
The answer to this question came from my observation that Vpslp was bound to division-
competent mature peroxisomes of wild-type or aoxlA, aox2A and aox3A mutant strains 
(Figure 2.33). In the membranes of mature peroxisomes of all these strains, LPA was 
converted to PA and DAG (Figure 2.6). In contrast, Vpslp was not attached to mature 
peroxisomes of aox4A, aox5A or PEX16-TH mutant strains (Figure 2.33). All these 
strains are deficient in the division of mature peroxisomes [45], being unable to convert 
LPA to PA and DAG in the peroxisomal membrane (Figures 2.6 and 2.12). I 
therefore concluded that the recruitment of Vpslp from the cytosol to the surface of 
mature peroxisomes relies on the Pexl6p/Aox-dependent biosynthesis of PA and DAG in 
their membranes. 
w * • • * mmm mmm •* Vpslp 
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Figure 2.33. Only division-competent mature peroxisomes recruit Vpslp from the cytosol to the outer face 
of their membrane. Mature peroxisomes P6 were purified from wild-type and mutant cells. Equal quantities 
(20 ug) of protein from these peroxisomes were analyzed by immunoblotting with the indicated antibodies. 
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2.4.8 The recruitment of Vpslp to the peroxisomal membrane results in the 
formation of a multiprotein complex 
To test whether Vpslp interacts with other components of the peroxisomal membrane, 
Dr. Guo used a combination of cross-linking, immunoprecipitation with anti-Vpslp 
antibodies and mass spectrometry of co-immunoprecipitated proteins. Using this 
approach, she revealed a Vpslp-containing complex on the outer face of the peroxisomal 
membrane. The following 6 components of this complex were identified by mass 
spectrometry: 1) Vpslp, a dynamin-like GTPase that is required for the division of 
mature peroxisomes (see above); 2) Slalp, a protein that regulates actin cytoskeleton 
organization and dynamics [188]; 3) Abplp, a protein that promotes F-actin assembly 
[189]; 4) Actlp, a structural constituent of actin cytoskeleton in yeast [190]; 5) the 
peroxin Pexl9p, a protein required for the import and/or membrane assembly of 
numerous PMPs [15, 165]; and 6) the peroxin PexlOp, an integral PMP required for 
peroxisomal matrix protein import [15]. Dr. Guo also provided evidence that: 1) the 
PexlOp- and Pex 19p-dependent recruitment of Vpslp from the cytosol to the surface of 
the mature peroxisome is mandatory for the attachment of Slalp, Abplp and Actlp to 
this division-competent peroxisomal subform [51]; 2) Vpslp, Slalp and Abplp initially 
form a complex in the cytosol; 3) this complex is then targeted from the cytosol to the 
surface of mature peroxisomes; and 4) only after its binding to mature peroxisomes, the 
Vpslp-Slalp-Abplp complex is able to promote the attachment of Actlp to the 
peroxisomal membrane. 
But what is the role of Vpslp-associated proteins in the division of mature 
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peroxisomes P6? My electron microscopic analysis revealed that, akin to Vpslp (see 
above), each of the two other components of the Vpslp-Slalp-Abplp complex is 
required for the division of mature peroxisomes P6. In fact, lack of either Slalp or Abplp 
resulted in a reduced number of greatly enlarged peroxisomes (Figure 2.34). 
In summary, my findings and Dr. Guo's data strongly suggest that the assembly 
of the Vpslp-Slalp-Abplp complex in the cytosol precedes its attachment to the surface 
of division-competent mature peroxisomes P6. The Vpslp-Slalp-Abplp complex binds 
to P6 by interacting with Pexl9p, a component of the Pexl0p-Pexl9p complex that is 
formed in the peroxisomal membrane during the earliest steps of peroxisome assembly 
and maturation. Only after it has been attached to the membrane of P6, the Vpslp-Slalp-
Abplp complex is able to interact with Actlp, thereby promoting the recruitment of actin 
to the surface of these division-competent peroxisomes. 
Figure 2.34. The Slalp and Abplp components of the Vpslp-Slalp-Abplp complex are required for the 
division of mature peroxisomes P6. Transmission electron micrographs of wild-type, slalA and abplA 
strains grown for 9 h in oleic acid-containing medium. P, peroxisome. 
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2.5 Discussion 
Altogether the above findings suggest the following model for peroxisome division in Y. 
lipolytica (Figure 2.35). In immature peroxisomal vesicles PI to P5, Pexl6p binds LPA 
in the lumenal leaflet of the peroxisomal membrane. The binding of Pexl6p to LPA 
prevents the biosynthesis of PA and DAG in a two-step pathway, which includes two 
consecutive enzymatic reactions catalyzed by Slclp (LPAAT) and Dpplp (PAP). The 
stepwise import of distinct subsets of matrix proteins into immature peroxisomal vesicles 
PI to P5 provides them with an increasing fraction of the matrix proteins present in 
mature peroxisomes. The increase in the total mass of matrix proteins above a critical 
level, which occurs only inside mature peroxisomes, causes the redistribution of Aox 
from the matrix to the membrane and its subsequent binding to Pexl6p. This, in turn, 
greatly decreases the affinity between Pex 16p and LPA, thereby allowing LPA to enter 
the two-step biosynthetic pathway leading to the formation of PA and DAG. The 
glycerophospholipid PC, which is transferred to the peroxisomal membrane from the P3-
and P4-associated subcompartment of the ER, activates both LPAAT and PAP. The 
resulting accumulation of PA and DAG in the lumenal leaflet of the membrane of mature 
peroxisomes triggers a cascade of events ultimately leading to peroxisome division. This 
cascade of events is initiated by the spontaneous flipping of DAG, which is known for its 
very fast transbilayer translocation, between the two membrane leaflets. The movement 
of DAG, a particularly potent cone-shaped inducer of membrane bending, from the 
lumenal to the cytosolic leaflet of the membrane bilayer coincides with the translocation 
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Figure 2.35. The Pexl6p- and Aox-dependent intraperoxisomal signaling cascade drives the division of 
mature peroxisomes P6 by promoting the stepwise remodeling of lipid and protein composition of the 
peroxisomal membrane. See Discussion for details. 
DAG and PS generates a lipid imbalance across the bilayer, which may promote the 
destabilization and bending of the membrane. The biosynthesis of PA and DAG in the 
membrane of mature peroxisomes and, perhaps, the bending of the membrane due to the 
bi-directional transbilayer movement of DAG and PS promote the docking of the Vpslp-
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Slalp-Abplp complex to the surface of mature peroxisomes. This pre-assembled in the 
cytosol protein complex binds to mature peroxisomes by interacting with the peroxin 
Pexl9p. Pexl9p is a component of the Pexl0p-Pexl9p complex that is formed in the 
peroxisomal membrane during the earliest steps of peroxisome assembly. After its 
attachment to the peroxisomal membrane, the Vpslp-Slalp-Abplp complex interacts 
with Actlp, thereby recruiting this structural constituent of actin cytoskeleton to the 
surface of mature peroxisomes. The subsequent fission of the peroxisomal membrane 
leads to peroxisome division. 
It remains to be established how exactly Vpslp promotes peroxisome division. 
Initially, this dynamin-like GTPase interacts in the cytosol with Slalp and Abplp. Vpslp 
then functions in the attachment of the Vpslp-Slalp-Abplp protein complex to its 
docking factor Pexl9p on the surface of mature peroxisomes, thereby promoting the 
subsequent recruitment of actin to the membrane of division-competent peroxisomes. 
Therefore, it seems unlikely that Vpslp acts only as a mechanochemical enzyme [187] 
whose GTPase activity provides the mechanical force required for membrane fission in 
the constricted neck. Our data suggest that this dynamin-like protein may rather function 
as a regulatory GTPase [100] whose GTP-bound form promotes the multistep assembly 
of the membrane fission machinery, initially in the cytosol and then on the surface of 
division-competent mature peroxisomes. This machinery includes the Slalp, Abplp and 
Actlp components of actin cytoskeleton. The mechanism by which actin cytoskeleton 
regulates the terminal step of peroxisome division is currently being investigated. 
Similar to mitotic Golgi fragmentation [160, 191] and mitochondrial division 
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during apoptosis [192], peroxisome division is served by a protein team that is assembled 
on the peroxisomal surface in a stepwise fashion. The multicomponent protein 
machineries serving Golgi fragmentation and mitochondrial division are assembled in 
response to extraorganellar stimuli [160, 192]. In contrast, the protein team that executes 
peroxisome division undergoes multistep assembly in response to an intraperoxisomal 
signaling cascade (Figure 2.35). While this Pexl6p- and Aox-dependent signaling 
cascade is turned off inside immature peroxisomal vesicles, it is activated inside mature 
peroxisomes. Thus, it seems likely that the intraperoxisomal cascade for fine-tuning the 
fission of peroxisomal membrane is an intrinsic feature of the multistep peroxisome 
biogenesis program. Perhaps, this program has been evolved in order to separate the 
dramatic changes in the composition and architectural design of the membrane bilayer, 
all of which occur during peroxisome division, from the process of protein translocation 
across this bilayer, which takes place during peroxisome assembly. One of the benefits of 
employing such a strategy for the temporal separation of the processes of peroxisome 
assembly and division is that some of the membrane components can efficiently function 
in both processes. In fact, the peroxins PexlOp and Pexl9p known for their essential role 
in peroxisomal import of numerous matrix proteins and PMPs [15] are also required for 
the assembly of the peroxisome division machinery on the surface of mature 
peroxisomes. 
2.6 Conclusions 
My findings support the notion that a distinct set of lipid metabolic pathways operating in 
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organellar membranes and specific changes in the distribution of some lipids across the 
membrane bilayers provide a driving force for organelle division [141, 157 - 160, 163, 
193]. It is tempting to speculate that, after its spontaneous flipping between the two 
leaflets of the peroxisomal membrane (Figure 2.35), DAG undergoes the selective 
enrichment in distinct lipid domains that: 1) facilitate membrane fission through 
coordinated changes in local membrane curvature; 2) initiate the assembly of the Vpslp-
containing protein complexes on the surface of peroxisomes; and/or 3) promote the 
clustering of these protein complexes at the membrane fission site. A challenge for the 
future will be to define the spatial distribution of DAG and Vpslp-containing protein 
complexes in the membrane of division-competent mature peroxisomes. 
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3 The role of Acyl-CoA oxidase and other peroxisomal enzymes of fatty acid 
oxidation in controlling the rate of chronological aging 
3.1 Abstract 
Calorie restriction (CR) is found to extend lifespan in a wide variety of 
Eukaryotes including the single-celled budding yeast Saccharomyces cerevisiae. The 
commonly accepted "free radical theory" of aging proclaims that: (1) A variety of 
metabolic reactions within the cell and exogenous agents generate free radicals, including 
ROS; (2) ROS damage various cellular constituents such as nucleic acids, proteins and 
lipids; (3) some of this damage cannot be reversed, and thus accumulates over time; and 
(4) the accumulation of damaged cellular constituents causes aging and associated 
degenerative disorders. My findings provide the first comprehensive evidence that ROS 
that are produced in the peroxisome in the first, Aox-catalyzed reaction of fatty acid P-
oxidation do not regulate longevity in yeast under CR conditions. Moreover, I found that 
mitochondria, not peroxisomes generate the bulk of ROS in chronologically aging yeast 
placed on a CR diet. Unexpectedly, my studies aimed at elucidating the role for 
peroxisomal fatty acid oxidation in yeast longevity revealed that the formation of acetyl-
CoA, not of ROS, via peroxisomal P-oxidation of neutral lipids-derived fatty acids is 
mandatory for extending lifespan of CR yeast. My findings also led to the conclusion that 
the rate of peroxisomal P-oxidation of fatty acids that originate from stored neutral lipids 




Most of the known genetic manipulations that extend lifespan have been shown to 
cause major side effects, including irreversible developmental or reproductive defects 
[194]. An alternative way in which lifespan has been shown to be lengthened in various 
organisms is to impose a calorie restriction (CR) diet, which refers to a dietary regimen 
low in calories without undernutrition. It is well established that CR significantly extends 
lifespan of a remarkable range of organisms, including yeast, rotifers, spiders, worms, 
fish, mice, rats, and nonhuman primates [79, 81, 82, 194, 195]. This longevity results 
from the limitation of total calories derived from carbohydrates, fats or proteins to a level 
25% - 60% below that of control animals fed ad libitum [79, 194]. 
In yeast, CR can be imposed by reducing the glucose concentration in the 
complete YEPD medium from the usual 2% to 0.5% [89] or to 0.2% (this study). 
Because cells continue to feed on yeast extract plus peptone, which are rich in amino 
acids, nucleotides, and vitamins, the growth rate remains rapid as glucose levels are 
lowered. Thus, the reduction in glucose from 2% to 0.5% or to 0.2% could impose a state 
of partial energy (ATP) limitation. 
Even though CR is known for many years as the most effective way of extending 
lifespan of various organisms without genetically altering them, the mechanism(s) of its 
anti-aging action remain(s) unclear. Its complexity lies in multiple effects including 
metabolic, neuroendocrine, and apoptotic changes, which vary in intensity and exhibit 
striking differences among specific organ systems [73, 77]. A leading theory is that aging 
is caused by cumulative oxidative damage generated by ROS produced during respiration 
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[94, 95]. Oxidative damage to DNA, RNA, protein, and lipids has indeed been 
demonstrated to occur with aging [93 - 96]. This damage may limit life span. In fact, 
overexpression of the enzyme superoxide dismutase (SOD), which reduces ROS, extends 
lifespan in Drosophila [97] and in stationary phase yeast cells [98]. 
ROS are generated in multiple compartments and by multiple enzymes within the 
cell (Figure 3.1). Although the vast majority (estimated at approximately 90%) of these 
harmful compounds is produced in mitochondria (Figure 3.1) [99 - 102], ROS are also 
generated by NADP/H oxidases and phagocytic oxidases in the plasma membrane [99 -
102], in several oxidative reactions that are catalyzed by amino acid oxidases, 
cyclooxygenases, lipid oxigenase and xanthine oxidase in the cytosol [99 - 102], and 
during lipid metabolism in peroxisomes [7, 30] (Figure 3.1). The steady-state level of 
ROS within the cell is the result of a delicate balance that exists between the rates of ROS 
formation and of their detoxification in antioxidant scavenger reactions taking place in 
various cellular locations (Figure 3.2). The CuZnSOD (SOD1) subform of superoxide 
dismutase in the cytosol and the MnSOD (SOD2) subform of this enzyme in the 
mitochondrion convert superoxide radicals to a less toxic and more stable compound, 
namely hydrogen peroxide (Figure 3.2) [99 - 102]. The subsequent detoxification of 
hydrogen peroxide depends on the following enzymes (Figure 3.2) [99 - 102]: 1) 
glutathione peroxidases in the cytosol, mitochondria and peroxisomes; 2) catalases in the 
cytosol, mitochondria and peroxisomes; and 3) peroxiredoxins in the cytosol, 
mitochondria and peroxisomes. 








Figure 3.1. ROS are generated by numerous enzymes in multiple compartments within the cell, mostly (~ 
90%) within mitochondria. 
reaction leading to the formation of hydrogen peroxide, the most abundant ROS molecule 
in the cell, is catalyzed by Aox. This peroxisomal enzyme promotes the first step in the 
metabolic pathway for [3-oxidation of fatty acids, thereby controlling the level of ROS 
produced in the peroxisome. On the other hand, a peroxisomal catalase, encoded by the 
CTA1 gene, can detoxify hydrogen peroxide inside the organelle, and is known to aid in 
the resistance to exogenously added hydrogen peroxide. 
My research began investigating a possible link between steady state levels of 
peroxisomal ROS and CR-dependant chronological lifespan extension. By reducing the 
steady state level of ROS in peroxisomes of CR yeast using genetic manipulations, I was 
hoping to extend lifespan by further limiting the amount of ROS produced in the cell. 
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Figure 3.2. Detoxification of ROS occurs in antioxidant scavenger reactions that take place in the cytosol, 
mitochondria and peroxisomes. 
Unexpectedly, I discovered that lack of the ROS-producing peroxisomal Aox shortened, 
not extended, the chronological lifespan of CR yeast. Thus, contrary to my initial 
hypothesis, the rate of ROS production in peroxisomes does not control the rate of 
chronological aging. On the other hand, my observation that lack of Aox causes 
premature aging suggested that some processes taking place in the peroxisome, perhaps 
P-oxidation of fatty acids, play essential role in the aging process. I therefore decided to 
elucidate: 1) how exactly, in molecular terms, lipid metabolism in peroxisomes control 
yeast aging; and 2) what are the logistics of integrating peroxisomal lipid metabolism into 
a network of cellular processes that govern yeast aging. 
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3.3 Materials and Methods 
Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATa his3Al leu2A0 lys2A0 
ura3A0) and mutant strains pexlA (MATa his3Al leu2A0 lys2A0 ura3A0 
pexlA::kanMX4), pex5A (MATa his3Al leu2A0 lys2A0 ura3A0pex5A::kanMX4),pex6A 
(MATa his3Al leu2A0 lys2A0 ura3A0 pex6A::kanMX4), pex7A (MATa his3Al leu2A0 
lys2A0 ura3A0 pex7A::kanMX4), foxJA (MATa his3Al leu2A0 lys2A0 ura3A0 
foxlA::kanMX4\ ctalA (MATa his3Al leu2A0 lys2A0 ura3A0 ctalA::kanMX4), fox2A 
(MATa his3Al leu2A0 lys2A0 ura3A0 fox2A::kanMX4), mdh3A (MATa his3Al leu2A0 
lys2A0 ura3A0 mdh3A::kanMX4), and fox3A (MATa his3Al leu2A0 lys2A0 ura3A0 
fox3A::kanMX4) were used in this study. Media components were as follows: 1) YEPD 
(0.2% Glucose), 1% yeast extract, 2% peptone, 0.2% glucose; and 2) YEPD (2% 
Glucose), 1% yeast extract, 2% peptone, 2% glucose. 
A plating assay for the analysis of chronological life span 
Cells were grown in YEPD (0.2% Glucose) medium at 30°C with rotational shaking at 
200 rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. A sample of 
cells was removed from each culture at various time points. A fraction of the cell sample 
was diluted in order to determine the total number of cells per ml of culture using a 
hemacytometer. 10 ul of serial dilutions (1:10 to 1:103) of cells were applied to the 
hemacytometer, where each large square is calibrated to hold 0.1 ul. The number of cells 
in 4 large squares was then counted and an average was taken in order to ensure greater 
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accuracy. The concentration of cells was calculated as follows: number of cells per large 
square x dilution factor x 10 x 1,000 = total number of cells per ml of culture. A second 
fraction of the cell sample was diluted and serial dilutions (1:102 to 1:105) of cells were 
plated onto YEPD (2% Glucose) plates in triplicate in order to count the number of viable 
cells per ml of each culture. 100 \x\ of diluted culture was plated onto each plate. After a 
48-h incubation at 30°C, the number of colonies per plate was counted. The number of 
colony forming units (CFU) equals to the number of viable cells in a sample. Therefore, 
the number of viable cells was calculated as follows: number of colonies x dilution factor 
x 10 = number of viable cells per ml. For each culture assayed, % viability of the cells 
was calculated as follows: number of viable cells per ml / total number of cells per ml x 
100%. The % viability of cells in mid-logarithmic phase was set at 100% viability for that 
particular culture. 
Plating assays for the analysis of resistance to various stresses 
For the analysis of hydrogen peroxide resistance, serial dilutions (1:10 to 1:10 ) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of plates. One 
set of plates contained YEPD (2% Glucose) medium alone, whereas the other set 
contained YEPD (2% Glucose) medium supplemented with 5 mM hydrogen peroxide. 
Pictures were taken after a 3-day incubation at 30°C. 
For the analysis of oxidative stress resistance, serial dilutions (1:10 to 1:10 ) of 
wild-type and mutant cells removed from mid-logarithmic phase (day 1) and from 
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diauxic phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of 
plates. One set of plates contained YEPD (2% Glucose) medium alone, whereas the other 
set contained YEPD (2% Glucose) medium supplemented with 2.5 raM of the 
superoxide/hydrogen peroxide-generating agent paraquat. Pictures were taken after a 3-
day incubation at 30°C. 
For the analysis of heat-shock resistance, serial dilutions (1:10 to 1:10 ) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of YEPD (2% 
Glucose) plates. One set of plates was incubated at 30°C. The other set of plates was 
initially incubated at 55°C for 30 min, and was then transferred to 30°C. Pictures were 
taken after a 3-day incubation at 30°C. 
For the analysis of salt stress resistance, serial dilutions (1:10 to 1:10 ) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of plates. One 
set of plates contained YEPD (2% Glucose) medium alone, whereas the other set 
contained YEPD (2% Glucose) medium supplemented with 0.5 M NaCl. Pictures were 
taken after a 3-day incubation at 30°C. 
For the analysis of osmotic stress resistance, serial dilutions (1:10 to 1:10 ) of 
wild-type and mutant cells removed from mid-logarithmic phase (day 1) and from 
diauxic phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of 
plates. One set of plates contained YEPD (2% Glucose) medium alone, whereas the other 
set contained YEPD (2% Glucose) medium supplemented with 1 M sorbitol. Pictures 
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were taken after a 3-day incubation at 30°C. 
Monitoring the formation of ROS 
Wild-type and mutant cells grown in YEPD (0.2% Glucose) were tested microscopically 
for the production of ROS by incubation with dihydrorhodamine 123 (DHR). In the cell, 
this nonfluorescent compound can be oxidized to the fluorescent chromophore rhodamine 
123 by ROS. Cells were also probed with a fluorescent counterstain Calcofluor White 
M2R (CW), which stains the yeast cell walls fluorescent blue. CW was added to each 
sample in order to label all cells for their proper visualization. DHR was stored in the 
dark at -20°C as 50 ul aliquots of a 1 mg/ml solution in ethanol. CW was stored in the 
dark at -20°C as the 5 mM stock solution in anhydrous DMSO (dimethylsulfoxide). 
The concurrent staining of cells with DHR and CW was carried out as follows. 
The required amounts of the 50 ul DHR aliquots (1 mg/ml) and of the 5 mM stock 
solution of CW were taken out of the freezer and warmed to room temperature. The 
solutions of DHR and CW were then centrifuged at 21,000 x g for 5 min in order to clear 
them of any aggregates of fluorophores. For cell cultures with a titre of - 107 cells/ml, 
100 ul was taken out of the culture to be treated. If the cell titre was lower, proportionally 
larger volumes were used. 6 ul of the 1 mg/ml DHR and 1 ul of the 5 mM CW solutions 
were added to each 100 ul aliquot of culture. After a 2-h incubation in the dark at room 
temperature, the samples were centrifuged at 21,000 x g for 5 min. Pellets were 
resuspended in 10 ul of PBS buffer (20 mM KH2P04/KOH, pH 7.5, and 150 mM NaCl). 
Each sample was then supplemented with 5 ul of mounting medium, added to a 
106 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides 
were prepared, they were visualized under the Zeiss Axioplan fluorescence microscope 
mounted with a SPOT Insight 2 megapixel color mosaic digital camera. Several pictures 
of the cells on each slide were taken, with two pictures taken of each frame. One of the 
two pictures was of the cells seen through a rhodamine filter in order to detect cells dyed 
with DHR. The second picture was of the cells seen through a DAPI filter in order to 
visualize CW, and therefore all the cells present in the frame. 
For evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool 
(Version 3.0) software was used to calculate both the total number of cells and the 
number of stained cells. Fluorescence of individual DHR-positive cells in arbitrary units 
was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-
5 independent experiments, the value of median fluorescence was calculated by analyzing 
at least 800-1000 cells that were collected at each time point. The median fluorescence 
values were plotted as a function of the number of days cells were cultured. 
Visualization of intracellular lipid bodies 
Wild-type and mutant cells grown in YEPD (0.2% Glucose) were tested microscopically 
for the presence of intracellular lipid bodies (LB) by incubation with BODIPY 493/503. 
Cells were also probed with a fluorescent counterstain CW in order to visualize all cells 
in the population. BODIPY 493/503 was stored in the dark at -20°C as 100 jal aliquots of 
a 1 mM solution in ethanol. CW was stored in the dark at -20°C as the 5 mM stock 
solution in anhydrous DMSO. 
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The concurrent staining of cells with BODIPY 493/503 and CW was carried out 
as follows. The required amounts of the 100 ul BODIPY 493/503 aliquots (1 mM) and of 
the 5 mM stock solution of CW were taken out of the freezer and warmed to room 
temperature. The solutions of DHR and CW were then centrifuged at 21,000 x g for 5 
min in order to clear them of any aggregates of fluorophores. For cell cultures with a titre 
of- 107 cells/ml, 100 ul was taken out of the culture to be treated. If the cell titre was 
lower, proportionally larger volumes were used. The samples were then centrifuged at 
21,000 x g for 1 min, and pelleted cells were resuspended in 100 ul of TNT buffer (25 
mM Tris/HCl (pH 7.5), 150 mM NaCl and 0.2 % Triton X-100). After a 10-min 
incubation at room temperature, the samples were centrifuged at 21,000 x g for 1 min. 
Pellets were then resuspended in 100 ul of TN buffer (25 mM Tris/HCl (pH 7.5), 150 
mM NaCl), and the samples were subjected to centrifugation at 21,000 x g for 1 min. 
Pelleted cells were finally resuspended in 100 ul of TN buffer. Each 100 ul aliquot of 
cells was then supplemented with 1 ul of the 1 mM BODIPY 493/503 and 1 ul of the 5 
mM CW solutions. After a 15-min incubation in the dark at room temperature, the 
samples were centrifuged at 21,000 x g for 5 min. Pellets were resuspended in 100 ul of 
TN buffer. The samples were centrifuged again at 21,000 x g for 5 min, and pellets were 
resuspended in 100 ul of TN buffer. 10 ul of the BODIPY 493/503- and CW-treated cell 
suspension was then added to a microscope slide and covered with a coverslip. The slides 
were then sealed using nail polish. Once the slides were prepared, they were visualized 
under the Zeiss Axioplan fluorescence microscope mounted with a SPOT Insight 2 
megapixel color mosaic digital camera. Several pictures of the cells on each slide were 
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taken, with two pictures taken of each frame. One of the two pictures was of the cells 
seen through a fluorescein filter in order to detect cells dyed with BODIPY 493/503. The 
second picture was of the cells seen through a DAPI filter in order to visualize CW, and 
therefore all the cells present in the frame. For evaluating the percentage of BODIPY 
493/503-positive cells, the UTHSCSA Image Tool (Version 3.0) software was used to 
calculate both the total number of cells and the number of stained cells. 
Immunofluorescence microscopy 
Cell cultures were fixed in 3.7% formaldehyde for 45 min at room temperature. The cells 
were washed in solution B (100 mM KH2PO4/KOH pH 7.5, 1.2 M sorbitol), treated with 
Zymolyase 100T (MP Biomedicals, 1 ug Zymolyase 100T/1 mg cells) for 30 min at 30°C 
and then processed as previously described [66]. Monoclonal antibody raised against 
porin (Invitrogen, 0.25 ug/ul in TBSB buffer [20 mM Tris/HCl pH 7.5, 150 mM NaCl, 
lmg/ml BSA]) was used as a primary antibody. Alexa Fluor 568 goat anti-mouse IgG 
(Invitrogen, 2 ug/ul in TBSB buffer) was used as a secondary antibody. The labeled 
samples were mounted in mounting solution (16.7 mM Tris/HCl pH 9.0, 1.7 mg/ml p-
phenylenediamine, 83% glycerol). Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic 
digital camera (Spot Diagnostic Instruments). 
Oxygen consumption assay 
The rate of oxygen consumption by yeast cells recovered at various time points was 
109 
measured continuously in a 2-ml stirred chamber using a custom-designed biological 
oxygen monitor (Science Technical Center of Concordia University) equipped with a 
Clark-type oxygen electrode. 1 ml of YEPD medium supplemented with 0.2% glucose 
was added to the electrode for approximately 5 minutes to obtain a baseline. Cultured 
cells of a known titre were spun down at 3,000 x g for 5 minutes. The resulting pellet was 
resuspended in YEPD medium supplemented with 0.2% glucose and then added to the 
electrode with the medium that was used to obtain a baseline. The resulting slope was 
used to calculate the rate of oxygen consumption in C>2% x min"1 x 109 cells. 
Electron microscopy and morphometric analysis 
Cells were fixed in 1.5% KMn04 for 20 min at room temperature, dehydrated by 
successive incubations in increasing concentrations of ethanol, and embedded in 
Poly/Bed 812 epoxy resin (Polysciences). Ultrathin sections were cut using an Ultra-Cut 
E Microtome (Reichert-Jung). Silver/gold thin sections from the embedded blocks were 
examined in a JEOL JEM-2000FX transmission electron microscope. For morphometric 
analysis of random electron microscopic sections of cells, digitized images were analyzed 
using the UTHSCSA Image Tool (Version 3.0) software. In each of 2 independent 
experiments, the percentage of cells that contain pexopodia and/or accumulate gnarled 
LB was calculated by analyzing at least 300 cells that were collected at each time point. 
The values of the percentage of cells containing pexopodia and/or accumulating gnarled 
LB were plotted as a function of the number of days cells were cultured. 
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3.4 Results 
3.4.1 Kinetics of growth and aging of wild-type cells on various glucose 
concentrations 
Cells were grown in an aqueous medium containing YEP (1% yeast extract and 
2% bacto peptone) and one of four concentrations of glucose: 0.2%, 0.5%, 1%, and 2%. 
The full growth cycle of wild-type culture in each of these four media begins with 
logarithmic phase and progresses through diauxic and post-diauxic phases to stationary 
phase (Figure 3.3 A). In logarithmic phase, the cells use glucose to make energy via 
glycolysis (Figure 3.3 B). The diauxic and post-diauxic phases occur when nutrients 
become limited and energy metabolism shifts to respiration, at which point mitochondrial 
proteins are synthesized, growth rate slows, and cells utilize ethanol and other two and 
three carbon compounds for energy production. After a 7-day incubation, wild-type cells 
enter stationary phase. In this phase, the metabolic rate slows and cells are unable to 
divide. 
Using a plate assay for monitoring chronological lifespan (Figure 3.4; see the 
"Materials and methods" section of this chapter for a detailed description of the assay), I 
examined the lifespans of yeast cultures grown on four different concentrations of 
glucose. It should be stressed that the plate assay that we are employing for monitoring 
chronological life span is a standard assay that is routinely used for this purpose by other 
laboratories (Figure 3.5) [196]. Furthermore, the terms "survival" and "alive cells" 
(Figure 3.5) are widely used for referring to survival by quiescent yeast cells of the aging-
promoted accumulation of molecular and cellular damage [196]. 
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Figure 3.3. Kinetics of growth and glucose consumption by wild-type strain. (A) Cells undergo four phases 
of growth. In the logarithmic (L) phase, cells ferment glucose and grow exponentially. In the diauxic (D) 
phase, cells use ethanol as a carbon source and their growth rate is reduced. In the post-diauxic (PD) phase, 
the growth rate is reduced even more and finally in stationary (ST) phase the cells stop dividing. (B) 
Glucose in the medium is almost entirely consumed by the end of the first day of cell growth, regardless of 
how much was in the medium to begin with. 
As shown in Figure 3.6, CR cells grown on 0.5% or 0.2% glucose lived significantly 
longer than non-CR-yeast grown on 1% or 2% glucose. Mean lifespan of the cells grown 
on 0.5% glucose nearly doubled that of those grown on 2% (Figures 3.6 B and C). Thus, 
0.5% is an optimal concentration of glucose for achieving the benefit of CR-dependent 
age extension. Those cells grown at 1% outlived those grown at 2%, while those grown at 
0.5% outlived those grown at 1 %, representing a dose-response relationship between the 
rate of chronological aging and the degree of CR (Figure 3.6 B). 
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cells per ml of the culture 
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Figure 3.4. A plating assay for the analysis of chronological lifespan. Chronological lifespan in yeast, 
which mimics aging of nondividing or "post-mitotic" cells of higher eukaryotic organisms, is the length of 
time a population of yeast cells remains viable in a nondividing state. 
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Figure 3.5. The plate assay that we are employing for monitoring chronological life span is a standard 
assay that is routinely used for this purpose by other laboratories. Data from Fabrizio et al. Cell (2005) 
123:655-667. 
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Figure 3.6. A dose-response relationship between the rate of aging and the degree of calorie restriction. (A) 
Cells begin to die by the end of the post-diauxic phase. The death of cells grown under CR conditions (i.e., 
on 0.2% or 0.5% glucose) is delayed, as compared to cells grown under non-CR conditions (i.e., on 1.0% or 
2.0% glucose). (B) Cells grown on 0.5% glucose have the highest mean lifespan of cells grown on the four 
glucose concentrations tested. (C) Mean lifespans of cells grown on 0.2%, 0.5%, 1.0% or 2.0% glucose. 
Importantly, the measurement of ATP in cells grown on four different concentrations of 
glucose revealed that the intracellular levels of ATP and the dynamics of their change 
during chronological aging were very similar in CR and non-CR yeasts (unpublished data 
from Dr. Titorenko's laboratory). Thus, yeast cells placed on the CR diet are not starving. 
Based on my aforementioned findings, I hypothesized that: (1) CR yeast remodel their 
metabolism in order to match the level of ATP produced by non-CR yeast; and (2) such 
specific remodeling of metabolism in CR yeast extends their lifespan. 
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3.4.2 ROS that are produced in peroxisomes are not essential for chronological 
aging 
With a portion of the intracellular ROS being produced in the Aox-dependent 
reaction of peroxisomal fatty acid oxidation, I set out to see if the amount of peroxisome-
produced ROS plays a role in chronological aging under CR conditions. Peroxisomal 
Aox, a product of the S. cerevisiae FOX1 gene, catalyzes the reaction whereby activated 
free fatty acids are oxidized to form trans-2-enol-CoA. This reaction produces a quantity 
of hydrogen peroxide that can then be detoxified, using the peroxisomal catalase Ctalp, 
to form water and molecular oxygen (Figure 3.7). I tested a fox] A mutant strain for the 
rate of chronological aging on 0.2% glucose, hence knocking out its ROS-producing 
reaction, with the hypothesis that limiting the amount of ROS in the peroxisome may 
increase the lifespan of yeast cells. Contrary to my expectation, the mutant strain 
exhibited a shortened lifespan, aging prematurely once the cells reached the stationary 
phase of growth (Figure 3.7). In addition to the foxl A mutant strain, I also tested a ctalA 
mutant strain placed on the CR diet, under the same hypothesis as that was made for 
Foxlp. It appeared that lack of the ROS-decomposing peroxisomal catalase Ctalp has 
little effect on chronological aging under CR conditions (Figure 3.7). Not only does this 
finding suggest a very little or no role for peroxisomal ROS in chronological aging under 
CR, but it also provides evidence for an important regulatory role for peroxisomal P-
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Figure 3.7. ROS that are produced in peroxisomes during fatty acid oxidation are not essential for 
chronological aging of CR yeast. Lack of the H202-producing peroxisomal Foxlp shortens, not extends, 
life span. Lack of the H202-decomposing peroxisomal Ctalp has little effect on chronological aging under 
CR. 
3.4.3 Mitochondria, not peroxisomes, consume the vast majority of 0 2 and 
produce the bulk of ROS 
To test further my hypothesis that peroxisomal ROS produced in the oxygen-
consuming reaction catalyzed by Foxlp (Aox) do not affect the rate of chronological 
aging in CR-dieting yeast, I measured the rate of oxygen consumption and the level of 
ROS production by CR cells that lack this protein. I found that the rate of oxygen 
consumption by CR cells of wild-type strain significantly increased when these cells 
entered the diauxic phase of growth on 0.2% glucose and then gradually declined through 
the post-diauxic and stationary phases (Figure 3.8). In contrast, after a dramatic increase 
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Figure 3.8. Peroxisomes do not consume significant amounts of oxygen in CR yeast cells. Dynamics of 
changes in the rate of oxygen consumption by CR cells during chronological aging of the wild-type, foxlA 
and ctalA strains grown on 0.2% glucose. 
significantly exceeded those by respiring wild-type cells, the rate of oxygen consumption 
by foxlA mutant cells abruptly decreased so that upon entering stationary phase mutant 
cells consumed negligible amounts of oxygen (Figure 3.8). The observed during diauxic 
phase spike in the rate of oxygen consumption by foxl A mutant cells lacking Aox, which 
is the only known oxygen-consuming peroxisomal protein, strongly suggest that: (1) 
peroxisomes do not consume significant amounts of oxygen in CR yeast cells; and (2) the 
bulk of oxygen in CR yeast is consumed by mitochondria engaged into oxidative 
phosphorylation. My findings also suggested that the observed abrupt decline of oxygen 
consumption rate by CR foxl A mutant cells during post-diauxic phase, which followed 
the spike of respiration rate in diauxic phase, was due to the failure of oxidative 
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phosphorylation in mitochondria of foxlA mutant cells placed on the CR diet. This 
second assumption appeared to be correct (please see below). 
I then used the fluorescent dye Dihydrorhodamine-123 (DHR) for monitoring the 
dynamics of changes in the intracellular levels of ROS during chronological aging of 
wild-type and mutant strains. In the cell, this nonfluorescent compound can be oxidized 
to the fluorescent chromophore rhodamine 123 by ROS (Figure 3.9). I found that the 
number of ROS-positive CR cells of wild-type strain significantly increased when these 
cells entered the diauxic phase of growth on 0.2% glucose and then gradually declined 
through the post-diauxic and stationary phases (Figures 3.10 and 3.11). In contrast, after a 
substantial increase of ROS-positive CR cells of foxlA mutant strain entering the diauxic 
phase of growth on 0.2% glucose to the numbers very similar to those for wild-type 
strain, the number of ROS-positive foxl A mutant cells abruptly decreased so that only a 
minor portion of these cells had detectable levels of ROS upon entering stationary phase 
(Figures 3.10 and 3.11). The quantitation of the intensity of fluorescence signal detected 
by fluorescence microscopy in ROS-positive cells revealed that the intracellular level of 
ROS in CR wild-type strain significantly increased when these cells entered the diauxic 
phase of growth on 0.2% glucose and then gradually declined through the post-diauxic 
and stationary phases (Figure 3.11). In contrast, after a dramatic increase in CR cells 
entering the diauxic phase of growth on 0.2% glucose to the level that significantly 
exceeded that detected in wild-type cells, the intracellular level of ROS in foxl A mutant 
strain rapidly decreased so that upon entering stationary phase mutant cells possessed 
negligible amounts of ROS (Figure 3.11). The observed during diauxic phase spike in the 
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Figure 3.9. Using the fluorescent dye Dihydrorhodamine-123 (DHR) for monitoring the dynamics of 
changes in the intracellular levels of ROS during chronological aging of CR wild-type strain grown on 
0.2% glucose. In the cell, DHR can be oxidized to the fluorescent chromophore rhodamine 123 by ROS. 





Day 2 (D) 
Day 5 (PD) 
foxIA ctalA 
Figure 3.10. Peroxisomes do not produce significant amounts of ROS in CR yeast. ROS were visualized 
using fluorescence microscopy with DHR. 
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Figure 3.11. Peroxisomes do not produce the major portion of ROS in CR yeast. Dynamics of changes in 
the number of ROS-positive cells and intracellular level of ROS during chronological aging of the wild-
type, foxJA and ctalA strains grown on 0.2% glucose. 
intracellular level of ROS mfoxlA mutant strain lacking Aox, which is the only known 
ROS-generating peroxisomal protein, strongly suggest that: (1) peroxisomes do not 
produce significant amounts of ROS in CR yeast; and (2) the bulk of ROS in CR yeast is 
produced by mitochondria due to the transfer of electrons from components of the 
electron transport chain to oxygen consumed by these organelles. My conclusion that 
peroxisomes do not produce significant amounts of ROS in CR yeast cells was further 
supported by my observation that both the number of ROS-positive cells and the 
intracellular levels of ROS during aging of the ctalA mutant strain lacking catalase, 
which is the only known ROS-degrading peroxisomal protein, were very similar to those 
found in aging wild-type strain (Figure 3.11). 
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3.4.4 The formation of acetyl-CoA via peroxisomal P-oxidation of neutral lipids-
derived fatty acids is required for extending lifespan of CR yeast 
Altogether, my aforementioned findings provided evidence that: (1) the Aox-
dependent reaction in peroxisomes does not consume significant amounts of oxygen in 
CR yeast cells; and (2) the Aox-dependent reaction in peroxisomes does not produce 
significant amounts of ROS in CR yeast cells. On the other hand, lack of Aox in the 
fox J A mutant strain led to premature chronological aging of CR cells. Not only do these 
findings suggest a very little or no role for the Aox-dependent generation of peroxisomal 
ROS in modulating the pace of chronological aging under CR conditions, but they also 
strongly suggest that peroxisomal P-oxidation of fatty acids plays an important regulatory 
role in the beneficial effect of CR on yeast longevity. Because Aox catalyzes the first step 
in a three-step pathway of fatty acid oxidation in the peroxisome, I hypothesized that the 
formation of acetyl-CoA via peroxisomal P-oxidation of fatty acids is required for 
extending lifespan of CR yeast cells. I therefore tested the rates of chronological aging of 
the mutant strains fox2A and fox3A. These two mutants lack the enzymes that catalyze, 
respectively, the second and third steps of peroxisome-associated P-oxidation of free fatty 
acids leading to the formation of acetyl-CoA (Figure 3.12). I found that lack of any of 
these two proteins shortened chronological life span in a fashion similar to that for the 
strain lacking Foxlp, with a sharp decline in the percentage of alive cells occurring after 
entering the post-diauxic phase of growth on 0.2% glucose (Figure 3.12). In addition, 
each mutant lacking either one of the three peroxisomal P-oxidation enzymes suffered 
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Figure 3.12. Any yeast mutant that lacks an enzyme required for the formation of acetyl-CoA in 
peroxisomes ages and dies as soon as it enters the post-diauxic phase of growth on 0.2% glucose. 
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Figure 3.13. The inability of CR yeast entering post-diauxic phase to produce acetyl-CoA in peroxisomes 
results in the sharp decrease of mitochondrially synthesized ATP. 
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of growth (Figure 3.8). Taken together, my findings strongly suggested that the formation 
of acetyl-CoA via peroxisomal (3-oxidation of fatty acids is required for extending 
lifespan of CR yeast cells only when they enter post-diauxic phase. The inability of CR 
yeast entering post-diauxic phase to produce acetyl-CoA in peroxisomes resulted in the 
sharp decrease of mitochondrially synthesized ATP (Figure 3.13), and thereby 
accelerated the aging process. 
It should be stressed that the CoA-activated pool of fatty acids entering the |3-
oxidation pathway in peroxisomes is formed due to the lipolysis of neutral lipids that are 
deposited in lipid bodies (LB) [197]. LB of the yeast S. cerevisiae consist of a highly 
hydrophobic core of neutral lipids, mainly triacylglycerols and ergosteryl esters, 
surrounded by a phospholipid monolayer [198, 199]. Yeast LB also contain 16 major 
proteins, all of which are involved in lipid synthesis and degradation [197, 198]. The well 
known function of LB is storage of neutral lipids and fatty acids as an energy source and 
as a source of components needed for membrane biogenesis [197 - 199]. A reduction in 
the intracellular level of neutral lipids, the most abundant lipid of LB, was proposed to be 
a primary way by which calorie restriction extends lifespan [200, 201]. Therefore, I used 
fluorescent microscopy to monitor the kinetics of changes in the abundance of LB during 
chronological aging of wild-type and fox mutant cells. The neutral lipids stored in LB 
were visualized in living cells using the fluorescence lipophilic dye BODIPY 493/503 
(Figure 3.14). I found that the entering of wild-type cells into the post-diauxic growth 
phase on 0.2% glucose initiates rapid consumption of LB (Figures 3.14 and 3.15). In CR 
wild-type cells LB were almost entirely consumed by the beginning of stationary phase 
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Figure 3.15. Lack of any of the three enzymes involved in peroxisomal P-oxidation of fatty acids impairs 
the mobilization of neutral lipids from lipid bodies. In CR wild-type cells lipid bodies were almost entirely 
consumed by the beginning of stationary phase. In contrast, no dramatic decrease in the abundance of lipid 
bodies was seen in chronologically aging CR cells of the short-lived foxlA,fox2A and fox3A mutant strains 
grown on 0.2% glucose. 
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(Figures 3.14 and 3.15). In contrast, no dramatic decrease in the abundance of LB was 
seen in chronologically aging CR cells of the short-lived foxlA,fox2A and fox3A mutant 
strains grown on 0.2% glucose (Figure 3.15). Thus, lack of any of the three enzymes 
involved in peroxisomal P-oxidation of fatty acids impaired the mobilization of neutral 
lipids from LB, perhaps by preventing or slowing down the lipolysis of LB-stored neutral 
lipids. 
This hypothesis has been confirmed by using thin-layer chromatography (TLC) of 
neutral lipids extracted from whole cells of the wild-type and fox mutant strains. I 
revealed that, in aging wild-type cells, CR promoted: (1) lipolysis of the two neutral 
lipids, triacylglycerols (TAG) and ergosteryl esters (EE), whose hydrolysis by lipases 
represents the first step in the generation of free fatty acids (FFA) in LB; (2) the 
consumption of diacylglycerol (DAG), a product of the lipolysis of TAG by LB-bound 
lipases and a substrate of the second lipolytic reaction leading to the formation of FFA in 
LB; and (3) the consumption of FFA (Figures 3.16 and 3.17). Importantly, any of the 
three mutants (i.e.,foxlA,fox2A andfox3A) that lacks an enzyme of the peroxisomal P-
oxidation of neutral lipids-derived FFA, when grown on 0.2% glucose, was unable to 
hydrolyze TAG, EE and DAG (Figures 3.18 and 3.19). Furthermore, as soon as any of 
the three fox mutants enters stationary phase on 0.2% glucose, it begins accumulating 
FFA (Figures 3.18 and 3.19). Interestingly, the closer to the beginning of the peroxisomal 
P-oxidation pathway the missing in a fox mutant reaction is, the more of FFA is 
accumulated within cells (Figures 3.18 and 3.19). 
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Figure 3.16. In aging wild-type cells, CR promotes: 1) lipolysis of the two neutral lipids, triacylglycerols 
(TAG) and ergosteryl esters (EE), whose hydrolysis by lipases represents the first step in the generation of 
free fatty acids (FFA) in lipid bodies (LB); 2) the consumption of diacylglycerol (DAG), a product of the 
lipolysis of TAG by LB-bound lipases and a substrate of the second lipolytic reaction leading to the 
formation of FFA in LB; and 3) the consumption of FFA. 
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Figure 3.17. In aging wild-type cells, CR promotes the lipolysis of triacylglycerols (TAG) and ergosteryl 
esters (EE), degradation of diacylglycerol (DAG) and the consumption of free fatty acids (FFA). 
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Figure 3.18. Any mutant that lacks an enzyme of the peroxisomal P-oxidation of neutral lipids-derived 
FFA, when grown on 0.2% glucose, is unable to hydrolyze TAG, EE and DAG deposited in lipid bodies. 
As soon as any of the three fox mutants enters stationary phase on 0.2% glucose, it begins accumulating 
FFA. The closer to the beginning of the peroxisomal P-oxidation pathway the missing in a fox mutant 
reaction is, the more of FFA is accumulated within cells. 
But where in the cells of fox mutants entering stationary phase on 0.2% glucose these 
various lipid species (i.e., TAG, EE, DAG and FFA) accumulated? Using the TLC 
analysis of lipids extracted from purified ER (which serves as a template for the 
formation of LB) and LB, I demonstrated that the prematurely aging fox mutants grown 
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Figure 3.19. The prematurely aging^a* mutants grown on 0.2% glucose accumulate FFA, as well as TAG, 
EE and DAG, in their ER-derived lipid bodies (LB). The closer to the beginning of the peroxisomal P-
oxidation pathway the missing in a fox mutant reaction is, the more of FFA and DAG is accumulated in LB. 
(Figure 3.19). Interestingly, the closer to the beginning of the peroxisomal p-oxidation 
pathway the missing in a fox mutant reaction is, the more of FFA and DAG is 
accumulated in LB (Figure 3.19). 
But where in the cells of fox mutants entering stationary phase on 0.2% glucose 
these various lipid species (i.e., TAG, EE, DAG and FFA) accumulated? Using the TLC 
analysis of lipids extracted from purified ER (which serves as a template for the 
formation of LB) and LB, I demonstrated that the prematurely aging fox mutants grown 
on 0.2% glucose accumulate FFA, as well as TAG, EE and DAG, in their ER-derived LB 
(Figure 3.19). Interestingly, the closer to the beginning of the peroxisomal p-oxidation 
pathway the missing in a fox mutant reaction is, the more of FFA and DAG is 
accumulated in LB (Figure 3.19). 
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Figure 3.20. In yeast cells grown on oleic acid, the extensive physical contact between peroxisomes and 
lipid bodies (LB) promotes the coupling of lipolysis of neutral lipids within LB with oxidation of FFA in 
peroxisomes (Binns et al. J. Cell Biol. (2006) 173:719-731). 
It should be noted that, in yeast cells grown on oleic acid, the extensive physical contact 
between peroxisomes and LB promotes the coupling of lipolysis of neutral lipids within 
LB with oxidation of FFA in peroxisomes (Figure 3.20) [202]. Using transmission 
electron microscopy followed by morphometric analysis, I showed that, as soon as fox 
mutants enter stationary phase on 0.2% glucose, their LB begin to build up so called 
"pexopodia" and "gnarls". "Pexopodia" represent extensions and intrusions of 
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Figure 3.21. As soon as fox mutants enter stationary phase on 0.2% glucose, their lipid bodies (LB) begin 
build up so called "pexopodia" and "gnarls". "Pexopodia" represent extensions and intrusions of 
peroxisomes into LB, whereas "gnarls" epitomize organized arrays of FFA accumulated within LB. The 
closer to the beginning of the peroxisomal P-oxidation pathway the missing in a fox mutant reaction is, the 
more of both "pexopodia" and "gnarls" are accumulated within LB. 
within LB (Figure 3.21) [202]. It should be stressed that the closer to the beginning of the 
peroxisomal P-oxidation pathway the missing in a. fox mutant reaction is, the more of 
both "pexopodia" and "gnarls" are accumulated within LB (Figure 3.21). 
Altogether, my aforementioned findings provide the comprehensive evidence 
that: (1) the formation of acetyl-CoA via peroxisomal P-oxidation of neutral lipids-
derived fatty acids is required for extending lifespan of CR yeast cells; (2) in CR yeast, 
the extensive physical contact between peroxisomes and LB promotes the coupling of 
lipolysis of neutral lipids within LB with oxidation of FFA in peroxisomes; and (3) the 
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rate of peroxisomal p-oxidation of neutral lipids-derived fatty acids is a key factor 
controlling the rate of lipolysis of neutral lipids within LB and, ultimately, the rate of 
chronological aging in yeast placed on the CR diet. 
3.4.5 The rate of peroxisomal P-oxidation of neutral lipids-derived fatty acids 
controls the rate of chronological aging by modulating essential processes in 
mitochondria 
As described above, lack of any of the three Fox proteins: (1) shortened 
chronological life span of CR yeast; (2) in "young" CR cells entering diauxic growth 
phase, dramatically increased the amplitude of the observed spike in the rates of oxygen 
consumption and ROS generation by mitochondria; (3) in aging CR cells entering post-
diauxic growth phase, resulted in the sharp decrease of the rates of oxygen consumption 
and ROS generation by mitochondria; and (4) in aging CR cells entering post-diauxic 
growth phase, considerably decreased the intracellular level of mitochondrially 
synthesized ATP. 
All these findings strongly suggest that the formation of acetyl-CoA via 
peroxisomal P-oxidation of neutral lipids-derived fatty acids modulate essential processes 
in mitochondria, including the electron transport chain and oxidative phosphorylation. It 
seems that that the observed spike in the rate of ROS generation by mitochondria of the 
fox mutants irreversibly damages key mitochondrial proteins. In fact, lack of any of the 
three Fox proteins resulted in rapid inactivation of cytochrome c oxidase and aconitase in 
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mitochondria of the prematurely aging fox mutants entering post-diauxic growth phase 
(Figure 3.22). Both these mitochondrial proteins represent the key targets for the 
oxidative damage by ROS [99 - 102]. 
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Figure 3.22. Lack of any of the three Fox proteins results in rapid inactivation of cytochrome c oxidase and 
aconitase in mitochondria of the prematurely aging fox mutants entering post-diauxic growth phase. Both 
these mitochondrial proteins represent the key targets for the oxidative damage by ROS. Abbreviations: 
CCO, cytochrome c oxidase; ACO, aconitase. 
Furthermore, using the fluorescence dye Rhodamine 123 for monitoring the 
mitochondrial membrane potential (AT) (Figure 3.23), I demonstrated that lack of any of 
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Figure 3.23. Using Rhodamine 123 for monitoring the mitochondrial membrane potential (^A) in living 
cells. 
dramatically increased the value of AT, thereby leading to the hyper-polarization of the 
inner mitochondrial membrane (Figures 3.24 and 3.25); and (2) in aging CR cells 
entering post-diauxic growth phase, resulted in the sharp decrease of the value of AT 
(Figures 3.24 and 3.25), thereby rapidly abrogating the AT-dependent processes in 
mitochondria, including the transport of solutes and the synthesis of ATP. 
Although lack of any of the three Fox proteins caused age-related changes in 
essential mitochondrial processes, it did not affect the abundance of mitochondria in 
chronologically aging CR yeast. In fact, the level of porin - one of the most abundant 
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Figure 3.24. The foxIA mutation greatly increases the mitochondrial membrane potential (A*F) in cells 
entering diauxic (D) phase and causes its sharp decline in cells entering post-diauxic (PD) phase. 
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Figure 3.25. Lack of any of the three Fox proteins: (1) in "young" CR cells entering diauxic growth phase, 
dramatically increases the value of TA, thereby leading to the hyper-polarization of the inner mitochondrial 
membrane; and (2) in aging CR cells entering post-diauxic growth phase, results in the sharp decrease of 
the value of ^A. 
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Figure 3.26. Although lack of any of the three Fox proteins causes age-related changes in essential 
mitochondrial processes, it does not affect the abundance of mitochondria in CR yeast. 
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Figure 3.27. Lack of any of the three Fox proteins greatly affects the morphology of mitochondria in CR 



































Figure 3.28. Morphology of mitochondria depends on a balance between the processes of mitochondrial 
fission, fusion & tubulation. 
diauxic growth phase was very similar to that seen in wild-type cells (Figure 3.26). 
However, I found that lack of any of the three Fox proteins greatly affected the 
morphology of mitochondria in CR yeast. In fact, mitochondria in chronologically aging 
WT cells formed a tubular network (Figure 3.27). In contrast, in the foxlA mutant strain, 
this network was fragmented into individual mitochondria (Figure 3.27). Thus, the 
efficiency with which peroxisomes supply acetyl-CoA for its oxidation via the TCA cycle 
in mitochondria modulates, by a yet-to-be established mechanism, a delicate balance 
between the processes of mitochondrial fission, fusion and tubulation. Such balance plays 
a pivotal role in establishing and maintaining the morphological appearance of 
mitochondria (Figure 3.28) [203, 204]. 
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3.5 Discussion 
To study the effect of CR on the chronological lifespan of the yeast S. cerevisiae, I 
incubated wild-type strain BY4742 in rich YP medium initially containing 0.2%, 0.5%, 
1% or 2% glucose. I chose YP medium for chronological aging studies because, in 
contrast to a synthetic medium, it is rich in amino acids, nucleotides, vitamins and other 
nutrients. I therefore thought that the reduction of glucose concentration in YP medium 
would lower the number of available calories without compromising the supply of 
essential nutrients, thereby modeling a traditional CR dietary regimen established in 
experiments with laboratory rodents [205]. An equally important reason for choosing rich 
YP medium for chronological aging studies is that the recent isolation of quiescent and 
nonquiescent cells from yeast stationary-phase cultures grown in this medium provided a 
novel, valuable system for elucidating the mechanisms linking chronological aging to 
quiescence, the mitotic cell cycle and apoptosis [206, 207]. My choice of the strain 
BY4742 was based on its relatively short chronological lifespan [208], thereby offering 
considerable time savings for chronological aging studies of yeast cultivated in rich YP 
medium. Importantly, this yeast strain serves as one of the two haploid genetic 
backgrounds of the widely used Yeast Knock-Out Collection available from Open 
Biosystems. Using the developed assay for studying the chronological aging of yeast, I 
found that CR cells grown on 0.2% or 0.5% glucose lived significantly longer than cells 
grown under non-CR conditions on 1 % or 2% glucose. 
The mean chronological lifespan of cells grown on 0.2% glucose was extended by 
more than 60% and that of cells grown on 0.5% glucose was extended by almost 2-fold, 
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as compared to the mean chronological lifespan of cells grown on 2% glucose. Thus, the 
chronological lifespan of yeast can be extended by CR in a dose-dependent manner. Of 
note, CR yeast grown on 0.5% glucose lived longer than CR yeast grown on 0.2% 
glucose. Hence, 0.5% is an optimal concentration of glucose for achieving the benefit of 
CR-dependent longevity extension. Moreover, my findings imply that CR yeast cells 
remodel their metabolism in order to match the level of ATP produced by non-CR yeast 
cells. It is conceivable that such specific remodeling of metabolism in CR yeast cells 
extends their life span. The validity of this hypothesis has been recently confirmed in Dr. 
Titorenko's laboratory by using a systems biological approach for analyzing the age-
dependent dynamics of changes in proteomes and metabolomes of chronologically aging 
yeast. 
One of my objectives was to understand what role (if any) acyl-CoA oxidase and, 
perhaps, other peroxisomal enzymes of fatty acid oxidation may play in regulating yeast 
longevity. A priory, there are two different mechanisms by which fatty acid oxidation in 
peroxisomes could influence longevity of yeast under CR conditions. First, the formation 
of hydrogen peroxide in the Aox (Foxlp)-dependent reaction of fatty acid oxidation and 
its decomposition by peroxisomal catalase could modulate the level of this ROS 
molecule, which is known for its essential role in regulating longevity. However, my 
evaluation of the chronological lifespans of the foxlA mutant strain, which lacks the 
hydrogen peroxide-producing Aox, and the ctalA mutant strain, which lacks the 
hydrogen peroxide-decomposing peroxisomal catalase, provided convincing evidence 
that peroxisomally produced ROS do not influence yeast longevity under CR conditions. 
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Moreover, by monitoring the age-dependent dynamics of changes in the rates of oxygen 
consumption and ROS production by foxlA and ctalA cells, I established that in 
chronologically aging CR yeast: (1) peroxisomes do not consume significant amounts of 
oxygen and do not produce significant amounts of ROS; and (2) the bulk of oxygen is 
consumed and the major portion of ROS is generated by mitochondria due to the transfer 
of electrons from components of the electron transport chain to oxygen consumed by 
these organelles. Another mechanism by which fatty acid oxidation in peroxisomes could 
influence longevity of yeast under CR conditions consists in the ability of peroxisomes to 
generate considerable levels of acetyl-CoA, the final product of peroxisomal fatty acid 
oxidation. I hypothesized that, following its delivery to mitochondria for the oxidation via 
the tricarboxylic acid cycle, this peroxisomally produced acetyl-CoA could be 
responsible for the synthesis of the major portion of ATP in mitochondria. In support of 
this hypothesis, my analysis of the lifespans of mutants lacking Foxlp, Fox2p or Fox3p, 
along with the monitoring of oxygen consumption and ATP synthesis by their cells, 
provided evidence that the formation of acetyl-CoA via peroxisomal |3-oxidation of fatty 
acids is mandatory for the beneficial effect of CR on yeast longevity. Moreover, by 
monitoring the age-dependent dynamics of changes in the abundance of various lipid 
species during chronological aging of wild-type and fox mutant cells, I established that 
the rate of peroxisomal [3-oxidation of neutral lipids-derived fatty acids is a key factor 
controlling the rate of lipolysis of neutral lipids within LB and, ultimately, the rate of 
chronological aging in yeast placed on the CR diet. Finally, my evaluation of the effect of 
mutations eliminating individual enzymes of peroxisomal p-oxidation of neutral lipids-
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derived fatty acids on mitochondria-confined processes provided evidence that the 
formation of acetyl-CoA - the end product of such fatty acid oxidation - modulates 
essential processes in mitochondria, including enzymatic activities of cytochrome c 
oxidase, succinate dehydrogenase and aconitase, the mitochondrial membrane potential 
(A^), and a balance between the processes of mitochondrial fission, fusion and 
tabulation. 
3.6 Conclusions 
Altogether, my aforementioned findings led to the following conclusions. First, 
peroxisomes do not produce significant quantities of ROS in chronologically aging CR 
yeast. Second, ROS that are produced in peroxisomes during fatty acid oxidation are not 
essential for chronological aging of yeast placed on a CR diet. Third, both the formation 
of free fatty acids due to lipolysis of LB-deposited neutral lipids and their subsequent 
Foxlp (Aox)-, Fox2p- and Fox3p-dependent peroxisomal oxidation are mandatory for the 
observed extension of lifespan by CR. Fourth, by the beginning of PD phase, CR yeast 
synthesize the bulk of their ATP in mitochondria by oxidizing the pool of acetyl-CoA 
that has been generated in peroxisomes via Foxlp (Aox)-, Fox2p- and Fox3p-dependent 
fatty acid oxidation. I therefore concluded that fatty acid oxidation in peroxisomes 
controls longevity by modulating the rate of ATP synthesis in mitochondria, but not by 
generating the ROS hydrogen peroxide. Finally, my findings led to the conclusion that 
the efficiency of acetyl-CoA formation via peroxisomal fatty acid oxidation modulates: 
(1) the efficiencies of electron flow through the mitochondrial electron transport chain; 
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(2) activities of several well-known target enzymes for the oxidative damage by ROS 
(i.e., cytochrome c oxidase, succinate dehydrogenase and aconitase); (3) the 
mitochondrial membrane potential (AT); and (4) a balance between the processes of 
mitochondrial fission, fusion and tubulation, which plays a pivotal role in establishing 
and maintaining the morphological appearance of mitochondria. 
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4 By modulating ROS production in mitochondria, a distinct set of 
peroxisomal proteins mediates the ability of a novel anti-aging small 
molecule to extend yeast longevity 
4.1 Abstract 
Recent studies in Dr. Titorenko's laboratory identified 22 novel small molecules 
that greatly increase the chronological lifespan of yeast. My experiments with one of 
these novel anti-aging drugs, a commercially available compound further referred to as 
"LA", revealed that it extends yeast longevity under CR conditions. My studies aimed at 
elucidating the molecular mechanisms by which LA increases yeast lifespan revealed that 
lack of Aox or any other enzyme of peroxisomal fatty acid oxidation does not impair the 
anti-aging effect of LA. Thus, although fatty acid oxidation in peroxisomes is essential 
for delaying aging, it is not required for the ability of LA to extend yeast longevity. 
Moreover, my findings imply that the presence of peroxisomes in yeast cells is not a 
requirement for life-span extending ability of LA. However, two proteins needed for the 
import of soluble proteins into the peroxisomal matrix, which are called Pexlp and 
Pex6p, appeared to be critical for the ability of LA to extend yeast longevity. The 
essential role of at least one of these proteins - the AAA ATPase Pex6p - in mediating 
life-span extending ability of LA is due to its involvement in promoting the ability of 
another organelle, the mitochondrion, to maintain ROS homeostasis within a cell. My 
findings demonstrated that LA extends yeast longevity by: (1) reducing the damaging 
effect of ROS on cellular macromolecules; and (2) amplifying the so-called "hormetic" 
effect of ROS through the activation of stress-protecting and other anti-aging proteins. 
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4.2 Introduction 
Using a custom-designed microplate assay for monitoring yeast chronological 
lifespan, Dr. Titorenko's laboratory recently conducted a high-throughput screening of 
several combinatorial chemical libraries in search for small molecules that can increase 
yeast longevity. This screening procedure resulted in the identification of 22 novel 
compounds that cause a 6- to 10-fold extension of the chronological lifespan of a short-
lived mutant strain and belong to 5 chemically distinct groups. My experiments with a 
commercially available compound that belongs to one of these groups and is called LA 
revealed that, similar to its effect on the short-lived mutant used for the high-throughput 
screen, LA extends the chronological lifespan of wild-type strain under CR conditions 
(Figure 4.1). Importantly, all of the novel anti-aging compounds that have identified by 
Dr. Titorenko's laboratory - including LA - are structurally distinct from resveratrol, a 
constituent of red wine that extends the replicative lifespan of yeast [209] and the 
chronological lifespans of worms, flies and fishes [210 - 215] by activating so-called 
sirtuins of the Sir2p protein family. Furthermore, all these novel anti-aging compounds -
including LA - are structurally unrelated to several other small molecules that, similar to 
resveratrol, activate the sirtuin SIRT1, improve health and survival, and delay the onset 
of age-related diseases in rodent models [216-218]. Thus, it is conceivable that LA and 
the other novel anti-aging compounds that have been identified by Dr. Titorenko's 
laboratory target longevity-related cellular processes that are not modulated by 
resveratrol and other known activators of sirtuins. 
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Figure 4.1. The anti-aging small molecule LA extends the chronological life span of wild-type strain. 
acetyl-CoA via peroxisomal p-oxidation of neutral lipids-derived fatty acids is mandatory 
for increasing the chronological lifespan of CR yeast. I was intrigued therefore by a role 
(if any) for the Foxlp (Aox)-, Fox2p- and Fox3p-dependent peroxisomal fatty oxidation 
in the ability of LA to extend longevity of CR yeast. Moreover, the proper localization of 
Foxlp (Aox), Fox2p and Fox3p to the peroxisomal matrix depends on a distinct subset of 
at least 32 proteins that are collectively termed peroxins and encoded by the PEX genes 
[6 -8, 18, 22, 219 - 223]. The peroxins Pexlp, Pex5p and Pex6p are required for 
peroxisomal import of numerous matrix proteins targeted to the peroxisome by their 
carboxyl-terminal peroxisomal targeting signal type 1 (PTS1), including Foxlp (Aox) 
and Fox2p (Figure 4.2) [2,30]. Therefore, the pexlA, pexSA and pex6A mutants are 
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deficient in peroxisomal import of Foxlp (Aox) and Fox2p and accumulate them in the 
cytosol (Figure 4.2) [6, 8]. In contrast, thiolase (Fox3p), the third enzyme of peroxisomal 
p-oxidation of fatty acids, does not contain the PTS1, is targeted to the peroxisome by its 
amino-terminal PTS2 and, thus, accumulates only in the matrix of peroxisomes in pexlA, 
pex5A and pex6A mutant cells (Figure 4.2) [7, 8]. Furthermore, the peroxin Pex7p 
functions as a cytosolic shuttling receptor for peroxisomal import of Fox3p (thiolase), the 
third enzyme of peroxisomal P-oxidation of fatty acids that carries the PTS2 (Figure 4.2) 
[6, 8]. Therefore, Fox3p accumulates exclusively in the cytosol of pex7A mutant cells 
(Figure 4.2) [30]. In contrast, the pexlA mutation does not affect peroxisomal import of 
the first two enzymes of P-oxidation of fatty acids, namely Foxlp (Aox) and Fox2p 
(Figure 4.2) [2, 30]. Consequently, both these enzymes can be found exclusively in the 
peroxisomal matrix of pex7A mutant cells (Figure 4.2) [6, 8]. Moreover, the peroxin 
Pex3p is required for the formation of peroxisomes from the ER template (Figure 4.2) 
[125, 224]. Hence, all three enzymes of peroxisomal fatty acid oxidation accumulate 
exclusively in the cytosol of pex3 A mutant cells (Figure 4.2). The ability of mutant strains 
carrying various pex mutations to have the entire peroxisomal fatty acid P-oxidation 
pathway, or only some of its individual reactions, to take place in the cytosol opened an 
opportunity to evaluate the requirement of peroxisomal localization of this pathway for 
the ability of LA to extend longevity of CR yeast. 
It should be stressed that some peroxins and peroxisomal proteins possess a dual 
subcellular localization and function. Although proteins belonging to this distinct group 
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Figure 4.2. Roles for Pex and Fox proteins in peroxisome biogenesis and function. 
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function, they have turned out to be also required for a distinct set of cellular processes 
that do not directly relate to peroxisome biogenesis and function, including certain 
developmental, differentiation and morphogenetic programs [38]. Recent studies have 
provided strong evidence that the developmental role of these bifunctional peroxisomal 
proteins with dual subcellular localization is independent of metabolic pathways 
operating in peroxisomes. In particular, while the peroxisome-associated pools of these 
proteins operate in peroxisome biogenesis and function, their pools in other subcellular 
organelles promote certain developmental decisions regardless of the metabolic state of 
peroxisomes [38]. For example, the human peroxin Pexl4p is an integral peroxisomal 
membrane protein that functions as the initial docking site for cargo-laden cytosolic 
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shuttling receptors of peroxisomal matrix proteins [7]. Human Pexl4p is also a nuclear 
protein [33]. Targeted to the nucleus by its nuclear localization signal, human Pexl4p 
interacts specifically with the p45 subunit of a DNA binding transcription factor, NF-E2. 
NF-E2 is a transcriptional regulator of erythroid and megakaryotic genes in pluripotential 
hematopoietic stem cells of the blood and lymphoid systems [33]. In the nucleus, a 
complex formed between Pexl4p and a histone deacetylase is proposed to act as a 
corepressor of the NF-E2-mediated transcription of these genes [33]. Furthermore, the 
essential roles of three peroxisome-bound peroxins of the yeast Yarrowia lipolytica, 
Pex2p, Pex6p and Pexl6p, in peroxisome biogenesis are well established [38]. Y. 
lipolytica Pex2p and Pexl6p are initially sorted to the ER and are then delivered in a 
Pex6p-dependent manner from the ER to peroxisomes via ER-derived vesicles [23, 42]. 
Whereas the major portion of Pex2p, Pex6p and Pexl6p resides in peroxisomes, a minor 
fraction is ER-associated [42]. While the peroxisome-bound pools of Pex2p, Pex6p and 
Pex 16p operate in peroxisome assembly and division, their ER-bound pools orchestrate a 
specific cell polarization and differentiation program, the dimorphic transition from a 
round yeast form to a filamentous (mycelial) form, by promoting the delivery of 
mycelium-specific proteins from the ER to the cell envelope 23, 42]. The role for at least 
one peroxisome- and ER-localized bifunctional protein, Pexl6p, in development and 
differentiation is evolutionarily conserved among yeasts and plants. The Arabidopsis 
ortholog of Y. lipolytica Pexl6p, the SSE1 protein, is required not only for peroxisome 
assembly but also for the biogenesis of protein and lipid bodies, a cellular differentiation 
program for energy storage in maturing seeds [24]. The biogenesis of protein and lipid 
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bodies depends on the ER and involves the sorting of oleosins, the most abundant protein 
components of oil bodies, via the ER [225]. Importantly, Pexl6p complements 
developmental defects in a cross-species fashion, as the Arabidopsis SSE1 protein 
re-establishes the dimorphic transition in the Y. lipolytica pexl6 mutant deficient in the 
delivery of mycelium-specific proteins from the ER to the tip of the growing filament 
[24]. Moreover, another bifunctional peroxisomal membrane protein of plants, CTS, is 
not only involved in the transport of acyl-CoA esters of fatty acids (FA-CoAs) into the 
peroxisome but is also essential for the transition from dormancy to germination, an 
important step in the embryonic development of Arabidopsis [32]. Seeds carrying cts 
mutations do not germinate and exhibit a "forever dormant" phenotype. Importantly, the 
inability of cts mutants to metabolize lipid body-derived FA-CoAs cannot account for the 
"forever dormant" phenotype, suggesting that the functions of CTS in the peroxisomal 
transport of FA-CoAs and in embryo development are different [32]. CTS is an ortholog 
of the human peroxisomal protein ALDP, a member of the ABC transporter family. 
Because the binding of other known ABC transporters to certain passive ion channels 
modulates their development-related activities [226], it has been proposed that the 
activity of CTS in embryo dormancy may involve its interaction with such channels [32]. 
It remains to be established what subcellular compartment serves as an organizing 
platform for the involvement of CTS in development. It is noteworthy that a human 
peroxisomal ABC transporter is present in a specialized subdomain of the ER from which 
peroxisomes form [227]. It has been therefore proposed that the ER-associated form of 
CTS promotes embryo development, while its peroxisomal form functions in the 
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transport of FA-CoAs into this organelle [38]. Finally, the peroxin Pex6p in the yeast S. 
cerevisiae functions not only in peroxisome biogenesis (Figure 4.2) but also in the import 
of the Atp2p, a |3-subunit of FjFo-ATPase, into mitochondria [228]. 
Altogether, the aforementioned findings greatly stimulated my interest in defining 
a role (if any) for peroxisome-associated enzymes (including Aox) and peroxins in the 
anti-aging effect of LA. The objective of studies described in this chapter was therefore 
to investigate if the ability of the peroxisome to oxidize fatty acids {i.e., a Fox-dependent 
function) or assemble properly {i.e., a Pex-dependent function) is essential for the ability 
of LA to increase the chronological lifespan of CR yeast. I was also intrigued by a 
possibility that some of the peroxins could mediate the anti-aging effect of LA by being 
involved in the cellular processes that do not directly relate to peroxisome biogenesis and 
function. 
4.3 Materials and Methods 
Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 {MATa his3Al leu2A0 
lys2A0 ura3A0) and mutant strains pexlA {MATa his3Al leulAO lys2A0 ura3A0 
pexlA::kanMX4),pex5A {MATa his3Al leu2A0 lys2A0 ura3A0pex5A::kanMX4), pex6A 
{MATa his3Al leu2A0 lys2A0 ura3A0 pex6A::kanMX4), pex7A {MATa his3Al leu2A0 
lys2A0 ura3A0 pex7A::kanMX4), foxJA {MATa his3Al leu2A0 lys2A0 ura3A0 
foxlA::kanMX4), ctalA {MATa his3Al leu2A0 lys2A0 ura3A0 ctalA::kanMX4), fox2A 
{MATa his3Al leu2A0 lys2A0 ura3A0fox2A::kanMX4),mdh3A{MATahis3Alleu2A0 
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lys2A0 ura3A0 mdh3A::kanMX4), and fox3A (MATa his3Al leu2A0 lys2A0 ura3A0 
fox3A::kanMX4) were used in this study. Media components were as follows: 1) YEPD 
(0.2% Glucose), 1% yeast extract, 2% peptone, 0.2% glucose; and 2) YEPD (2% 
Glucose), 1% yeast extract, 2% peptone, 2% glucose. 
A plating assay for the analysis of chronological life span 
Cells were grown in YEPD (0.2% Glucose) medium at 30°C with rotational 
shaking at 200 rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. 
A sample of cells was removed from each culture at various time points. A fraction of the 
cell sample was diluted in order to determine the total number of cells per ml of culture 
using a hemacytometer. 10 JJ.1 of serial dilutions (1:10 to 1:103) of cells were applied to 
the hemacytometer, where each large square is calibrated to hold 0.1 ui. The number of 
cells in 4 large squares was then counted and an average was taken in order to ensure 
greater accuracy. The concentration of cells was calculated as follows: number of cells 
per large square x dilution factor x 10 x 1,000 = total number of cells per ml of culture. A 
second fraction of the cell sample was diluted and serial dilutions (1:102 to 1:105) of cells 
were plated onto YEPD (2% Glucose) plates in triplicate in order to count the number of 
viable cells per ml of each culture. 100 ul of diluted culture was plated onto each plate. 
After a 48-h incubation at 30°C, the number of colonies per plate was counted. The 
number of colony forming units (CFU) equals to the number of viable cells in a sample. 
Therefore, the number of viable cells was calculated as follows: number of colonies x 
dilution factor x 10 = number of viable cells per ml. For each culture assayed, % viability 
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of the cells was calculated as follows: number of viable cells per ml / total number of 
cells per ml x 100%. The % viability of cells in mid-logarithmic phase was set at 100% 
viability for that particular culture. 
Plating assays for the analysis of resistance to various stresses 
For the analysis of hydrogen peroxide resistance, serial dilutions (1:10 to 1:10 ) 
of wild-type and mutant cells removed from mid-logarithmic phase (day 1) and from 
diauxic phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of 
plates. One set of plates contained YEPD (2% Glucose) medium alone, whereas the other 
set contained YEPD (2% Glucose) medium supplemented with 5 mM hydrogen peroxide. 
Pictures were taken after a 3-day incubation at 30°C. 
For the analysis of oxidative stress resistance, serial dilutions (1:10 to 1:10 ) of 
wild-type and mutant cells removed from mid-logarithmic phase (day 1) and from 
diauxic phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of 
plates. One set of plates contained YEPD (2% Glucose) medium alone, whereas the other 
set contained YEPD (2% Glucose) medium supplemented with 2.5 mM of the 
superoxide/hydrogen peroxide-generating agent paraquat. Pictures were taken after a 3-
day incubation at 30°C. 
For the analysis of heat-shock resistance, serial dilutions (1:10 to 1:10 ) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of YEPD (2% 
Glucose) plates. One set of plates was incubated at 30°C. The other set of plates was 
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initially incubated at 55°C for 30 min, and was then transferred to 30°C. Pictures were 
taken after a 3-day incubation at 30°C. 
For the analysis of salt stress resistance, serial dilutions (1:10 to 1:10 ) of wild-
type and mutant cells removed from mid-logarithmic phase (day 1) and from diauxic 
phase (days 2 and 3) in YEPD (0.2% Glucose) were spotted onto two sets of plates. One 
set of plates contained YEPD (2% Glucose) medium alone, whereas the other set 
contained YEPD (2% Glucose) medium supplemented with 0.5 M NaCl. Pictures were 
taken after a 3-day incubation at 30°C. For the analysis of osmotic stress resistance, serial 
dilutions (1:10 to 1:10 ) of wild-type and mutant cells removed from mid-logarithmic 
phase (day 1) and from diauxic phase (days 2 and 3) in YEPD (0.2% Glucose) were 
spotted onto two sets of plates. One set of plates contained YEPD (2% Glucose) medium 
alone, whereas the other set contained YEPD (2% Glucose) medium supplemented with 1 
M sorbitol. Pictures were taken after a 3-day incubation at 30°C. 
Monitoring the formation of ROS 
Wild-type and mutant cells grown in YEPD (0.2% Glucose) were tested 
microscopically for the production of ROS by incubation with dihydrorhodamine 123 
(DHR). In the cell, this nonfluorescent compound can be oxidized to the fluorescent 
chromophore rhodamine 123 by ROS. Cells were also probed with a fluorescent 
counterstain Calcofluor White M2R (CW), which stains the yeast cell walls fluorescent 
blue. CW was added to each sample in order to label all cells for their proper 
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visualization. DHR was stored in the dark at -20°C as 50 ul aliquots of a 1 mg/ml 
solution in ethanol. CW was stored in the dark at -20°C as the 5 mM stock solution in 
anhydrous DMSO (dimethylsulfoxide). 
The concurrent staining of cells with DHR and CW was carried out as follows. 
The required amounts of the 50 ul DHR aliquots (1 mg/ml) and of the 5 mM stock 
solution of CW were taken out of the freezer and warmed to room temperature. The 
solutions of DHR and CW were then centrifuged at 21,000 x g for 5 min in order to clear 
them of any aggregates of fluorophores. For cell cultures with a titre of ~ 107 cells/ml, 
100 ul was taken out of the culture to be treated. If the cell titre was lower, proportionally 
larger volumes were used. 6 ul of the 1 mg/ml DHR and 1 JLII of the 5 mM CW solutions 
were added to each 100 ul aliquot of culture. After a 2-h incubation in the dark at room 
temperature, the samples were centrifuged at 21,000 x g for 5 min. Pellets were 
resuspended in 10 ul of PBS buffer (20 mM KH2P04/KOH, pH 7.5, and 150 mM NaCl). 
Each sample was then supplemented with 5 ul of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides 
were prepared, they were visualized under the Zeiss Axioplan fluorescence microscope 
mounted with a SPOT Insight 2 megapixel color mosaic digital camera. Several pictures 
of the cells on each slide were taken, with two pictures taken of each frame. One of the 
two pictures was of the cells seen through a rhodamine filter in order to detect cells dyed 
with DHR. The second picture was of the cells seen through a DAPI filter in order to 
visualize CW, and therefore all the cells present in the frame. 
For evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool 
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(Version 3.0) software was used to calculate both the total number of cells and the 
number of stained cells. Fluorescence of individual DHR-positive cells in arbitrary units 
was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-
5 independent experiments, the value of median fluorescence was calculated by analyzing 
at least 800-1000 cells that were collected at each time point. The median fluorescence 
values were plotted as a function of the number of days cells were cultured. 
Visualization of intracellular lipid bodies 
Wild-type and mutant cells grown in YEPD (0.2% Glucose) were tested 
microscopically for the presence of intracellular lipid bodies (LB) by incubation with 
BODIPY 493/503. Cells were also probed with a fluorescent counterstain CW in order to 
visualize all cells in the population. BODIPY 493/503 was stored in the dark at -20°C as 
100 ul aliquots of a 1 mM solution in ethanol. CW was stored in the dark at -20°C as the 
5 mM stock solution in anhydrous DM SO. 
The concurrent staining of cells with BODIPY 493/503 and CW was carried out 
as follows. The required amounts of the 100 ul BODIPY 493/503 aliquots (1 mM) and of 
the 5 mM stock solution of CW were taken out of the freezer and warmed to room 
temperature. The solutions of DHR and CW were then centrifuged at 21,000 x g for 5 
min in order to clear them of any aggregates of fluorophores. For cell cultures with a titre 
of - 107 cells/ml, 100 ul was taken out of the culture to be treated. If the cell titre was 
lower, proportionally larger volumes were used. The samples were then centrifuged at 
21,000 x g for 1 min, and pelleted cells were resuspended in 100 ul of TNT buffer (25 
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mM Tris/HCl (pH 7.5), 150 mM NaCl and 0.2 % Triton X-100). After a 10-min 
incubation at room temperature, the samples were centrifuged at 21,000 x g for 1 min. 
Pellets were then resuspended in 100 ul of TN buffer (25 mM Tris/HCl (pH 7.5), 150 
mM NaCl), and the samples were subjected to centrifugation at 21,000 x g for 1 min. 
Pelleted cells were finally resuspended in 100 ul of TN buffer. Each 100 ul aliquot of 
cells was then supplemented with 1 ul of the 1 mM BODIPY 493/503 and 1 ul of the 5 
mM CW solutions. After a 15-min incubation in the dark at room temperature, the 
samples were centrifuged at 21,000 x g for 5 min. Pellets were resuspended in 100 ul of 
TN buffer. The samples were centrifuged again at 21,000 x g for 5 min, and pellets were 
resuspended in 100 ul of TN buffer. 10 ul of the BODIPY 493/503- and CW-treated cell 
suspension was then added to a microscope slide and covered with a coverslip. The slides 
were then sealed using nail polish. Once the slides were prepared, they were visualized 
under the Zeiss Axioplan fluorescence microscope mounted with a SPOT Insight 2 
megapixel color mosaic digital camera. Several pictures of the cells on each slide were 
taken, with two pictures taken of each frame. One of the two pictures was of the cells 
seen through a fluorescein filter in order to detect cells dyed with BODIPY 493/503. The 
second picture was of the cells seen through a DAPI filter in order to visualize CW, and 
therefore all the cells present in the frame. For evaluating the percentage of BODIPY 
493/503-positive cells, the UTHSCSA Image Tool (Version 3.0) software was used to 
calculate both the total number of cells and the number of stained cells. 
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Immunofluorescence microscopy 
Cell cultures were fixed in 3.7% formaldehyde for 45 min at room temperature. 
The cells were washed in solution B (100 mM KH2POVKOH pH 7.5, 1.2 M sorbitol), 
treated with Zymolyase 100T (MP Biomedicals, 1 ng Zymolyase 100T/1 mg cells) for 30 
min at 30°C and then processed as previously described [47]. Monoclonal antibody raised 
against porin (Invitrogen, 0.25 ug/ul in TBSB buffer [20 mM Tris/HCl pH 7.5, 150 mM 
NaCl, lmg/ml BSA]) was used as a primary antibody. Alexa Fluor 568 goat anti-mouse 
IgG (Invitrogen, 2 jig/ul in TBSB buffer) was used as a secondary antibody. The 
labeled samples were mounted in mounting solution (16.7 mM Tris/HCl pH 9.0, 1.7 
mg/ml /7-phenylenediamine, 83% glycerol). Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic 
digital camera (Spot Diagnostic Instruments). 
Oxygen consumption assay 
The rate of oxygen consumption by yeast cells recovered at various time points 
was measured continuously in a 2-ml stirred chamber using a custom-designed biological 
oxygen monitor (Science Technical Center of Concordia University) equipped with a 
Clark-type oxygen electrode. 1 ml of YEPD medium supplemented with 0.2% glucose 
was added to the electrode for approximately 5 minutes to obtain a baseline. Cultured 
cells of a known titre were spun down at 3,000 x g for 5 minutes. The resulting pellet was 
resuspended in YEPD medium supplemented with 0.2% glucose and then added to the 
electrode with the medium that was used to obtain a baseline. The resulting slope was 
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used to calculate the rate of oxygen consumption in 02% x min"1 x 109 cells. 
Electron microscopy and morphometric analysis 
Cells were fixed in 1.5% KMn04 for 20 min at room temperature, dehydrated by 
successive incubations in increasing concentrations of ethanol, and embedded in 
Poly/Bed 812 epoxy resin (Polysciences). Ultrathin sections were cut using an Ultra-Cut 
E Microtome (Reichert-Jung). Silver/gold thin sections from the embedded blocks were 
examined in a JEOL JEM-2000FX transmission electron microscope. For morphometric 
analysis of random electron microscopic sections of cells, digitized images were analyzed 
using the UTHSCSA Image Tool (Version 3.0) software. In each of 2 independent 
experiments, the percentage of cells that contain pexopodia and/or accumulate gnarled 
LB was calculated by analyzing at least 300 cells that were collected at each time point. 
The values of the percentage of cells containing pexopodia and/or accumulating gnarled 
LB were plotted as a function of the number of days cells were cultured. 
4.4 Results 
4.4.1 Fatty acid oxidation in peroxisomes is not essential for the ability of LA to 
increase the chronological lifespan of CR yeast 
To investigate if the ability of the peroxisome to oxidize fatty acids (i.e., a Fox-
dependent function) or assemble properly (i.e., a Pex-dependent function) is a 
requirement for the anti-aging action of LA in chronologically aging yeast under CR 
conditions, I developed a definition of a protein or process that is critical for such action 
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of LA (Figure 4.3). I assumed that if lack of a protein or a mutational impairment of a 
process does not cause a statistically significant reduction or rise of the fold increase of 
mean chronological lifespan by LA, such protein or process is not essential for the anti-
aging action of LA (Figure 4.3). Conversely, if lack of a protein or a mutational 
impairment of a process causes a statistically significant reduction of the fold increase of 
mean chronological lifespan by LA, such protein or process is essential for the ability of 
LA to extend longevity (Figure 4.3). Furthermore, if lack of a protein or a mutational 



































Figure 4.3. A definition of a protein or process that is critical for the ability of LA to extend longevity of 
chronologically aging yeast under CR conditions. Process 1 is not essential for the anti-aging action of LA. 
Processes 2 and 4 are essential for the ability of LA to extend longevity. Process 3 weakens the anti-aging 
effect of LA. MLS, mean chronological life span. 
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chronological lifespan by LA, such protein or process weakens the ability of LA to 
extend longevity (Figure 4.3). It should be stressed that my definition of a protein or 
process that is critical for the anti-aging action of LA ignores an age-related or age-
unrelated role that this protein or process might play in the absence of LA. Such role 
could consist in the ability of a protein or process to delay or promote aging in the 
absence of exogenous LA or simply to maintain fitness of yeast that are not exposed to 
this anti-aging compound. 
According to the definition of a protein or process that is critical for the ability of 
LA to extend longevity of chronologically aging yeast under CR conditions, none of the 
120 | — — ^ . - — • » — ^ ^ ^ — — — » — — 
110 • 1 1 1—I 1 \-
Figure 4.4. Foxlp (Aox) is not essential for the ability of LA to extend yeast longevity under CR 
conditions. 
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three enzymes of peroxisomal fatty acid oxidation (i.e., Foxlp (Aox), Fox2p and Fox3p) 
is essential for the anti-aging action of LA. In fact, although the fox1A, fox2 A and fox3 A 
mutations decreased the chronological lifespan of CR yeast that have not been exposed to 
LA, none of these mutations caused a statistically significant reduction or rise of the fold 
increase of mean chronological lifespan by LA (Figures 4.4, 4.5 and 4.6). Therefore, I 
concluded that, although fatty acid oxidation in peroxisomes is essential for delaying 
aging or increasing fitness of yeast under CR conditions, it is not required for the ability 
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Figure 4.5. Fox2p is not essential for the ability of LA to extend yeast longevity under CR conditions. 
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4.4.2 Import of soluble proteins into the peroxisomal matrix is not essential for the 
ability of LA to increase the chronological lifespan of CR yeast 
The peroxin Pex5p is a cytosolic shuttling receptor for peroxisomal import of 
numerous matrix proteins targeted to the peroxisome by their carboxyl-terminal PTS1, 
including Foxlp (Aox) and Fox2p (Figure 4.2) [2, 30]. 
\_^ |_ !•!_ SEl<gff> \ / _ FA-f»FA-CoA — > ™ > JL >Ac-CoA 
fox3A Peroxisome 
-WT - LA 
-WT • 25 microM LA 
-WT + 50 microM LA 
-FOX3- LA 
-FOX3 + 25 microM LA 
-FOX3 • 50 microM LA 
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0 1 2 3 4 5 6 7 8 9 10 1112 1314151617 1819 2 2 1 2 2 2 2 2 2 2 2 3 
0 2 3 4 5 6 7 8 9 0 
Daysin culture 
1.5 2 2.5 
Fold increase of mean chronological life span by LA 
Figure 4.6. Fox3p is not essential for the ability of LA to extend yeast longevity under CR conditions. 
Furthermore, the peroxin Pex7p functions as a cytosolic shuttling receptor for 
peroxisomal import of Fox3p (thiolase), the third enzyme of peroxisomal P-oxidation of 
fatty acids that carries the PTS2 (Figure 4.2) [6, 8]. 
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According to the definition of a protein or process that is critical for the ability of 
LA to extend longevity of chronologically aging yeast under CR conditions, neither 
LD PD ST 
1 5 10 15 20 25 30 35 
Days in culture 
Figure 4.7. Pex5p is not essential for the ability of LA to extend longevity of CR yeast. 
Pex5p nor Pex7p is essential for such anti-aging ability of LA. Indeed, although the 
pex5A and pex7A mutations decreased the chronological lifespan of CR yeast that have 
not been exposed to LA, none of these mutations caused a statistically significant 
reduction or rise of the fold increase of mean chronological lifespan by LA (Figures 4.7 
and 4.8). I therefore concluded that, although both the Pex5p-dependent peroxisomal 
import of PTS1-containing proteins and Pex7p-dependent peroxisomal import of PTS2-
containing proteins are essential for delaying aging or increasing fitness of yeast under 
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Figure 4.8. Pex7p is not essential for the ability of LA to extend longevity of CR yeast. 
4.4.3 Presence of peroxisomes in yeast cells is not a requirement for life-span 
extending ability of LA 
The peroxin Pex3p is required for the formation of peroxisomes from the ER 
template (Figure 4.2) [125, 224]. According to the definition of a protein or process that 
is critical for the ability of LA to extend longevity of chronologically aging yeast under 
CR conditions, Pex3p not is essential for such anti-aging ability of LA. Indeed, although 
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Figure 4.9. Pex3p is not essential for the ability of LA to extend longevity of CR yeast. 
exposed to LA, it did not cause a statistically significant reduction or rise of the fold 
increase of mean chronological lifespan by LA (Figure 4.9). I therefore concluded that, 
although the ability to form peroxisomes from the ER template is essential for delaying 
aging or increasing fitness of yeast under CR conditions, it is not required for the ability 
of LA to extend yeast longevity. Thus, presence of peroxisomes in yeast cells is not a 
requirement for life-span extending ability of LA. 
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4.4.4 Pexlp weakens the ability of LA to extend the chronological lifespan of CR 
yeast 
Together with Pex5p and Pex6p, the peroxin Pexlp is required for peroxisomal 
import of numerous matrix proteins targeted to the peroxisome by their carboxyl-terminal 
peroxisomal targeting signal type 1 (PTS1), including Foxlp (Aox) and Fox2p (Figure 
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Figure 4.10. Pexlp weakens the ability of LA to extend longevity of CR yeast. 
Additionally, in the yeast Yarrowia lipolytica and Pichiapastoris, Pexlp - in cooperation 
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with Pex6p - drives the fusion of immature peroxisomal vesicles during an early stage of 
the multistep peroxisome assembly pathway (see Chapter 2) [7, 30, 45, 46, 50, 125, 171]. 
According to the definition of a protein or process that is critical for the ability of LA to 
extend longevity of chronologically aging yeast under CR conditions, Pexlp weakens 
such anti-aging ability of LA. Indeed, although the pexlA mutation decreased the 
chronological lifespan of CR yeast that have not been exposed to LA, it caused a 
statistically significant rise of the fold increase of mean chronological lifespan by LA 
(Figure 4.10). Thus, lack (or low level) of Pexlp is a requirement for the ability of LA to 
extend yeast longevity. 
4.4.5 Pex6p is essential for the ability of LA to extend the chronological lifespan of 
CR yeast 
Jointly with Pexlp and Pex5p, the peroxin Pex6p is required for peroxisomal 
import of numerous matrix proteins targeted to the peroxisome by their carboxyl-terminal 
peroxisomal targeting signal type 1 (PTS1), including Foxlp (Aox) and Fox2p (Figure 
4.2) across phyla [2, 30]. Moreover, in the yeast Yarrowia lipolytica and Pichia pastoris, 
Pexlp - in concert with Pex6p - promotes the fusion of immature peroxisomal vesicles 
during an early stage of the multistep peroxisome assembly pathway (see Chapter 2) [7, 
30, 45, 46, 50, 125, 171]. Furthermore, in the yeast S. cerevisiae Pex6p functions not only 
in peroxisome biogenesis but also in the import of the Atp2p, a (3-subunit of F)Fo-
ATPase, into mitochondria [228]. According to the definition of a protein or process that 
is critical for the ability of LA to extend longevity of chronologically aging yeast under 
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CR conditions, Pex6p is essential for the ability of LA to extend the chronological 
lifespan of CR yeast. In fact, not only the pex6A mutation decreased the chronological 
lifespan of CR yeast that have not been exposed to LA, but it also almost completely 
abolished the anti-aging effect of LA under CR conditions (Figure 4.11). 
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PEX6 • 25 m i c r o M LA 
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Figure 4.11. Pex6p is essential for the ability of LA to extend longevity of CR yeast. 
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4.4.6 LA alters the age-dependent dynamics of several mitochondrial activities in 
CR yeast: A hypothesis for a dual role of ROS in regulating longevity 
My aforementioned findings provided evidence that the presence of peroxisomes 
in yeast cells is not a requirement for life-span extending ability of LA. However, the 
peroxin Pexlp weakens the ability of LA to extend the chronological lifespan of CR yeast 
(Chapter 4.4.4), whereas Pex6p - another AAA ATPase - is indispensable for such 
ability, being essential for the anti-aging action of LA (Chapter 4.4.5). Taken together, 
these findings strongly suggest that the critical role of both Pexlp and Pex6p in mediating 
the anti-aging effect of LA on CR yeast does not relate to their involvement in 
peroxisome biogenesis. It should be stressed that at least one of these two AAA ATPases, 
namely Pex6p, functions not only in peroxisome biogenesis but also in the import of the 
Atp2p, a P-subunit of FiFo-ATPase, into mitochondria [228]. Thus, Pex6p not only 
controls the biogenesis of the peroxisome but also modulates the functional state of 
another cellular organelle, the mitochondrion. I therefore suggested that the functionality 
of mitochondria is a requirement for the anti-aging effect of LA on CR yeast. This 
suggestion is indirectly supported by my observation that LA alters the age-dependent 
dynamics of several mitochondrial activities in CR yeast, including oxygen consumption, 
mitochondrial membrane potential (AT) and ROS generation. In particular, in CR yeast 
entering D phase, LA decreases the amplitude of the spike in all these mitochondrial 
activities (Figures 4.12, 4.13 and 4.14). Furthermore, during PD and ST phases, LA 
prevents a sharp decline of all these activities, maintaining them at the levels they 
reached by the end of PD phase (Figures 4.12, 4.13 and 4.14). Based on these findings, I 
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hypothesized that one of the mechanisms by which mitochondria regulate yeast longevity 
is based on the LA-dependent ability of mitochondria in aging yeast to maintain ROS 
homeostasis. I proposed that ROS, which are mostly generated as by-products of 
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Figure 4.12. LA alters the age-dependent dynamics of cellular respiration by modulating mitochondrial 
oxygen consumption. 
yeast mitochondria are unable - due to a dietary regimen (see Chapter 3) or unavailability 
of LA - to maintain ROS concentration below a critically high level, ROS promote aging 
by oxidatively damaging certain mitochondrial proteins (such as cytochrome c oxidase 
[CCO], succinate dehydrogenase [SDH] and aconitase [ACO]; see Chapter 3). Second, if 
yeast mitochondria can - due to a dietary regimen (see Chapter 3) or availability of LA -
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Figure 4.13. LA alters the age-dependent dynamics of mitochondrial membrane potential (TA). 
maintain ROS concentration at an "optimal" level, ROS delay aging. This "optimal" level 
of ROS is insufficient to damage cellular macromolecules but can activate certain 
signaling networks [101, 229, 231 - 235] that extend life span by increasing the 
abundance or activity of stress-protecting and other anti-aging proteins. The term 
"mitohormesis" has been coined for such anti-aging role of mitochondrially produced 
ROS [236]; the term "hormesis" refers to a beneficial defence response of an organism to 
a low-intensity biological stress [237, 238]. In my hypothesis for a dual role of ROS in 
regulating longevity, LA extends the chronological lifespan of CR yeast by: (1) reducing 
the damaging effect of ROS on cellular macromolecules during L, D and PD growth 
phases; and (2) amplifying the "hormetic" effect of ROS during ST growth phase (i.e., in 
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Figure 4.14. LA alters the age-dependent dynamics of ROS generation in mitochondria. 
proteins (Figure 4.15). Recent data from Dr. Titorenko's laboratory provided a 
conformation for the ability of LA to amplify the "hormetic" effect of ROS in senescent 
yeast cells through the activation of stress-protecting and other anti-aging proteins by 
showing that: (1) LA greatly enhances the resistance of non-proliferating yeast cells that 
have reached ST phase to acute oxidative stress and heat shock; and (2) LA considerably 
increases the intracellular levels of molecular chaperones protecting yeast from oxidative 
stress-induced protein aggregation. 
4.4.7 The age-dependent dynamics of changes in the levels of ROS in cells of Afox 
and Apex mutants exposed to LA confirms the validity of the hypothesis for a 
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Figure 4.15. In my hypothesis for a dual role of ROS in regulating longevity, LA extends the chronological 
lifespan of CR yeast by: (1) reducing the damaging effect of ROS on cellular macromolecules during L, D 
and PD growth phases; and (2) amplifying the "hormetic" effect of ROS during ST growth phase (i.e., in 
senescent yeast cells) through the activation of stress-protecting and other anti-aging proteins. 
In my hypothesis for a dual role of ROS in regulating longevity, LA extends the 
chronological lifespan of CR yeast by: (1) reducing the damaging effect of ROS on 
cellular macromolecules during L, D and PD growth phases; and (2) amplifying the 
"hormetic" effect of ROS during ST growth phase (i.e., in senescent yeast cells) through 
the activation of stress-protecting and other anti-aging proteins. If my hypothesis is valid, 
then any Afox or Apex mutation that in the presence of LA significantly decreases (as 
compared to LA-untreated wild-type cells) the "early" spike in ROS during L and D 
phases and, simultaneously, significantly increases (as compared to LA-untreated wild-
type cells) the "late" spike in ROS during ST phase could enhance the anti-aging effect of 
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LA. In fact, such a mutation is expected - according to my hypothesis - to reduce the 
damaging effect of ROS on cellular macromolecules during L and D phases and, 
simultaneously, to enhance the "hormetic" effect of ROS during ST phase. The validity 
of my hypothesis is supported by the observation that the pexl A mutation - which in the 
presence of LA resulted in a considerable reduction of ROS level during L and D phases 
and, simultaneously, in a significant rise of ROS level during ST phase (Figure 4.16) -
caused a statistically significant rise of the fold increase of mean chronological lifespan 
by LA (Figure 4.10). Furthermore, if my hypothesis is valid, then any Afox or Apex 
mutation that in the presence of LA significantly increases (as compared to LA-untreated 
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Figure 4.16. In the presence of LA, the pexl A mutation - which causes a statistically significant rise of the 
fold increase of mean chronological lifespan by LA (Figure 4.10) - results in a considerable reduction (as 
compared to LA-untreated wild-type cells) of ROS level during L and D phases and, simultaneously, in a 
significant rise (as compared to LA-untreated wild-type cells) of ROS level during ST phase. 
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significantly decreases (as compared to LA-untreated wild-type cells) the "late" spike in 
ROS during ST phase could eliminate the anti-aging effect of LA. Indeed, such a 
mutation is expected - according to my hypothesis - to enhance the damaging effect of 
ROS on cellular macromolecules during L and D phases and, simultaneously, to weaken 
the "hormetic" effect of ROS during ST phase. The validity of my hypothesis is 
supported by the observation that the pex6A mutation - which in the presence of LA 
resulted in a considerable rise of ROS level during L and D phases and, simultaneously, 
in a significant decrease of ROS level during ST phase (Figure 4.17) - caused a 
statistically significant reduction of the fold increase of mean chronological lifespan by 
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Figure 4.17. In the presence of LA, the pex6A mutation - which causes a statistically significant reduction 
of the fold increase of mean chronological lifespan by LA (Figure 4.11) - results in a considerable rise (as 
compared to LA-untreated wild-type cells) of ROS level during L and D phases and, simultaneously, in a 
significant decrease (as compared to LA-untreated wild-type cells) of ROS level during ST phase. 
in the presence of LA significantly increases (as compared to LA-untreated wild-type 
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cells) the "early" spike in ROS during L and D phases and, simultaneously, significantly 
increases (as compared to LA-untreated wild-type cells) the "late" spike in ROS during 
ST phase could have no influence on the anti-aging effect of LA. Indeed, although such a 
mutation is expected - according to my hypothesis - to enhance the damaging effect of 
ROS on cellular macromolecules during L and D phases, it would at the same time 
enhance the "hormetic" effect of ROS during ST phase. The validity of my hypothesis is 
supported by the observation that none of the foxlA, fox2A, fox3A, pex3A and pex7A 
mutations - all of which in the presence of LA resulted in a considerable rise of ROS 
level during L and D phases and, simultaneously, in an increase of ROS level during ST 
phase (Figures 4.18, 4.19, 4.20, 4.21 and 4.22) - caused a statistically significant 
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Figure 4.18. In the presence of LA, the foxl A mutation - which does not cause a statistically significant 
reduction or rise of the fold increase of mean chronological lifespan by LA (Figure 4.4) - results in an 
increase (as compared to LA-untreated wild-type cells) of ROS level during L and D phases and, 
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Figure 4.19. In the presence of LA, thefox2A mutation - which does not cause a statistically significant 
reduction or rise of the fold increase of mean chronological lifespan by LA (Figure 4.5) - results in an 
increase (as compared to LA-untreated wild-type cells) of ROS level during L and D phases and, 
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Figure 4.20. In the presence of LA, the fox3A mutation - which does not cause a statistically significant 
reduction or rise of the fold increase of mean chronological lifespan by LA (Figure 4.6) - results in an 
increase (as compared to LA-untreated wild-type cells) of ROS level during L and D phases and, 
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Figure 4.21. In the presence of LA, the pex3A mutation - which does not cause a statistically significant 
reduction or rise of the fold increase of mean chronological lifespan by LA (Figure 4.9) - results in an 
increase (as compared to LA-untreated wild-type cells) of ROS level during L and D phases and, 
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Figure 4.22. In the presence of LA, the pex7A mutation - which does not cause a statistically significant 
reduction or rise of the fold increase of mean chronological lifespan by LA (Figure 4.8) - results in an 
increase (as compared to LA-untreated wild-type cells) of ROS level during L and D phases and, 
simultaneously, in an increase (as compared to LA-untreated wild-type cells) of ROS level during ST 
phase. 
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reduction or rise of the fold increase of mean chronological lifespan by LA (Figures 4.4, 
4.5, 4.6, 4.7, 4.8 and 4.9). 
4.4.8 Chronology of aging biomarkers in the idhlA and idhlA mutants confirms 
the validity of the hypothesis for a dual role of ROS in regulating longevity 
In my hypothesis for a dual role of ROS in regulating longevity, if yeast 
mitochondria are unable - due to a dietary regimen (see Chapter 3) or unavailability of 
LA (see sections 4.4.6 and 4.4.7 of this chapter) - to maintain ROS concentration below a 
critically high level, ROS promote aging by oxidatively damaging certain mitochondrial 
proteins (such as CCO, SDH and ACO; see Chapter 3). Conversely, if yeast mitochondria 
can - due to a dietary regimen (see Chapter 3) or availability of LA (see sections 4.4.6 
and 4.4.7 of this chapter) - maintain ROS concentration at an "optimal" level, ROS delay 
aging. This "optimal" level of ROS is insufficient to damage cellular 
macromolecules but can activate certain signaling networks [101, 229, 231 - 235] that 
extend life span by increasing the abundance or activity of stress- protecting and other 
anti-aging proteins. My analysis of the age-dependent dynamics of changes in the levels 
of ROS in cells of Afox and Apex mutants exposed to LA validated this hypothesis (see 
section 4.4.7 of this chapter). To further evaluate the validity of my hypothesis, I 
developed and tested a complementary experimental approach that uses a different 
longevity-extending intervention. This approach is based on the fact that certain 
components of the mitochondrial tricarboxylic acid (TCA) cycle and electron transport 
chain (ETC) are redundant. The redundant components of the mitochondrial TCA cycle 
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include the Pdxlp and Lpdlp subunits of pyruvate dehydrogenase, the Citlp, Cit2p and 
Cit3p isoforms of citrate synthase, the Idhlp and Idh2p subunits of isocitrate 
dehydrogenase, the Lsclp and Lsc2p subunits of succinyl-CoA ligase, and the Sdhlp, 
Sdh2p, Sdh3p and Sdh4p subunits of SDH (Figure 4.23A). I reason that mitochondria 
lacking a single redundant component would still be able to produce NADH and FADH2, 
the two donors of electrons for the ETC, but in reduced amounts. This, in turn, would 
reduce mitochondrial ROS generated as by-products of electron flow through the ETC. 
The same logic applies to the NADHrubiquinone oxidoreductase Ndilp, the Cyclp and 
Cyc2p isoforms of cytochrome c, and the cytochrome c peroxidase Ccplp. While lack of 
any of these redundant ETC components does not affect growth in glucose-containing 
medium [239], it would reduce mitochondrial ROS by weakening electron flow through 
the ETC. I expected therefore that, if my hypothesis that mitochondrial ROS play a dual 
role in regulating longevity is accurate, lack of a single redundant component of the ETC 
or TCA cycle would extend the life span of CR yeast grown on 0.2% glucose. This 
glucose concentration provides a modest life-span extension, as compared to that for 
0.5% glucose (see Chapter 3). I reason that, by decreasing the level of mitochondrial 
ROS, a mutation that eliminates only one of these redundant components would enable 
mitochondria of yeast grown on 0.2% glucose to maintain ROS at a level that is 
insufficient to damage cellular macromolecules but can increase the abundance and/or 
activity of stress-protecting proteins that delay aging. Remarkably, my analysis of yeast 
strains carrying mutations that eliminate either the Idhlp or the Idh2p subunit of 
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Figure 4.23. The idhlA and idhlA mutations extend the chronological life span of CR yeast. (A) Outline of 
metabolic flux through the mitochondrial TCA cycle. (B) Survival of chronologically aging WT, idhlA and 
idh2A. (C) The mean life spans of WT, idhlA and idhlA. Data are presented as ± SEM (n = 3-5). Cells 
were cultured in YEP medium containing 0.2% glucose. 
of CR yeast grown on 0.2% glucose (Figure 4.23B), making it very similar to that of CR 
yeast grown on 0.5% glucose (Figure 4.23C). Furthermore, as my hypothesis for a dual 
role of ROS in regulating longevity predicts, the idhlA and idh2A mutations altered the 
age-dependent dynamics of mitochondrial oxygen consumption, ROS production, A*F 
maintenance, and activities of CCO, SDH and ACO. Specifically, in CR yeast entering 
the D phase of growth on 0.2% glucose, both mutations decreased the amplitude of the 
spike in all of these mitochondrial activities (Figure 4.24). Moreover, during PD and ST 
phases, both mutations prevented a sharp decline of all of these activities, maintaining 
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Figure 4.24. The idhlA and idh2A mutations alter the age-dependent dynamics of essential mitochondrial 
processes. The age-dependent dynamics of oxygen consumption (A), mitochondrial membrane potential 
TA (B), intracellular levels of reactive oxygen species (ROS) (C), and enzymatic activities of cytochrome c 
oxidase (CCO) (D), succinate dehydrogenase (SDH) (E) and aconitase (ACO) (F) for WT, idhlA and 
idh2A. The ACO activity was measured with or without the reactivation agents Fe3+ and Na2S. Cells were 
cultured in YEP medium containing 0.2% glucose. 
Noteworthy, the idhlA and idh2A averted the loss of CCO and SDH activities, which 
represent the major mitochondrial targets of oxidative damage by ROS [101, 106] 
(Figures 4.24D and 4.24E). Moreover, both mutations protected mitochondrial ACO 
from inactivation (Figure 4.24F) caused by the oxidation-dependent loss of one iron from 
its Fe/S cluster [240]. It should be stressed that recent studies in Dr. Titorenko's 
laboratory revealed that both mutations increased the abundance of cytosolic and 
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mitochondrial anti-stress chaperones, ROS-decomposing proteins, and proteins that bind 
to mitochondrial DNA and protect it from oxidative damage. Consistent with the elevated 
levels of these proteins, I found that both mutations enhanced heat-shock and oxidative 
stress resistance of chronologically aging CR yeast (Figure 4.25). 
Dayl(L) Day 2(D) Day4(PD) Day 9 (ST) Day 12 (ST) 
Figure 4.25. The idhlA and idh2A mutations enhance stress resistance of CR yeast. Heat-shock and 
oxidative stress resistance of WT, idhlA and idh2A. Cells grown in YEP medium containing 0.2% glucose 
were taken for analyses at the indicated time-points. 
4.5 Discussion 
In a high-throughput screening of several combinatorial chemical libraries that 
Dr. Titorenko's laboratory used to identify novel anti-aging small molecules, the short-
lived pex5A mutant was used as a tester strain. This mutant strain lacks Pex5p, a cytosolic 
shuttling receptor for peroxisomal import of numerous matrix proteins targeted to the 
peroxisome by their carboxyl-terminal PTS1, including Foxlp (Aox) and Fox2p [2, 30]. 
My experiments with one of the novel anti-aging drugs identified by Dr. Titorenko's 
laboratory, a commercially available compound LA, revealed that it extends longevity 
not only of the pex5A mutant but also of wild-type strain cultured under CR conditions. 
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Based on these findings, it was conceivable that LA extends the lifespan of the pex5A 
mutant by somehow by-passing the function of Pex5p in peroxisome biogenesis. 
Furthermore, my findings described in Chapter 3 led to the conclusion that the rate of 
peroxisomal (3-oxidation of fatty acids that originate from stored neutral lipids controls 
the pace of chronological aging under CR conditions. Altogether, these data suggested 
that LA could extend yeast longevity in part by targeting certain processes related to the 
biogenesis and/or function of peroxisomes. To investigate if the ability of the peroxisome 
to oxidize fatty acids {i.e., a Fox-dependent function) or assemble properly (i.e., a Pex-
dependent function) is a requirement for the anti-aging action of LA in chronologically 
aging yeast under CR conditions, I developed a definition of a protein or process that is 
critical for such action of LA (see section 4.4.1 of this chapter). Using my approach for 
defining processes that are critical for the ability of LA to extend longevity of 
chronologically aging yeast, I found - somewhat unexpectedly - that, although fatty acid 
oxidation in peroxisomes is essential for delaying aging or increasing fitness of yeast 
under CR conditions, it is not required for the ability of LA to extend their longevity (see 
section 4.4.1 of this chapter). Furthermore, my analysis of the ability of LA to influence 
the chronological lifespans of the pex5A and pex7A mutant strains provided evidence 
that, although both the Pex5p-dependent peroxisomal import of PTS1-containing proteins 
and Pex7p-dependent peroxisomal import of PTS2-containing proteins are essential for 
delaying aging or increasing fitness of yeast under CR conditions, none of these 
processes is required for the ability of LA to extend their longevity (see section 4.4.2 of 
this chapter). Moreover, my finding that the pex3A mutation - which eliminates a peroxin 
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essential for the formation of peroxisomes from the ER template [125, 224] - does not 
cause a statistically significant reduction or rise of the fold increase of mean 
chronological lifespan by LA implies that the ability to form peroxisomes from the ER 
template is not required for the ability of LA to extend yeast longevity (see section 4.4.3 
of this chapter). Taken together, my findings provide conclusive evidence that the 
presence of peroxisomes in yeast cells is not a requirement for life-span extending ability 
of LA. However, it appeared that at least two peroxins that play an essential role in 
peroxisome biogenesis, namely the AAA ATPases Pexlp and Pex6p, are critical for the 
ability of LA to extend longevity of chronologically aging yeast under CR conditions. 
One of these peroxins, Pexlp, weakens the anti-aging ability of LA so that the absence of 
this protein causes a statistically significant rise of the fold increase of mean 
chronological lifespan by LA (see section 4.4.4 of this chapter). It remains to be 
established how exactly, in molecular terms, Pexlp modulates the ability of LA to extend 
yeast longevity. One could suggest that, in addition to its essential role in peroxisome 
biogenesis, this peroxin controls an age-related process that does not relate to its function 
in the assembly of the peroxisome and is one of the targets of LA. This suggestion seems 
reasonable considering my finding that another AAA ATPase, Pex6p, functions not only 
in peroxisome biogenesis but also in the import of the Atp2p, a P-subunit of FiF0-
ATPase, into mitochondria [228] and - as I revealed - is indispensable for the anti-aging 
ability of LA (see section 4.4.5 of this chapter). Thus, Pex6p not only controls the 
biogenesis of the peroxisome but also modulates - in an LA-dependent fashion - the 
functional state of another cellular organelle, the mitochondrion. It should be stressed that 
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my conclusion that the critical roles of the peroxins Pexlp and Pex6p in the anti-aging 
ability of LA do not relate to their function in peroxisome biogenesis further support a 
concept [38] that some peroxins are bifunctional proteins controlling not only 
peroxisomal functions but also vital cellular processes unrelated to peroxisome assembly 
and maintenance. 
Based on the essential role of Pexlp in modulating - in an LA-dependent fashion -
the aging-related functional state of the mitochondrion and taking into consideration my 
observation that LA alters the age-dependent dynamics of several mitochondrial activities 
in CR yeast, including oxygen consumption, mitochondrial membrane potential (A^F) and 
ROS generation (see section 4.4.6 of this chapter), I hypothesize that one of the 
mechanisms by which mitochondria regulate yeast longevity is based on the LA-
dependent ability of mitochondria in aging yeast to maintain ROS homeostasis. In 
particular, I propose that ROS, which are mostly generated as by-products of 
mitochondrial respiration [229, 230], play a dual role in regulating longevity. First, if 
yeast mitochondria are unable - due to a dietary regimen (see Chapter 3) or unavailability 
of LA - to maintain ROS concentration below a critically high level, ROS promote aging 
by oxidatively damaging certain mitochondrial proteins (such as CCO, SDH and ACO; 
see Chapter 3). Second, if yeast mitochondria can - due to a dietary regimen (see Chapter 
3) or availability of LA - maintain ROS concentration at an "optimal" level, ROS delay 
aging. While this "optimal" level of ROS is insufficient to damage cellular 
macromolecules, it can activate certain signaling networks [101, 229, 231 - 235] that 
extend life span by increasing the abundance or activity of stress-protecting and other 
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anti-aging proteins. Two lines of evidence described in this chapter support my 
hypothesis for a dual role of ROS in regulating longevity. First, my analysis of the age-
dependent dynamics of changes in the levels of ROS in cells of Afox and Apex mutants 
exposed to LA provides evidence that LA extends the chronological lifespan of CR yeast 
by: (1) reducing the damaging effect of ROS on cellular macromolecules during L, D and 
PD growth phases; and (2) amplifying the "hormetic" effect of ROS during ST growth 
phase (i.e., in senescent yeast cells) through the activation of stress-protecting and other 
anti-aging proteins (see section 4.4.7 of this chapter). Second, my analysis of yeast strains 
carrying mutations eliminating either the Idhlp or the Idh2p subunit of isocitrate 
dehydrogenase - the two redundant components of the mitochondrial TCA cycle -
revealed that, in agreement with hypothesis, both mutations: (1) extend the chronological 
lifespan of CR yeast; (2) alter the age-dependent dynamics of mitochondrial oxygen 
consumption, ROS production, A*F maintenance, and activities of CCO, SDH and ACO; 
(3) avert the loss of CCO and SDH activities, which represent the major mitochondrial 
targets of oxidative damage by ROS [101, 106]; (4) protect mitochondrial ACO from 
inactivation, which is known to be caused by the oxidation-dependent loss of one iron 
from its Fe/S cluster [240]; and (5) enhance heat-shock and oxidative stress resistance of 
chronologically aging CR yeast (see section 4.4.8 of this chapter). 
4.6 Conclusions 
Altogether, my findings described in this chapter led to the following conclusions. 
First, although the ability of the peroxisome to oxidize fatty acids (i.e., a Fox-dependent 
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function) or assemble properly (i.e., a Pex-dependent function) is essential for delaying 
aging or increasing fitness of yeast under CR conditions, it is not a requirement for the 
anti-aging action of LA. My data provide the comprehensive evidence that the presence 
of peroxisomes in yeast cells is not required for life-span extending ability of LA. 
Second, at least two peroxins that play an essential role in peroxisome biogenesis, namely 
the AAA ATPases Pexlp and Pex6p, are critical for the ability of LA to extend yeast 
longevity under CR conditions. The ability of one of these peroxins, the AAA ATPase 
Pexlp, to weaken the anti-aging effect of LA does not relate to its essential role in the 
assembly of a functional peroxisome. Another AAA ATPase, Pex6p, which functions not 
only in peroxisome biogenesis but also in mitochondrial import of the P-subunit of FiF0-
ATPase, is indispensable for the anti-aging ability of LA. It seems that the essential role 
of Pex6p in mediating the longevity-extending effect of LA relates to its involvement in 
the biogenesis of mitochondria, not peroxisomes. Thus, some peroxins are bifunctional 
proteins controlling not only peroxisomal functions but also vital cellular processes that 
do not relate to peroxisome assembly and maintenance and are targeted by the anti-aging 
drug LA. Third, mitochondrially produced ROS play a dual role in regulating longevity. 
If yeast mitochondria are unable - due to a dietary regimen, unavailability of LA or 
genotype - to maintain ROS concentration below a critically high level, ROS promote 
aging by oxidatively damaging its mitochondrial target proteins (such as CCO, SDH and 
ACO). Conversely, if yeast mitochondria can - due to a dietary regimen, availability of 
LA or genotype - maintain ROS concentration at an "optimal" level, ROS delay aging. 
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While this "optimal" level of ROS is insufficient to damage cellular macromolecules, it 
can activate certain signaling networks that extend lifespan by increasing the abundance 
or activity of stress-protecting and other anti-aging proteins. 
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5 Conclusions and suggestions for future work 
5.1 General conclusions 
5.1.1 Aox controls a multistep process of peroxisome division 
Altogether, my findings reported in Chapter 2 suggest the following model for 
peroxisome division in Y. lipolytica (Figure 5.1). In immature peroxisomal vesicles PI to 
P5, Pexl6p binds LPA in the lumenal leaflet of the peroxisomal membrane. The binding 
of Pexl6p to LPA prevents the biosynthesis of PA and DAG in a two-step pathway, 
which includes two consecutive enzymatic reactions catalyzed by Slclp (LP A AT) and 
Dpplp (PAP). The stepwise import of distinct subsets of matrix proteins into immature 
peroxisomal vesicles PI to P5 provides them with an increasing fraction of the matrix 
proteins present in mature peroxisomes. The increase in the total mass of matrix proteins 
above a critical level, which occurs only inside mature peroxisomes, causes the 
redistribution of Aox from the matrix to the membrane and its subsequent binding to 
Pexl6p. This, in turn, greatly decreases the affinity between Pexl6p and LPA, thereby 
allowing LPA to enter the two-step biosynthetic pathway leading to the formation of PA 
and DAG. The glycerophospholipid PC, which is transferred to the peroxisomal 
membrane from the P3- and P4-associated subcompartment of the ER, activates both 
LPAAT and PAP. The resulting accumulation of PA and DAG in the lumenal leaflet of 
the membrane of mature peroxisomes triggers a cascade of events ultimately leading to 
peroxisome division. This cascade of events is initiated by the spontaneous flipping of 
DAG, which is known for its very fast transbilayer translocation, between the two 
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Figure 5.1. The Pexl6p- and Aox-dependent intraperoxisomal signaling cascade drives the division of 
mature peroxisomes P6 by promoting the stepwise remodeling of lipid and protein composition of the 
peroxisomal membrane. See Discussion for details. 
membrane leaflets. The movement of DAG, a particularly potent cone-shaped inducer of 
membrane bending, from the lumenal to the cytosolic leaflet of the membrane bilayer 
coincides with the translocation of the glycerophospholipid PS in the opposite direction. 
This bi-directional movement of DAG and PS generates a lipid imbalance across the 
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bilayer, which may promote the destabilization and bending of the membrane. The 
biosynthesis of PA and DAG in the membrane of mature peroxisomes and, perhaps, the 
bending of the membrane due to the bi-directional transbilayer movement of DAG and 
PS promote the docking of the Vpslp-Slalp-Abplp complex to the surface of mature 
peroxisomes. This pre-assembled in the cytosol protein complex binds to mature 
peroxisomes by interacting with the peroxin Pexl9p. Pexl9p is a component of the 
Pexl0p-Pexl9p complex that is formed in the peroxisomal membrane during the earliest 
steps of peroxisome assembly. After its attachment to the peroxisomal membrane, the 
Vpslp-Slalp-Abplp complex interacts with Actlp, thereby recruiting this structural 
constituent of actin cytoskeleton to the surface of mature peroxisomes. The subsequent 
fission of the peroxisomal membrane leads to peroxisome division. 
5.1.2 CR extends yeast lifespan by modulating the Aox-dependent fatty acid 
oxidation in peroxisomes 
Taken together, my findings described in Chapter 3 led to the following 
conclusions. First, peroxisomes do not produce significant quantities of ROS in 
chronologically aging CR yeast. Second, ROS that are produced in peroxisomes during 
fatty acid oxidation are not essential for chronological aging of yeast placed on a CR diet. 
Third, both the formation of free fatty acids due to lipolysis of LB-deposited neutral 
lipids and their subsequent Foxlp (Aox)-, Fox2p- and Fox3p-dependent peroxisomal 
oxidation are mandatory for the observed extension of lifespan by CR. Fourth, by the 
beginning of PD phase, CR yeast synthesize the bulk of their ATP in mitochondria by 
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oxidizing the pool of acetyl-CoA that has been generated in peroxisomes via Foxlp 
(Aox)-, Fox2p- and Fox3p-dependent fatty acid oxidation. I therefore concluded that fatty 
acid oxidation in peroxisomes controls longevity by modulating the rate of ATP synthesis 
in mitochondria, but not by generating the ROS hydrogen peroxide. Finally, my findings 
led to the conclusion that the efficiency of acetyl-CoA formation via peroxisomal fatty 
acid oxidation modulates: (1) the efficiencies of electron flow through the mitochondrial 
electron transport chain; (2) activities of several well-known target enzymes for the 
oxidative damage by ROS (i.e., cytochrome c oxidase, succinate dehydrogenase and 
aconitase); (3) the mitochondrial membrane potential (AT); and (4) a balance between 
the processes of mitochondrial fission, fusion and tubulation, which plays a pivotal role 
in establishing and maintaining the morphological appearance of mitochondria. 
5.1.3 A novel anti-aging small molecule LA extends yeast longevity by modulating 
mitochondrial ROS production in a Pexlp- and Pex6p-dependent fashion 
Altogether, my findings reported in Chapter 4 led to the following conclusions. 
First, although the ability of the peroxisome to oxidize fatty acids (i.e., a Fox-dependent 
function) or assemble properly (i.e., a Pex-dependent function) is essential for delaying 
aging or increasing fitness of yeast under CR conditions, it is not a requirement for the 
anti-aging action of LA. My data provide the comprehensive evidence that the presence 
of peroxisomes in yeast cells is not required for life-span extending ability of LA. 
Second, at least two peroxins that play an essential role in peroxisome biogenesis, namely 
the AAA ATPases Pexlp and Pex6p, are critical for the ability of LA to extend yeast 
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longevity under CR conditions. The ability of one of these peroxins, the AAA ATPase 
Pexlp, to weaken the anti-aging effect of LA does not relate to its essential role in the 
assembly of a functional peroxisome. Another AAA ATPase, Pex6p, which functions not 
only in peroxisome biogenesis but also in mitochondrial import of the P-subunit of F1F0-
ATPase, is indispensable for the anti-aging ability of LA. It seems that the essential role 
of Pex6p in mediating the longevity-extending effect of LA relates to its involvement in 
the biogenesis of mitochondria, not peroxisomes. Thus, some peroxins are bifunctional 
proteins controlling not only peroxisomal functions but also vital cellular processes that 
do not relate to peroxisome assembly and maintenance and are targeted by the anti-aging 
drug LA. Third, mitochondrially produced ROS play a dual role in regulating longevity. 
If yeast mitochondria are unable - due to a dietary regimen, unavailability of LA or 
genotype - to maintain ROS concentration below a critically high level, ROS promote 
aging by oxidatively damaging its mitochondrial target proteins (such as CCO, SDH and 
ACO). Conversely, if yeast mitochondria can - due to a dietary regimen, availability of 
LA or genotype - maintain ROS concentration at an "optimal" level, ROS delay aging. 
While this "optimal" level of ROS is insufficient to damage cellular macromolecules, it 
can activate certain signaling networks that extend lifespan by increasing the abundance 
or activity of stress-protecting and other anti-aging proteins. 
5.2 Suggestions for future work 
In my model for peroxisome division (Figure 5.1), the movement of DAG, which 
is synthesized in the inner leaflet of the membrane, into the outer leaflet of the membrane 
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in mature peroxisomes promotes their division. It is tempting to speculate that, after its 
spontaneous flipping between the two membrane leaflets, DAG undergoes the selective 
enrichment in distinct lipid domains that facilitate membrane scission through 
coordinated changes in local membrane curvature. To test this hypothesis, one would use 
fluorescence microscopy (FM) and immunoelectron microscopy (IEM) to monitor DAG 
in the outer leaflet of the membranes of different peroxisomal forms. I have used the 
DAG-binding Clb domain of protein kinase C for monitoring the dynamics of changes in 
the transbilayer distribution of DAG in the peroxisomal membrane during peroxisome 
maturation [51]. Clb would be produced, purified and labeled with the fluorophore Alexa 
Fluor 488 as described in the "Materials and methods" chapter. In addition, one would 
raise antibodies specific for Clb and use them for monitoring DAG in the membrane by 
IEM. Furthermore, one would use FM and IEM to visualize membrane lipids other than 
DAG. The following lipid-specific probes would be used for microscopy: 1) a tandem 
FYVE domain that specifically binds PI(3)P [167, 241]; 2) MED [242] and ENTH [243] 
domains specific for PI(4,5)P2 [244]; 3) the intrinsically fluorescent ergosterol ligand 
filipin and a biotinylated derivative of the sterol-binding ligand perfringolysin O [245, 
246]; 4) the PS-specific antibodies [45] and fluorescent sensor PSS-380 [247]; and 5) 
antibodies to ceramide [45]. The presence and spatial distribution of DAG and other lipid 
species in the outer leaflet of the peroxisomal membrane would be microscopically 
monitored in intact immature peroxisomal vesicles and mature peroxisomes. These 
organelles would be purified from wild-type cells and from aoxlA to aoxSA and PEX16-
TH mutant cells. Furthermore, using lipid-specific fluorescent probes, one would use the 
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established procedure for evaluating the arrangement of DAG and other lipid species 
between the two leaflets of the membrane bilayers in different peroxisomal subforms of 
the mutant strains aox4A, aox5A, PEX16-TH, slclA, dpplA, vpslA, slalA and abplA, all 
of which are deficient in peroxisome division (please see a detailed description of the 
procedure in the "Materials and methods" chapter). 
My data imply that the Pex2p-dependent transfer of PC from the P3- and P4-
associated ER subcompartment to the acceptor membranes of P3 and P4 provides these 
peroxisomal membranes with the bulk quantities of PC and is essential for the conversion 
of P4 to P5 (see Chapter 2). A distinct set of proteins associated only with the P3- and 
P4-bound ER subcompartment but not with the free form of the ER (see Chapter 2) may 
operate in the transfer of PC from the ER subcompartment to the membranes of P3 and 
P4 peroxisomes via membrane contact sites. These proteins would be analyzed by mass 
spectrometry and identified by database searching as described in the "Materials and 
methods" chapter. My data on mass spectrometric identification of proteins associated 
only with the P3- and P4-bound ER subcompartment would be then used to disrupt the 
encoding genes. The effects of knocking out these genes on the efficiency of delivery of 
PC to the membranes of different peroxisomal subforms in vivo would be determined. 
My findings provided evidence that the targeting of the dynamin-like protein 
Vpslp, which is essential for peroxisome division in this yeast, to the cytosolic face of 
mature peroxisomes from Y. lipolytica relies on the Pexl6p/Aox-dependent biosynthesis 
of PA and/or DAG in their membranes (see Chapter 2). In order to elucidate the role of 
various species of membrane lipids in the recruitment of Vpslp to the cytosolic face of 
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mature peroxisomes, one would monitor the efficiency of the binding of Vpslp to the 
outer face of liposomes reconstituted (as described in the "Materials and methods" 
chapter) with different quantities of DAG and other lipid species, including PA and PC, 
that, similar to DAG, regulate peroxisome division. To test whether Vpslp co-localizes 
with DAG and/or any other "regulatory lipid" in the outer leaflet of the membrane of 
mature peroxisomes, the wild-type strain and mutant strains deficient in peroxisome 
division, as well as P6 peroxisomes purified from these strains, would be analyzed by 
FM, IFM and IEM. Samples will be processed for double labelling with anti-Vpslp 
antibodies and with lipid-specific probes for monitoring the distribution of DAG, PI(3)P, 
PI(4,5)P2, ergosterol, PS and ceramide as described above. 
My findings provided evidence that ROS, which are mostly generated as by-
products of mitochondrial respiration, play a dual role in regulating longevity (see 
Chapters 3 and 4). First, if yeast mitochondria are unable - due to a dietary regimen, 
unavailability of LA or genotype - to maintain ROS concentration below a critically high 
level, ROS promote aging by oxidatively damaging certain mitochondrial proteins (such 
as CCO, SDH and ACO). Second, if yeast mitochondria can - due to a dietary regimen, 
availability of LA or genotype - maintain ROS concentration at an "optimal" level, ROS 
delay aging. This "optimal" level of ROS is insufficient to damage cellular 
macromolecules but can activate certain signaling networks that extend life span by 
increasing the abundance or activity of stress-protecting and other anti-aging proteins 
(see Chapters 3 and 4). To further evaluate the validity of my hypothesis for a dual role of 
ROS in regulating longevity, one would first change the levels of ROS accumulated in 
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CR yeast at different stages of the aging process by using genetic manipulations that alter 
the abundance of various antioxidant enzymes involved in the major ROS scavenging 
pathways. The abundance of the following ROS scavenging enzymes would be altered 
(Figure 5.2): 1) cytosolic (Sodlp) and mitochondrial (Sod2p) superoxide dismutases; 2) 
cytosolic (Cttlp) and peroxisomal (Ctalp) catalases; 3) mitochondrial cytochrome-c 
peroxidase (Ccplp); 4) mitochondrial thioredoxin (Trx3p) and thioredoxin reductase 
(Trr2p); 5) cytosolic thioredoxins 1 (Trxlp) and 2 (Trx2p), thioredoxin peroxidases 1 
(Tsalp) and 2 (Tsa2p), and thioredoxin reductase (Trrlp); and 6) glutathione peroxidases 
1 (Gpxlp) and 2 (Gpx2p). Two sets of mutant strains would be used in these 
experiments. One set would include mutants that lack each of the aforementioned 
enzymes, whereas the other set would include mutants that overproduce each of them 
under the control of a strong promoter. Mutant strains would be grown in medium 
containing 0.2% glucose plus LA. Concurrently with the assessment of the effect of LA 
on the life span of each of these mutants, one would measure ROS (visualized by 
fluorescence microscopy as described in "Materials and methods") accumulated in their 
cells at different stages of the aging process. Will genetic manipulations that increase 
ROS concentration in late ST phase above a certain "optimal" level or decrease it below 
such level annul the anti-aging effect of LA? Will genetic manipulations that further 
decrease the amplitude of the spike in ROS concentration during D phase enhance the 
beneficial effect of LA on longevity? 
As a further test of the validity of my hypothesis, one would use mass 
spectrometry-based quantitative proteomics to examine the effect of LA on the age-
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Figure 5.2. ROS scavenging enzymes of the yeast S. cerevisiae. 
related dynamics of changes in cellular and mitochondrial proteomes taking place in 
aging CR yeast. Will LA - perhaps, due to its ability to modulate the level of 
mitochondrially produced ROS - increase the abundance of cytosolic and mitochondrial 
anti-stress chaperones, ROS-decomposing proteins, and proteins that protect mtDNA 
from oxidative damage? Will the observed effect of LA on cellular and mitochondrial 
proteomes be reminiscent of that seen in the long-lived idhlA and idh2A mutants 
(unpublished data from Dr. Titorenko's laboratory)? Of note, both these mutants exhibit 
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the age-dependent dynamics of ROS that is similar to that observed in WT cells 
chronically exposed to LA (see Chapter 4). It is conceivable that the altered abundance of 
many stress-protecting proteins seen in the long-lived idhlA and idhlA mutants (and, 
based on the protective effect of LA on CR yeast exposed to chronic oxidative stress, is 
likely to be also observed in LA-treated WT cells) could be due to the global change in 
transcription of genes encoding these proteins. Therefore, as a step towards defining 
signaling pathways and downstream transcriptional networks through which the LA-
dependent modulation of ROS levels could extend longevity, one would compare age-
related transcriptional profiles between LA-treated and untreated yeast. Using DNA 
microarrays, one would examine age-related changes in gene expression during aging of 
WT cells grown in medium containing 0.2% glucose alone or 0.2% glucose plus LA. 
Cells would be taken at different stages of the aging process. It should be stressed that the 
genome-wide transcriptional profiles of yeast mutants that lack transcription factors 
regulating gene expression in response to various stresses (including oxidative stress) 
have been established and annotated [248 - 250]. Thus, the global analysis of gene 
expression changes caused by LA could help to identify transcription factors that 
orchestrate a distinct genomic expression program in response to LA-dependent 
modulation of ROS levels. 
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